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Abstract 
Plague is a notifiable disease caused by Yersinia pestis for which there is still no reliable 
vaccine available. The fraction 1 (F1) antigen forms an immunogenic capsule around the cell 
surface that decreases efficiency of phagocytosis. Many E. coli strains and other Gram-
negative bacteria coat themselves in similar, remarkably stable protein fibres assembled via 
specific, dedicated chaperone-usher (CU) pathways. Fibres are assembled through a pore 
within each usher protein, via a cycling of specific chaperone:subunit:usher interactions 
leading to subunit polymerisation and translocation to the cell surface. This project has used 
bioinformatics analysis and modelling to improve understanding of details of the Y. pestis F1 
chaperone:usher translocon and has applied this knowledge to enhance export of 
heterologous epitopes. The number of members of the γ3 family of ushers, which assemble 
simple fibres of one or two subunits, has been expanded and includes for the first time a CU 
system more closely related to that of the Yersinia Caf system. This plasmid encoded usher 
from the commensal E. coli SE11 shares 70% identity with Caf1A. Caf1A usher was 
modelled using Intfold and ITASSER, based on the crystal structures of E. coli FimD and 
PapC usher in the closed state (PDB: 2VQI, 3.2Å). The complete Caf translocon was 
modelled based on the open FimD structure (PDB: 3RFZ, 2.8Å) with the Caf1M 
chaperone:Caf1:Caf1 subunit structure (PDB:1Z9S, 2.2Å) docked in the translocon. Based 
on the modelled Caf translocon and multiple sequence alignments of related ushers, 
conserved residues within the β-barrel facing the pore cavity or subunit; residues interacting 
between the plug and β-barrel in the closed pore and residues interacting between β-barrel 
and subunit in the ‘open’ translocating pores were identified. These were then tested by 
mutagenesis for impact on F1 assembly. No single point mutation within the usher abolished 
F1 assembly. The most profound effect was following mutation of Ser289 to Ala, the level 
of surface F1 decreased to 70.81% ± 3.0 of levels with wildtype Caf1A. The potential of F1 
fibre to act as a carrier of epitopes was tested by replacing 4 loops within Caf1 with either 
Gly residues or charged residues. The model was used to understand and optimise limitations 
in export of modified fibres. One permissive site (loop 5) was identified as the optimum site 
for loop replacement and surface assembly of modified F1 was enhanced by mutation of a 
clashing Gln in the β-barrel wall. In addition, the study identified a critical role for a 
conserved Asn, Asn80, within loop 2 of Caf1 subunit that was modelled interacting with 
Tyr266 in the plug.   The permissive loop 5 was also adapted to export a polyhistidine 
sequence. While 4 His residues were readily accommodated, F1::1His6 conferred toxicity, 
although there was still evidence of surface polymer. Thus, this study demonstrated flexibility 
of the F1 CU pathway for surface display of short peptides and the ability to use the 
translocon model to identify problem areas and repair export. As F1 is considered to be 
unique to Y. pestis, the presence of a Caf related CU locus in a commensal E. coli was of 
interest to understanding its phylogenetic relationship to F1 and also in diagnostic 
applications in plague detection. Bioinformatic analysis and recombinant expression of the 
E. coli SE11-P2 CU locus, combined with mass spectrometry analysis, confirmed surface 
assembly of polymers of both subunits from this locus. A purification strategy for isolation 
of recombinant SE11-P2 polymers was developed. Purified protein will be used in future 
studies to raise antibody for further study of this CU system and to test for any cross-reaction 
with Y. pestis F1 antigen, that might potentially interfere with serological tests for Y. pestis.  
F1 antigen remains a component of interest in both anti-plague vaccine design and plague 
detection. Results from this study have potential to improve reliability of both approaches to 
plague control.    
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1.1 Yersinia pestis 
1.1.1 Overview of Yersinia pestis 
Yersinia pestis is a gram-negative coccobacillus bacteria. It is non-motile and 
facultatively anaerobic. It exists as a single organism or in short chains that can infect humans 
and animals; it causes the plague. AlexandreYersin and Shibasaburo Kitasato first described 
Y. pestis as the causative agent of plague during the Hong Kong epidemic in 1894. Alexandre 
Yersin extracted the fluid of enlarged lymph nodes from people who had died of the plague 
and injected into guinea pigs, which subsequently died. Organs of the guinea pigs were also 
infected with the same bacteria. He then discovered that the same microorganism infects both 
rats and humans causing the plague. The bacterium was subsequently named Yersinia pestis 
in honour of Yersin’s initial accurate observations and detailed  study (Bendiner, 1989; 
Rollins et al., 2003). 
Y. pseudotuberculosis is the most closely related bacterium to Y. pestis where they 
share more than 97% nucleotide identity in approximately 75% of their genes (Achtman et 
al., 1999; Skurnik et al., 2000). It was estimated that Y. pestis emerged from Y. 
pseudotuberculosis  as recently as the 14th century  (Bos et al., 2011; Parkhill et al., 2001). 
However, a paper published in 2015 reported that Y. pestis causes plague emerged from less 
phatogenic Y. pestis that was discovered from the teeth of Bronze Age humans originated 
around 5000 years ago. This less pathogenic Y. pestis does not cause bubonic plague because 
the lack of the murine toxin required for growth of this bacteria in flea gut, however, it is able 
to cause septicemic and pneumonic plague (Rasmussen et al., 2015). 
 
 22 
 
1.1.2 Plague 
There have been 3 major pandemics of plague; The Justinian plague, Black Death 
and the most recent pandemic called Modern plague. The Justinian plague began in the 
541 AD. It was spread across trade routes around the Mediterranean Sea and causes death 
between 50% and 60% of population in North Africa, Europe and central and South Asia  
(Perry and Fetherston, 1997; Inglesby et al., 2000; Ligon, 2006). The Justinian plague 
took place in early 1330s, originated from China and spreading to Europe through trade 
routes. This pandemic killed around 60% of the European population  (Inglesby et al., 
2000; Slack, 1989). In 1855, the modern plague arose from China and spread to Asia, 
Africa and America, carried by rats that travelled on steamships, and killed over 13 
million people (Darling et al., 2002; Stenseth et al., 2008; Keim and Wagner, 2009). In 
total, it is estimated that nearly 200 million people were killed in these three great 
pandemics (Perry and Fetherston, 1997). In the 21st century approximately 4000 plague 
cases are reported annually worldwide (Stenseth et al., 2008). 
People usually contract plague from being bitten by a rodent flea that is carrying Y. 
pestis or by handling the dead rodent. There are many species of fleas that can be the vectors 
of plague, but the most effective vector is the oriental rat flea, the Xenopsylla cheopis (Titball 
and Williamson, 2001). The initial step in infection is that the flea ingests Y. pestis from the 
rodent host. Then, Y. pestis multiplies in the flea gut. The ingested blood clots lay in the 
proventriculus. The haemin storage locus (hms) helps Y. pestis to colonise the proventriculus 
and the flea is unable to move food from its esophagus to the mid gut (Darby et al., 2002). 
Consequently, the flea eats more aggressively and regurgitates the infected blood into the 
dermis of the mammal on which it is feeding, in this case human. During this process, 
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approximately 25,000 to 100,000 Y. pestis are inoculated into the skin of the mammal host 
(Raoult et al., 2013; Rollins et al., 2003).  
When a human is bitten by an infected flea or gets infected by handling animal 
tissues, this causes bubonic plague. This is the most common form of plague. Y. pestis 
then multiplies in the lymphatic system and causes the lymph nodes to swell, known as 
bubo. The incubation period of bubonic plague is between 2-6 days and if left untreated, 
it can have a 40% to 70% mortality rate and mortality reduces to 10% with antibiotic 
treatment (Prentice and Rahalison, 2007; Rollins et al., 2003; Rosenzweig et al., 2011; 
Stenseth et al., 2008).  
Septicemic plague may develop from bubonic plague where the bacteria access 
the liver and spleen through the blood stream. The bacteria then replicates and spreads to 
other organs causing septicaemia and death by multiple organ failure (Sun et al., 2011). 
It also can occur without a bubo where the bacteria replicate in other tissues and enter the 
blood stream. The symptoms of septicemic plague begin approximately between 1-4 days 
after infection by Y. pestis. The mortality rate can be reduced with immediate antibiotic 
treatment, but humans infected by this type of plague generally die if left untreated 
(Stenseth et al., 2008; Rollins et al., 2003; Prentice and Rahalison, 2007).  
The third form of plague is pneumonic plague which can be spread through 
inhalation. Y. pestis invades the lungs and results in person to person transmission via air 
droplets. Pneumonic plague can also develop following initial bubonic or septicemic 
plague and then spread to the lungs. This form of plague is the most dangerous with 
nearly 100% mortality and death in 18 to 24 hours if left untreated (Prentice and 
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Rahalison, 2007; Hatkoff et al., 2012). However, the mortality can be reduced to 15% by 
streptomycin or gentamycin within 24 to 36 hours of infection (Rosenzweig et al., 2011). 
Despite its ability to cause natural infection, Y. pestis is also classified as category 
a A biological weapon. In the 14th century, Tatar Forces used plague victims and 
catapulted them to Kaffar (now known as Feodosia, Ukraine). Then, Japanese forces used 
plague-infected fleas and released it from aircraft over Chinese cities during World War 
II and the most recent case of use in bioterrorism was a man from Ohio who was 
connected to an extremist group and who tried to obtained Y. pestis from the American 
Type Culture collection (Mierzwa, 1975; Atlas, 1998; Sun et al., 2011). Y. pestis can be 
easily obtained from animal reservoirs making it an important bioterrorism threat (Perry 
and Fetherston, 1997). 
1.1.3 Virulence Factors of Y. pestis 
The first complete Y. pestis genome was sequenced in 2001 from Y. pestis strain 
CO92 (Parkhill et al., 2001). This bacterium possesses a 4.65 Mb chromosome and three 
plasmids of 100 kb, 70.3 kb and 9.6 kb. The 70.3 kb plasmid known as pYV or pCD1 is a 
common virulence plasmid throughout pathogenic Yersinia, therefore it is not species 
specific. On the other hand, Y. pestis has acquired two plasmids (pPCP1 and pMT1) that 
encode a range of virulence determinants making it unique (Parkhill et al., 2001). The 
common low calcium response pYV virulence plasmid encodes a type 3 secretion system 
(T3SS), that forms a needle like injectisome. This structure mediates transport of Yersinia 
outer proteins (Yops) directly into host cells where they modulate the host immune response, 
blocking phagocytosis, and triggering host cell death (Hatkoff et al., 2012). It also encodes 
V antigen (LcrV), a major protective immunogen that forms the tip of the needle (Brubaker, 
2003). V antigen also upregulates interleukin-10 (IL-10) and at the same time downregulates 
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tumor necrosis factor-alpha (TNFα) causing anti-inflammatory mechanisms and 
downregulates interferon-gamma (IFNγ) causing immunosuppression (Brubaker, 2003). 
Expression of these proteinsis temperature regulated, with expression at 37ºC with a low 
calcium concentration. In a study using a rat model, infection with pYV negative strains of Y 
pestis led to more polymorphonuclear leucocytes (PMNs) with fewer bacteria in bubos 
compared to wildtype pYV. This support the  earlier evidence  that pYV suppresses the  PMN 
response (Chanteau et al., 2003).  
The smaller unique plasmid (9.6 kb) is the pPst plasmid, also known as pPCP1. This 
plasmid encodes the plasminogen activator, Pla which plays a role in dissemination of Y. 
pestis by lysing fibrin clots and releases the bacteria to peripheral organs. This process takes 
place at 37ºC. Pla is also known as a key virulence factor for bubonic and pneumonic plague 
(Parkhill et al., 2001; Rosenzweig et al., 2011). It also reduces attraction of leukocytes to 
infected site by cleaving central complement component system (C3) (Lathem et al., 2005). 
The pH6 antigen (PsaA) expresses from chromosomal locus under regulation of RovA  which 
plays a role as antiphagocytic. It expresses at 37ºC in acidic medium, has function similar to 
F1 except it acts independently of F1 to resist phagocytosis by mouse and human macrophage 
(Huang and Lindler, 2004). Other virulence factors that are important are the non-fimbrial 
adhesins from yadBC operon that allow bacteria to adhere to epithelial cells and macrophages 
(Forman et al., 2008), lipopolysaccharide and lipoprotein that acts together to cause septic 
shock (Sha et al., 2008; Knirel et al., 2006).  
The second unique plasmid is known as pFra or pMT1 (Cherepanov et al., 1991; 
Protsenko et al., 1983; Parkhill et al., 2001). The size of the plasmid is variable between 
strains. In Y. pestis C092 (Parkhill et al., 2001), the size is 96.2 kb and 100.9 kb in Y. pestis 
KIM (Deng et al., 2002). This plasmid encodes two renowned virulence factors which are 
murine toxin that has phospholipase D activity and fraction 1 (F1) capsular antigen. Y. pestis 
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needs phospholipase D as it helps the bacteria to multiply and survive in flea midgut 
(Hinnebusch et al., 2002). The F1 capsule has been shown to prevent adhesion-receptor 
interactions thus reduces the ability of monocytes, macrophages and dendritic cells to take 
up bacteria cells. The F1 antigen is expressed at 37°C that allows the bacteria to multiply 
while resisting phagocytosis (Du et al., 2002; Hatkoff et al., 2012).  
Table 1.1: Virulence factors of Yersinia pestis (adapted from (Butler, 2009)) 
Product Role 
Type III secretion system (T3SS) 
(pYV or pCD1)  
Insertion of Yops through a needlelike 
injectisome into neutrophils, macrophages 
and dendritic cells (Marketon et al., 2005).  
V antigen (LcrV) 
(pYV or pCD1)  
Anti-inflammatory activity through 
interleukin 10 secretion and form tip of type 
III secretion system (Brubaker, 2003; 
Mueller et al., 2005).  
Yersinia outer proteins (Yops)  
(pYV or pCD1)  
Inhibit phagocytosis, platelet aggregation 
and cytokine production (Pouliot et al., 
2007; Zhou et al., 2005).  
Fraction 1 capsular antigen (F1) 
(pFra or pMT1)  
Inhibition of phagocytosis (Du et al., 2002).  
Murine toxin  
(pFra or pMT1)  
Survival of bacteria in flea gut (Hinnebusch 
et al., 2002).  
Plasminogen activator (Pla) 
(pPst or pPCP1)  
Activation of host plasminogen to plasmin 
for lysis of clots; cleavage of extracellular 
matrix to promote bacterial spread and 
bacterial multiplication in lung (Lathem et 
al., 2005).  
Hemin storage  
(Chromosomal pigmentation locus (pgm))  
Formation of obstructive biofilm in flea gut 
(Carniel, 1999).  
Yersinia bactin  
(Chromosomal pigmentation locus (pgm))  
Siderophore for iron transport (Huang and 
Lindler, 2004).  
pH6 antigen  
(Chromosomal locus under regulation of RovA)  
Inhibition of phagocytosis (Cathelyn et al., 
2006; Huang and Lindler, 2004).  
Outer membrane  
(Chromosomal locus for Ail proteins)  
Resistance to complement-mediated killing 
(Bartra et al., 2008).  
Lipopolysaccharide  
(Chromosomal locus for cell wall synthesis)  
Initiation of inflammatory responses leading 
to septic shock, also for anti-inflammatory 
no stimulation of Toll-like receptor 4 (Li 
and Yang, 2008).  
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1.2 Significance of F1 antigen in diagnosis and vaccination 
According to the World Health Organisation (WHO), recent plague outbreak 
reported in Madagascar in September 2014 resulted in 27% fatality rate (71 deaths) out 
of 263 cases. In July 2014, a plague case was reported in China where a man died of 
bubonic plague and 30,000 residents of Yumen city were quarantined from the outside 
world. In 2013, a plague outbreak was reported in Madagascar with 84 plague cases and 
32 deaths. In 2012, there were 256 cases of plague and 60 deaths reported in Madagascar. 
In 2010, it was confirmed that 17 people were infected with plague in Peru. Out of 17 
cases, 4 were pneumonic, 12 were septicemic and one bubonic (World Health 
Organization, 2013). The emerging of plague cases every year, the potential for rapid 
spread of the disease through air, and classification of plague as a category A biological 
weapon means that it remains a big problem and that it is very important to prevent and 
to treat the disease.   
A few diagnostic methods are used to detect Y. pestis in clinical specimens. Since 
the discovery of the bacteria in Hong Kong, the microrganism was isolated and cultured 
from bubo aspirates, blood or sputum specimen. This method is sensitive to detect the 
bacteria however it takes 2-3 days for identification. The other method is to gram stain or 
Wayson stain blood from the bubo aspirate. This diagnostic is rapid but with moderate 
sensitivity (Butler, 2009). For rapid diagnostic, PCR (Rahalison et al., 2000) and ELISA 
(Chanteau et al., 2000) tend to be used for detection of Y. pestis from bubo aspirates with 
sensitivity of moderate and high respectively. Real-time PCR is also used for rapid and 
specific test for plague diagnosis. In one study, bacteraemia in blood culture counts from 
patient with bubonic plague ranged from 10-4 - 107 cfu/mL (Perry and Fetherston, 1997) 
and real-time PCR with a probe for F1 antigen can detect 102-104 cfu/mL in less than 5 
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hours, which is very sensitive (Loiez et al., 2003).  Probe for detection of 16S RNA can 
give the results in less than 3 hours (Tomaso et al., 2003). A rapid diagnostic test (RDT) 
dipstick was developed for use ‘at the bedside’. It was trialled  in Madagascar and shown 
to detect F1 antigen at a concentration as low as 0.5 ng/mL (Chanteau et al., 2003). 
Efficacy of this assay is highlighted by the fact that the concentration of F1 antigen in 
patients who have died of plague is generally > 1 µg/mL (Chanteau et al., 1998). The 
RDT dipstick is very sensitive on bubo aspirates and other specimens compare to culture 
and ELISA assay. 
Antibiotic therapy has been used since 1948 where streptomycin was used to save 
lives in the Vietnam war (1960-1975). However, use of streptomycin was discontinued 
in most countries in the world, except Madagascar due to nephrotoxicity and ototoxicity 
(Butler, 2009). Madagascar produced its own streptomycin to treat bubonic plague and 
streptomycin was used together with trimethoprim-sulfamethoxazole. This combination 
saved the lives of two boys in 1995 where isolates from the first boy showed that the 
bacteria were resistance to streptomycin, chloramphenicol, tetracycline, sulphonamide, 
ampicillin, kanamycin, spectinomycin but sensitive to trimethoprim. The second case 
was a 14 year old boy with a strain resistance to streptomycin. Gentamycin has been used 
successfully in treating plague in the United States (Boulanger et al., 2004) and Tanzania 
(Mwengee et al., 2006). Tetracyclin and doxycycline are also effective treatments for 
plague. They can be taken orally and also used to prevent pneumonic plague (Butler, 
2009). In all cases, patients must be treated immediately with antibiotic to prevent fatality.  
Vaccines have been used in the past; in the military and for laboratory workers 
but available vaccines have limitations. Two forms of vaccine have been used, the live 
attenuated vaccine and the killed whole cell vaccine. In 1946, a killed whole cell vaccine 
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(USP) was developed for use in humans and F1 may be the primary protective component 
(Infectious Diseases Society of America. et al.). Vaccines were prepared by heating or 
treatment with formaldehyde. However, 10% of those immunised with killed whole cell 
vaccines suffered side effects such as malaise, headache, elevated temperature and 
lymphadenopathy (Titball and Williamson, 2001). USP was used to immunise US 
soldiers that served in Vietnam war in 1960s-1970s and was effective to prevent bubonic 
plague. However, incidences of pneumonic plague were reported at that time (Anderson 
et al., 1996; Meyer, 1970). There is also evidence from studies with mice and non-human 
primates that immunisation of killed whole cells protects against subcutaneous challenge 
but not against inhalation challenge with Y. pestis F1+ strain (Meyer, 1970; Titball and 
Williamson, 2004; Meyer et al., 1974a; Cohen and Stockard, 1967). The same challenges 
were tested on mice with an F1- strain and showed no protection at all (Anderson et al., 
1996). This highlights that F1 is the protective antigen, but would suggest that it is the 
only major protective antigen in the killed whole cells vaccine. Moreover, repeat 
immunisations of USP were required for protection. For these reasons, since 1999, this 
vaccine has not been used in the United States (Jones et al., 2003). 
A live attenuated vaccine, EV76, which has been used since 1908, is derived from 
a pigmentation negative derivative (Pgm) of a fully virulent strain of Y. pestis (Zhou and 
Yang, 2009; Eisen et al., 2006). A study from Lindler in 1998 showed that immunisation 
of mice with the EV76 vaccine protects mice against subcutaneous and inhalation 
challenges with Y. pestis. Despite the protection given by this vaccine, safety concerns of 
the use of this live vaccine have been raised because it is not avirulent. It caused fatality 
in approximately 1% of mice that were immunised with this strain (Lindler et al., 1998; 
Russell et al., 1995), exhibited virulence in non-human primates (Meyer et al., 1974b) 
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and was reactogenic in humans (Feodorova and Corbel, 2009). Williamson and co-
workers concluded that killed whole cells vaccine (USP) protect solely against bubonic 
plague due to lack of the T3SS V antigen in the formulation, while the live attenuated 
EV76 vaccine protects against both bubonic and pneumonic plague as both F1 and V 
antigen are present in the formulation (Williamson et al., 1995). 
Because of the poor protection from whole cell vaccines and safety concerns with 
the live attenuated EV76 vaccine, there has been more recent focus on subunit and 
recombinant vaccines. The two prime candidates for plague subunit vaccines have been 
the F1 and V antigens as discussed above. The F1 protein inhibits phagocytosis and 
produces a strong humoral response to F1, thus it remains a major component of a new 
generation of subunit vaccines. Purified preparations  of  both of these antigens have been 
tested on non-human primates (Cynomolgus macaque) and demonstrated to give 
protection against aerosol challenge when used individually or together (Cornelius et al., 
2008; Fellows et al., 2010; Williamson et al., 2011). The combined F1 and V antigen 
gave stronger protection than either individual antigen and the  killed and attenuated 
whole cell vaccines (Titball and Williamson, 2001; Williamson et al., 1995).  An alternate 
F1-V vaccine created by genetic fusion of caf1 and lcrV was also tested on macaques and 
baboons (Stacy et al., 2008) and was shown to give protection against bubonic plague. 
However, recombinant F1-V vaccine did not protect African green vervets despite its 
strong antibody response (Mizel et al., 2009).  While the F1 sequence is identical in all 
strains, limited polymorphism of lcrV in Y. pestis has been reported. This together with 
concern over F1- strains has continued a search for additional protective antigens 
(Feodorova and Corbel, 2009; Feodorova and Motin, 2012).  
 31 
 
There are many other new approaches to developing vaccines, particularly using 
heterologous bacteria, viral and plant delivery systems (Feodorova and Motin, 2012). The 
best characterised bacteria that has been used as a live carrier platform are strains of 
Salmonella. Attenuated Salmonella enteritica serovars Minnesota, Typhimurium, and 
Typhi have all been used to express F1, LcrV and a combination of both antigens 
(Feodorova and Motin, 2012; Andrews et al., 1996; Motin et al., 1994). This system also 
has been tested to express other surface antigens such as HmuR  and PsaA (pH6 antigen) 
(Feodorova and Motin, 2012). Salmonella like Yersinia, is a member of the family 
Enterobacteriaceae, this therefore means that the caf operon can be expressed and F1 
assembled efficiently in Salmonella. In addition, a study reported that a single dose of 
live attenuated Y. pseudotuberculosis,  producing F1 from Y. pestis, gives protection 
against pneumonic plague (Derbise et al., 2012). The same protection was observed in 
Salmonella producing F1 (Oyston et al., 1995).  
As plague is still endemic in some parts of the world and a potential bioweapon, 
there is continued interest in developing next-generation vaccines. The development of 
new vaccines should consider protection from all forms of plague, no adverse side effects 
and induction of long-term immunity from a minimum number of doses. Furthermore, 
there is a lot of interest in finding alternate antigens that could be used in combination 
with F1 and/or V Ag preparation, as well as in attenuated strains of Y. pestis and Y. 
pseudotuberculosis. 
1.3 F1 capsular antigen 
The F1 capsular antigen is one of the key components of plague vaccines (see above). 
It is produced at higher temperatures of 35-37oC and covers the bacterial surface making the 
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bacteria more resistant to phagocytosis. However, the F1 capsule is not expressed at 
temperatures of 26ºC and below, for example in the flea gut (MacIntyre, 2004).  
The F1 capsule consists of high molecular weight polymers built from a single protein 
subunit, Caf1 (15.6 kDa) which is encoded by the caf operon. The F1 polymer can easily 
extend to twice the diameter of the bacterial cell (MacIntyre et al., 2004). Assembly of Caf1 
requires additional genes of the caf operon, which is located on the pFra/pMT1 plasmid. The 
first caf operon was cloned and sequenced from Y. pestis pEV76 (Galyov et al., 1990; Perry 
and Fetherston, 1997). The caf operon encodes four genes: caf1R (Zavialov et al., 2002), caf1 
(Galyov et al., 1990), caf1A (Perry and Fetherston, 1997) and caf1M (Brubaker, 1972). Early 
genome sequences indicated identity of each of these genes among different strains of Y. 
pestis. With the dramatic increase in genome sequencing capabilities it remains to be seen if 
there are any exceptions to this.  Caf1R is synthesised as a 36.83kDa regulator and shares 
homology with the AraC family of regulators. The caf1 gene encodes the structural subunit 
of the F1 polymer. Caf1 is synthesised as a 17.6 kDa precursor and is processed to a 15.56 
kDa mature subunit during secretion across the inner membrane. This is not only an 
absolutely conserved surface protein, but Caf1 is also unique to Y. pestis. So far, no close 
homologues of Caf1 have been identified in the database. This is the reason that F1 and 
antibodies against F1 have proven to be so useful in diagnosis of plague and identification of 
Y. pestis.  Both caf1A and caf1M are assembly related genes where Caf1M, originally 
assigned as Caf1 mediator, is synthesised as a 28.76 kDa precursor of a 26.3 kDa periplasmic 
chaperone. The caf1A gene encodes Caf1A, which is synthesised as a 93.0 kDa precursor of 
a 90.52 kDa outer membrane usher (MacIntyre et al., 2004). The Caf operon belongs to a 
well characterised chaperone-usher assembly pathway that will be discussed later. 
The Caf1 subunits (15.56 kDa) assembly into fibres that collapse on the surface 
creating an antiphagocytic capsule-like structure that covers the cell surface. The 
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structure of the F1 fibre was derived from the crystal structure of a ternary 
Caf1M:Caf1:Caf1 complex (Zavialov et al., 2003). The thin linear F1 fibre with  diameter 
of 20Å was assembled by Caf1 subunits (Figure 1.1) (Zavialov et al., 2003). The F1 
polymer is remarkably stable, disassociates into individual oligomers and monomers only 
at  high temperatures above 87.5°C (Zavialov et al., 2005). In 0.5% SDS, the fibre begins 
to dissociate at 75°C. The periplasmic chaperone Caf1M forms a donor strand exchange 
(DSC) complementation with the unfolded Caf1SC subunit (Zavialov et al., 2003). This 
drives folding of the Caf1 subunit in the periplasm, but this interaction is very different 
from the subunit:subunit interaction (see below) dissociating at a temperature of 55°C 
(Zavialov et al., 2005). In the absence of Caf1M interaction, unfolded Caf1 subunit is 
degraded in the periplasm. 
 
Figure 1.1: Architecture of F1 fibre. Blue indicates the chaperone that binds to 
incompletely-folded subunit (Red).Yellow indicates folded subunits that form a fibre 
and are exported to the cell surface. Orange indicates the terminal extension of Caf1 
that helps to stabilise F1 polymer by donor strand exchange mechanism (Image taken 
from Zavialov et al., 2003).  
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1.4 Phylogeny of chaperone-usher (CU) families 
CU systems are widespread, particularly among the Enterobacteriaciae. It is not 
uncommon for a single strain to possess different operons encoding CU assembled pili 
or fibres. While there is no evidence thus far of a role of F1 in adhesion, many CU pili 
are important virulence factors, due to their key roles in adhering to specific host cells 
(Zavialov et al., 2007; Wright et al., 2007). The chaperone-usher families are organised 
into gene clusters that encode usher, chaperone and major subunit proteins with variable 
addition of regulator and/or adhesin or other minor assembly subunits (Nuccio and 
Baumler, 2007). The major subunits assemble into thin flexible fimbriae that consist of 
two subunits per helical turn or thick rigid fimbriae that consist of 3 to 3.4 subunits per 
helical turn. Minor subunits generally assemble into the tip of the fimbriae and act as tip 
adhesin, tip fibrillum or/and adaptor that join the structure (Baga et al., 1987; Bullitt and 
Makowski, 1995; Jacob-Dubuisson et al., 1993; Kuehn et al., 1992). The usher proteins 
shared conserved domain of PFAM00577 and COG388 (Nuccio and Baumler, 2007). 
Despite the fact that the usher  proteins share  homology with several proteins from other 
systems, the chaperone/subunit complexes are very specific to their own usher (Russell 
and Orndorff, 1992; Saulino et al., 1998). 
 Of the many non-flagellar surface appendages, including curli, type IV pili, type 
III secretion pili and type IV secretion pili (Figure 1.2), chaperone-usher (CU) pili are 
probably the most extensively studied. One mode of classification was based on 
chaperone studies (Zav'yalov et al., 1995; Hung et al., 1996). The chaperone-usher family 
were classified into two main structurally and functionally distinct groups, FGL (long F1-
G1 loop in the subunit binding domain) and FGS (short F1-G1 loop). These 2 groups 
corresponded to the assembly of thin fimbriae (fimbriae polyadhesins) and rod-like pili 
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(adhesive pili), respectively. Table 1.2 below shows a summary of the functional and 
structural classification of these fimbriae.  
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Table 1.2: Function-structure classification of chaperone-usher fimbrial adhesins.  
Mono-adhesive binding refers to adhesive pili with only one specialised adhesive domain (adhesin). Polyadhesive binding refers to usually thin 
flexible fimbriae that possess one or two independent binding sites specific to its host cell receptor.
 Function Morphology Chaperone 
No. of 
subunits, 
assembled by 
chaperone 
Adhesin 
subunit 
Invasin or 
invasin-like 
subunit 
References 
Mono-adhesive 
binding 
Thick rigid pili with a diameter 
of 7–8 nm 
FGS: PapD, PrsD, FimC, SfaE, FocC, 
HifB, HafB, FimB, MrpD, PmfC, LpfB, 
PefD, AftB, FasB 
5–7 
One domain 
(adhesin), on 
the tip 
Non-detected 
Bullitt & Makowski 
(1995),Thanassi et 
al. (1998),Soto & Hultgren 
(1999),Knight et 
al.(2000),Sauer (2000,2004) 
Mono-adhesive 
binding 
Thin flexible pili with a poorly 
defined diameter (2–4 nm) 
FGS: F17D, MrkB, RalE 
F17-2 Mrk-3 
Ral-4 
One domain 
(adhesin), on 
the tip 
Non-detected 
Lintermans 
(1988,1991),Gerlach et 
al.(1989), Bullitt & Makowski 
(1995),Adams et 
al.(1997),Sebghati et 
al. (1998),Soto & Hultgren 
(1999) 
Polyadhesive 
binding 
Thin flexible pili with a poorly 
defined diameter (2–4 nm) 
FGS: FaeE, FanE 5 
The main 
structural 
subunit: 
FaeG, FanG 
Non-detected 
Bakker et al.(1991), Soto & 
Hultgren (1999), van den 
Broeck (2000) 
Polyadhesive 
binding 
Atypical fimbrial structures FGL, SafD-like family: CssC 2 
The main 
structural 
subunit: CssA 
The main 
structural 
subunit: CssB 
(Di Yu et al., 2012), (Remaut 
et al., 2008) 
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Polyadhesive 
binding 
Unusually long, thin (2 nm 
diameter) SEF18 fimbriae were 
evident onSalmonella 
enteritidisandEscherichia 
coli by electron microscopy 
FGL, SafD-like family: SefB 2 
The main 
structural 
subunit: SefA 
The main 
structural subunit 
of alternative 
fimbriae: SefD 
(SEF18 fimbriae) 
Clouthier (1993, 1994) 
Polyadhesive 
binding 
Atypical fimbrial structures: 
amorphous or capsule-like at 
low resolution 
FGL, SafD-like family: SafB 2 
The main 
structural 
subunit: SafA 
One subunit on 
the tip: SafD 
Folkesson et 
al. (1999),McClelland 
(2001,2004), Denget 
al. (2003),Chiu et al.(2005) 
Polyadhesive 
binding 
Thin flexible fibers (2 nm 
diameter) were observed for Dr 
adhesin by electron microscopy 
FGL, Caf1M-like family: Afa-8B, 
AafD, Agg-3D, AggD, DafaB, Afa-3B, 
DraB, DaaB 
1 
The main 
structural 
subunit: Afa-
8E, AafA, 
Agg-3A, 
AggA, 
DafaE, Afa-
3E, DraE, 
DaaE 
One subunit 
might be 
displayed on the 
tip after 
chaperone/usher 
independent 
secretion 
Bilge et al.(1989),Garcia et 
al.(1994),Savarino et 
al. (1994),Elias et 
al.(1999),Lalioui & Le 
Bouguénec (2001),Bernier et 
al.(2002),Keller et 
al.(2002), Van Loy (2002),Le 
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Figure 1.2: Assembly of CU pili and curli is driven by simple systems, involving 
specific periplasmic chaperones and outer membrane ushers.  
On the other hand, assembly of type IV pili, type III secretion pili and type IV 
secretion pili is driven by large multisubunit complexes crossing the whole bacterial 
cell envelope. (Taken from Waksman G., 2008) 
As the number of sequenced CU systems greatly increased, Nuccio et al. (2007) 
classified CU systems according to the fimbrial usher protein (FUP) phylogeny. Ushers 
were classified into six major clades; α-fimbriae, β-fimbriae, γ-fimbriae (subdivided 
into γ1, γ2, γ3), κ-fimbriae, π-fimbriae and σ-fimbriae (Figure 1.3). From this study, it 
became clear that the FGL systems form a small monophyletic group (γ3-fimbrial 
clade), whereas FGS systems fall into a much larger and diverse number of clades. The 
major FUP clade is σ-fimbriae where the members of this clade have limited or no 
sequence homology to the members of alternate fimbriae (α-fimbriae) or to classical 
CU family (β-, γ-, κ-, and π-fimbriae). 
Type 1 pili are grouped together in γ1-fimbriae where it consists of the CU 
system from Citrobacter freundii (FimD), E. coli (AufC, FImD, Fm1C, FocD, SfaF, 
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SfmD, Ycbs and Ydet), Proteus mirabilis (AtfC) and S. enterica serotype Typhimurium 
(BcfC and FimD). Figure 1.3(B) shows that, with the exception of P. mirabilis atf 
operons of the γ1-fimbriae clade this clade all encode usher, chaperone, more than one 
subunit and a typical tip adhesin. Most type 1 pili have been well studied and in 
particular the E. coli fim operon. It encodes a rigid fimbrial shaft of FimA major subunit 
and ends with the tip adhesin FimH, connected by FimF and FimG minor subunits 
(Figure 1.2) (Hahn et al., 2002; Jones et al., 1995; Saulino et al., 2000). E. coli type I 
pili bind to mannosylated glycoproteins in the bladder and is a key virulence 
determinant in cystitis (Sokurenko et al., 1994; Mulvey et al., 1998).  
The γ3-fimbrial clade, to which Caf1A usher belongs, also contains the E. coli 
ushers AfaC-3, AfaC-7, AfaC-8, AggC, Agg3C, CS3-2, CssD, DraC, and HdaC, 
PSPPH_A0064 of Pseudomonas syringae, SefC of S. enterica serotype Enteritidis, 
SafC of S. enterica serotype Typhimurium, PsaC of Y. pestis and MyfC of Y. 
enterocolitica. In general, γ3-fimbriae do not contain specialized subunits with the 2-
domain structure of tip adhesins. They are composed of only one major subunit and 
some are accompanied by non-polymerising subunit (Afa/Dra of E. coli) to cut their 
distal end.  It assembles into thin flexible fibres of ~2-3 nm thickness and curl up on 
the cell surface to form capsule (Fronzes et al., 2008; Nuccio and Baumler, 2007). 
Caf1A, responsible for formation of the Caf1 Subunit into F1 fibres, is the best studied 
representative of the γ3-fimbrial clade. The widely studied P and type I pili cluster in 
the π and γ1- fimbrial clades, respectively. Pap and Fim chaperone usher systems from 
E. coli have been used as models to study FGS family and Caf chaperone usher system 
has been used as models of the γ3/FGL system (Russell et al., 1995; Zavialov et al., 
2007).  
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Figure 1.3: Phylogenetic tree of the fimbrial usher family. 
(A) Phylogenetic tree generated from usher amino acid sequences. The ushers grouped into six fimbrial clades called α, β, γ, κ, π and σ. (B) Gamma 
fimbrial clade are divided into three subgroup; γ1, γ2 and γ3. Y. pestis Caf1A usher lies in γ3 group where it neighboured with myfABC (Y. 
enterocolitica) and psaABC (Y. pestis).
A B 
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1.5 Assembly of F1 capsular antigen via chaperone-usher pathway 
The assembly of F1 starts with the translocation of the Caf1 precursor from the 
cytoplasm to the periplasm via the general Sec pathway (Figure 1.4). The periplasmic 
chaperone binds to the subunit, aids folding and stabilises a folding intermediate by 
capping the assembly surface. This in turn prevents proteolytic degradation of unfolded 
subunit (Chapman et al., 1999; MacIntyre et al., 2001). 
       
Figure 1.4: Summary of Caf CU pathway.  
(A) Assembly of F1 polymer mediated by the chaperone (Caf1M) and usher (Caf1A) 
which provides a pore for the polymer to be transported outside the cell. Major steps: 
(i) subunit enters periplasm (iia) Chaperone capture/fold of newly synthesised pilin 
subunit in the periplasmic space, forms subunit:chaperone complex with incomplete 
subunit fold (iib) subunit that does not bind by chaperone will be degraded. (iii) 
Chaperone:subunit complex binds to the usher and opening the pore and. (iv)Multiple 
cycles of DSE where the chaperone G1 strand is displaced by a subunit Gd strand to 
form a complete folded subunit module within the fiber and chaperone recycling. (v) 
elongation of fiber. (Image taken from MacIntyre, 2004). 
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1.5.1 Donor strand complementation (DSC) of subunit by chaperone 
Caf1 is bound to Caf1M to form an incomplete immunoglobulin (Ig) like 
structure with only six β-strands (A-F) of Caf1 (Figure 1.5). This process is called donor 
strand complementation (DSC) (MacIntyre et al., 2001; Yu et al., 2012). Caf1 subunits 
in the F1 polymer form a complete Ig fold where the missing seventh Gd strand is 
donated by the N-terminus of the adjacent subunit. In the absence of the seventh β-
strand, the subunit would have a deep hydrophobic cleft (Sauer et al., 2002; Knight, 
2007; Zavialov et al., 2003). This explains the instability of the free subunit, where it 
will aggregate and rapidly degrade. 
Figure 1.5: Topology Diagram and sequence of Caf1A. 
(A) Topology diagram of chaperone bound Caf1. Caf1 monomer consists of six β-
strands (A-F) with N-terminal extension. A1 and G1 (blue) are β-strands donated by 
Caf1M that stabilise the subunit (red) by hydrogen bonding to edge strands and filling 
the hydrophobic cleft. (B) The chaperone A1 and G1 filled the cleft of Caf1 (DSC) 
(Image of A and B taken from Zavialov et al., 2003). (C) Sequence of Caf1 subunit, 
149 residues. Underlined residues indicate β-strand secondary structure with strand 
assignment given below each strand. Shaded in orange is the N-terminal exension Gd 
donor strand.  Key donor residues (Ala5, Thr7, Ala9, Ala11 and Leu13) coloured in 
blue. (Image modified from MacIntyre et al., 2004).
C 
A B 
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  Caf1M consists of two Ig-like domains. In the first domain, the two edge β-
strands, A1 and G1 play an important role in stabilising and preventing subunit 
aggregation and degradation. Five hydrophobic residues in the G1 strand (Val126, 
Val128, Val130, Phe132 and 134Ile) which are larger than the corresponding Gd 
residues (Ala5, Thr7, Ala9, Ala11 and Leu13), bind to the subunit F strand in a parallel 
rather than the classic anti-parallel orientation (Figure 1.5 (B)). At the same time, the 
A1 strand from the chaperone stabilises the complex via edge-strand bonding to the 
subunit A strand in an anti-parallel interaction. The combination of edge strand 
interactions and  hydrophobic residue/ hydrophobic cleft interactions results in a closed 
“super-barrel”  and a Caf1:Caf1M intermediate that stabilises Caf1 subunit in an 
incompletely folded conformation (MacIntyre et al., 2001; Zavialov et al., 2003; Di Yu 
et al., 2012).  
1.5.2 Donor strand exchange (DSE) at periplasmic surface of Caf1A usher 
Caf1A is a typical β-barrel transmembrane outer membrane protein. It contains 
four additional functional domains: the N-terminal domain (NTD), a plug domain 
(structurally similar to Caf1 subunit) (Huang et al., 2009; Remaut et al., 2008; Yu et al., 
2009) and two C-terminal domains (CTD1 and CTD2) (Dubnovitsky et al., 2010; Ford 
et al., 2010; Phan et al., 2011). The NTD and middle domain/plug initiate the assembly 
of Caf1 subunit by allowing chaperone:subunit complex to bind to NTD and moving 
the plug out and opening the Caf1A barrel. At this step, how the pore opens is still 
unclear. Nine residues in Caf1A NTD (Tyr2a, Thr3a, Phe4a, Thr7a, Met8a, Leu9a, 
Leu17a, Val19a and Phe22a) interact with seven residues in Caf1M (Pro4m, Leu43m, 
Leu67m, Ile102m, Pro103m, Pro104m and Arg69m) via Van der Waals interactions. 
The seven residues from Caf1M provide a large hydrophobic usher binding surface 
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(UBS). Interaction between Caf1A with the UBS contributes to about 97% of the 
interaction, whereas, Caf1 contributes only about 3% to the USB pre-assemble complex 
(Di Yu et al., 2012). The mechanism by which the usher specifically recognises loaded 
chaperone has recently been explained (Figure 1.6). In free Caf1M, Pro104m is in a 
collapsed conformation. This results in a closed UBS, preventing Phe4a (a key usher 
residue) interact with Caf1M because the position is occupied by Pro104m. However, 
when Caf1M is in a complex with Caf1, there is an allosteric induced conformational 
change that rotates Pro103m and Pro104m and moves Pro104m forming an open Phe4 
for binding. This mechanism allows only the loaded incoming Caf1M:Caf1 complex to 
bind to usher (Di Yu et al., 2012). 
 
 
Figure 1.6: Caf1M:Caf1 complex allows proline lock (Pro104m) to open. 
In free Caf1M (cyan), UBS is closed by Pro104m (yellow). Caf1 (magenta) binds to 
Caf1M opening the UBS by moving Pro103m (yellow) and Pro104m. This allowing 
insertion of usher (orange) Phe4 to the open UBS, stabilising chaperone-usher 
interaction (Image taken from Di Yu et al., 2012).  
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Figure 1.7: Topology diagram of Caf1M:Caf1:Caf1 interactions.  
(A) The N-terminal extension of Caf1’ subunit (orange) fills the cleft following 
displacement of the chaperone G1 strand by DSE. This completes the Ig fold of Caf1”.  
(Zavialov et al., 2003). (B) Ribbon diagrams of Gd and G1 donor strands. Chaperone 
G1 and A1 strands in violet and subunit Gd strand in red. The G1 and Gd donor residues 
are shown in ball-and-stick labelled according to subunit acceptor cleft (P1-P5) (Image 
taken from MacIntyre, 2004).  
Donor strand exchange (DSE) takes place when Caf1 N-terminal extansion (Gd) 
from an incoming chaperone:subunit complex (Caf1M:Caf1’’) replaces the chaperone 
A1 and G1 strand from the chaperone:subunit complex (Figure 1.7(A) (Sauer et al., 
2002; Zavialov et al., 2002). As shown in Figure 1.7(B), there are five pockets in the 
Caf1 hydrophobic cleft. The DSE is initiated at P5 pocket of the subunit where the P5 
pocket, filled with Val126m is displaced by the corresponding Gd residue from Caf1’’ 
via zipper-like mechanism (Remaut et al., 2006; Zavialov et al., 2003). Binding of the 
Gd strand to the cleft forms a complete seven-stranded Ig fold. The Gd complemented 
subunit undergoes a conformational change during DSE, changing from a high-energy, 
incomplete folded chaperone bound form to a compact, highly stable, fibre inserted 
state (Zavialov et al., 2003; Zavialov et al., 2005). The translocation of the fiber to the 
cell surface is probably driven by the folding energy released (Zavialov et al., 2003; Yu 
A B 
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et al., 2012). The polymer keeps growing via additional DSE interactions of chaperone-
subunit complexes, leading to the localisation of the growing polymer through the usher 
protein to the cell surface. A fibre of F1 polymer can be built from more than 100 
subunits. The F1 fibres on the cell surface collapse into a capsule-like structure (Yu et 
al., 2012; Zavialov et al., 2002). 
1.6 Assembly at the E. coli ushers PapC and FimD  
The most extensively studied chaperone-usher pathways are the Pap and Fim 
systems in uropathogenic E. coli (UPEC) which assemble type P and type I pili, 
respectively (Busch and Waksman, 2012).  Type I pili are encoded by the fim gene 
cluster (fimA-fimI) where fimH encodes an adhesin responsible for targeting the bacteria 
to epithelial bladder and kidney cells (Korea et al., 2011). Type P pili are encoded by 
the gene cluster (papA-papK) where papG encodes the tip adhesin that promotes 
binding of the bacteria to kidney epithelial cells and erythrocytes.  
The assembly of pili via the Fim and Pap systems were first described for the 
FimC-FimH (Choudhury et al., 1999) and PapD-PapK (Sauer et al., 1999). The basic 
principle of assembly of Pap and Fim systems are similar to that of the Caf system 
except Pap and Fim systems assemble more than one type of subunit to form structured 
pili. In the Pap system, the assembly starts with adhesin protein PapG, followed by the 
adaptor subunit PapF, 10 copies of flexible tip fibrillum PapE, a single copy of another 
adaptor subunit PapK, a rigid rod consisting of a thousand units of PapA followed by 
the termination subunit PapH (Verger et al., 2006). On the other hand, in the Fim system, 
only 4 subunits are required to form a type I pili. It starts with the assembly of adhesin 
subunit FimH, one copy each of FimG and FimH to form the flexible tip fibrillum. This 
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is then followed by approximately 1000 copies of FimA. No termination subunit has 
yet been characterised in the Fim system (Hahn et al., 2002; Le Trong et al., 2010).  
The first structure solved for any usher membrane domain was that of  the barrel 
domain of PapC in 2008 (Remaut et al., 2008).  This 130-640 amino acid fragment 
crystallised as a 24-stranded β-barrel (residues146-635), 45 Å height, 65-45 Å outer 
dimension and 45-25 Å outer dimension (PDB:2VQI, 3.2 Å). In this structure, between 
transmembrane β6 and β7 forms a 6 stranded β sandwich fold (the plug or middle 
domain) located inside the barrel. As shown in Figure 1.8 (C). The β5-6 hairpin residues 
(Ile231 and Phe236) bend in towards the barrel and interact with residues on the barrel 
wall (Trp239, Phe357 and Val377) and α-helix (Met451) through hydrophobic 
interactions. There are also two electrostatic interactions that connect the β5-6 hairpin 
with the barrel wall (Glu361-Lys339-Asp234-Arg303) and β5-6 hairpin with α-helix 
(Arg237-Glu467-Arg305-Asp32) Figure 1.8 (C). These electrostatic interactions help 
the plug reside inside the PapC barrel (Remaut et al., 2008).  
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Figure 1.8: Crystal structure (3.2Å resolution) of PapC, PDB: 2VQI.  
(A) View from top of PapC usher showing all 24 β-strands. N and C indicate N and C 
terminus. (B) View from side of PapC usher. The β-barrel coloured in blue, plug domain 
in magenta, β5-6 hairpin in orange and α-helix in yellow. (C) Hydrophobic and 
electrostatic interactions between β-barrel, β5-6 hairpin and α-helix. (Image taken from 
Remaut et al. 2008).  
For the subunit fibre to go through the PapC barrel, the middle domain must 
move out of the barrel into the periplasm. It has been proposed that the binding of the 
chaperone: adhesion complex,  induced activation of the usher (Saulino et al., 1998). 
Opening of the barrel would create a 37 × 25Å translocation channel or a channel of 45 
× 25Å when α-helix or β5-6 hairpin are displaced from the barrel. It was suggested that 
the required conformational rotation of the plug is driven by energy coming from 
binding of the chaperone-adhesin complex (Remaut et al., 2008). 
A B 
C 
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In 2011, the crystal structures of FimD bound to the FimC:FimH complex and 
the unbound  usher were solved (Phan et al., 2011). FimD is the only usher for which a 
high-resolution structure has been solved with a subunit inserted into the pore. This 
study highlighted that the inserted FimC:FimH complex was bound to C-terminal 
domain 1 (residues 666-750) and to C-terminal domain 2 (residues 751-834).  The 
ternary complex also shows that the plug domain (residues 241-324) was not pushed 
out of the pore lumen as suggested earlier (Remaut et al., 2008) but resides on the 
periplasm face of the usher  in the loaded translocon (Phan et al., 2011; Yu et al., 2009). 
The correct ordering of the subunits has been attributed in part to the high, but differing 
affinity of subunit:chaperone complex for the PapC N-terminal domain (Sauer et al., 
1999; Dodson et al., 1993). 
There are now three solved structures of FimD, which are FimD membrane 
barrel (in closed state) without any periplasmic domain (PDB:3OHN, 3.01 Å) (Phan et 
al., 2011), FimD bound to FimC:FimH complex accommodating FimH subunit in the 
barrel (PDB:3RFZ, 2.8 Å) (Phan et al., 2011) and FimD bound to 
FimC:FimF:FimG:FimH complex accommodating FimH subunit in the barrel  
(PDB:4J3O, 3.8 Å) (Geibel et al., 2013). In 2011, Phan et al. reported that activation of 
the FimD usher on complexing FimC:FimH drives a dramatic conformational changes 
to the FimD barrel from diameter of 52 Å by 28 Å and near oval-shaped pore to 44 Å 
by 36 Å and a more circular pore (see Figure 1.9 (A)). This correlates with a change of 
closed to open state (removal of the plug), and insertion of the adhesin into the usher 
pore. Apparent flexibility of the β-barrel had not previously been seen in this or any 
other β-barrel outer membrane protein (Phan et al., 2011). Based on the paper published 
in 2013 by Geibel et al., upon translocation of type 1 pili, counterclockwise rotation of 
 50 
 
approximately 110° to 120° and an upward motion of approximately 50 Å of FimH was 
observed (see Figure 1.9 (B)). This hypothesized that the rotation prevents FimH from 
sliding back into the periplasm (Geibel et al., 2013). 
 
Figure 1.9: Closed and open structures of FimH.  
(A) Superimposed and comparison of FimD close and opened structure. (B) The 
rotation of the pili when FimD accommodates FimH and FimG (Image taken from 
Phan et al., 2011 and  Geibel et al., 2013).  
  
Available structures of the Caf system include, wildtype (PDB:1Z9S, 2.2 Å) and 
mutant (PDB:1P5U, 1.99 Å) of Caf1M:Caf1:Caf1 complexes, (Zavialov et al., 2005), 
the Caf1A C-terminal domain (PDB:2XET, 1.6 Å) (Dubnovitsky et al., 2010), 
recombinant Caf1A plug or soluble middle domain (PDB:3FCG, 2.85 Å) (Yu et al., 
2009) and subunit-free Caf1M (PDB:4AY0, 1.52 Å) as well as the Caf1A N-terminal 
domain alone (PDB:4B0E, 2.0 Å) and in complex with Caf1M:Caf1 (PDB: 4B0M, 
1.8Å) (Di Yu et al., 2012). The only remaining unsolved structure in Caf system is the 
Caf1A usher barrel.  
 Deletion of the Caf1A N-terminus (Caf1AN) showed a dramatic decrease in the 
production of F1 on the cell surface. The deletion of Caf1A Asn13-Gln28 and residues 
A B 
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Thr12-Pro99 decreased and abolished surface F1 production respectively thus 
suggesting that Caf1AN is crucial in assembly or may disrupt the structure of the domain 
(Pudney, 2006). The PapCN was suggested to have a recognition site for 
chaperone:subunit complexes. Ng et al (2004) also showed the substitution of Phe3 to 
Ala and deletion of residues 2-11 in the PapCN abolished pilus assembly (Ng et al., 
2004). It was also shown that the deletion of the FimD N-terminal tail (residues 1-24) 
completely abolished FimD function, suggested that the N-terminal tail contributes to 
recognition of chaperone subunit complex in the Fim CU pathway (Nishiyama et al., 
2005).  
Site-directed mutagenesis of Caf1AN residues involved in interaction with Caf1M, 
Phe5Ala and Phe23Ala dramatically decreased levels of F1 on the cell surface. Caf1AN 
Met9Ala also reduced surface F1 but not as dramatically as Caf1AN-Phe5 and -Phe23. 
This suggest that Caf1AN-Met9 is less important in binding with chaperone:subunit 
complex. These two important residues, namely Phe5 and Phe23 correspond to Phe4 
and Phe22 in FimDN and Phe3 and Phe21 in PapCN. Mutation of FimDN-Phe4Ala 
abolished binding of FimC-FimH explaining the loss of pili assembly (Nishiyama et al., 
2005). Mutation of PapCN-Phe3Ala also identified a critical requirement of this residues 
for binding Pap chaperone:subunit.. Mutation of PapCN-Phe21Ala showed that it can 
assemble tips (PapG) in the absence of major pili PapA but cannot assemble pili. It was 
therefore proposed that Phe21 is involved in assembly of an ordered pilus (Li et al., 
2010). A conserved region (disulphide loop) in FimDN (residues 70-79) and PapCN 
(residues 77-86) was deleted and shown to abolished catalytic activity of the usher. 
Mutations of FimDN  disulphide loop was able to bind chaperone:subunit complex, 
initiating assembly of pili but could only form a short pilus tip. However, mutations of 
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PapCN disulphide loop   was unable to form pili. These observations proposed that 
catalytic activity is critical to initiate pilus biogenesis in PapC and important for pilus 
extension in FimD (Henderson et al., 2011). The different functions of the catalytic 
activity in FimD and PapC may reflect the phylogenetic distance between these two 
ushers which are classified into γ and π FUP family, respectively. All of the evidence 
above suggests that the N-terminal domain is required for loaded chaperone to bind to 
usher and the middle domain 
1.7 Aims and objectives 
The aim of this project was to use a bioinformatics approach to further elucidate 
the Caf specific translocation process and to then apply knowledge of this to optimise 
export of additional short peptide sequences within the F1 scaffold. Strategic 
significance of this approach is related to the central importance of F1 in both diagnosis 
and prevention of plague (Perry and Fetherston, 1997). By using the available high-
resolution crystal structures of the Caf subunit:chaperone complex (Zavialov et al., 
2005) and the Fim translocon (Geibel et al., 2013; Phan et al., 2011) to model the Caf 
translocon, in silico analysis could be used to identify predicted conserved features and 
to guide the design of modified surface F1 polymer. This bioinformatics approach has 
then been readily complemented with established laboratory methods to monitor the 
efficiency of assembly of F1 carrying inserted peptides. During the search for additional 
γ3 FUP family members, an usher sequence closely related to Caf1A usher was 
identified in a plasmid sequence from a commensal strain of E. coli. Because of the 
current interest in evolution of Y. pestis to a flea-borne route of transmission 
(Hinnebusch, 2005) and the use of F1-based serotyping in plague (Simon et al., 2013; 
Schofield et al., 2012) detection, the relationship between this E. coli CU system and Y. 
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pestis Caf system was also investigated. The main specific objectives of the study were 
as follows: 
1. To characterize production of recombinant F1 from the low copy number plasmid 
pACYCF1 
2. To extend the γ3 family of fimbrial usher proteins and in particular identify any 
closely related to Caf1A 
3. To model the Caf translocon using the available structures of the Fim translocon 
and the Caf subunit:chaperone complex 
4. To use the model of the Caf translocon and multiple sequence alignments of 
related ushers to identify conserved residues that might influence translocation of 
F1 through the usher and to test this experimentally by mutagenesis. 
5. To monitor the flexibility and efficiency of four different loops within F1 to act as 
replacement sites for short peptides.  
6. Using the modelled translocon structure, identify and design repair of export 
‘blocks’ of modified F1 polymer 
7. Bioinformatic analysis of the E. coli SE11 chaperone usher cluster, the most 
closely related usher to Caf1A. 
8. Demonstration of functionality of SE11 CU locus from pSE11-2 by recombinant 
production and purification of surface E. coli SE11 subunit(s) polymer. 
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CHAPTER 2 MATERIAL AND 
METHODS 
  
 55 
 
2.1 Bacteria strain 
Table 2.1. below indicates details of E. coli strains used throughout this study. 
Initially, DH5α competent cells were used for protein expression and sequencing of 
site-directed and deletion mutants. Stellar™ Competent cells were used to perform 
InFusion cloning and sequencing of the infused plasmid. Both E. coli BW25113 and 
TOP10 were used for transformation and protein expression of loop mutations, as 
indicated. E. coli BL21(DE3) was used to express the recombinant gene from 
pACYCD1_MA_S123 construct. 
Table 2.1 List of competent cells used in this study 
Strain Genotype Reference 
DH5α 
endA1 hsdR17(r_k- m+k+ )supE44 thi - 1 recA1 
gyrA (Nalr)relA1 Δ(lacIZY A- argF)U169 deoR 
(ϕ80dlacΔ(lacZ)M15)  
Sambrook et al., 
1989  
TOP10 
F- mcrA Δ (mrr-hsdRMS-mcrBC) φ80lacZΔM15 
ΔlacΧ74 recA1 araD139Δ(ara-leu) 7697 galU 
galK rpsL (StrR) endA1 nupG λ-  
Invitrogen 
(Cat No. C4040) 
BW25113 
F-  Δ (araD-araB)567 Δ lacZ4787 (::rrnB-3), 
lacIp-4000(lacIQ) λ-  rph-1 Δ (rhaD-rhaB)568  
hsdR514  
Prof. Simon 
Andrew stock 
(SCE960) 
Stellar™ 
Competent 
Cells  
F–,endA1, supE44, thi-1, recA1, relA1, gyrA96, 
phoA, Φ80d_ lac ZΔM15, Δ(lacZYA- argF) 
U169, Δ (mrr- hsd RMS -mcrBC), ΔmcrA, λ–  
Clontech Takara, 
UK  
(Cat No. 636763) 
BL21 (DE3) 
fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS 
λ DE3 = λ sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5 
New England 
Biolab  
(Cat. No. C2527I) 
 
2.2 Media and culture conditions 
All E. coli strains were grown in Luria-Bertani broth (LB) (1% (w/v) tryptone, 
0.5% (w/v) yeast extract, 0.09 M NaCl pH 7.0) and Luria-Bertani agar (LA) (LB + 
1.5 % w/v agar). For expression of F1, single transformants or subcultures from -80°C 
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transformant stocks were inoculated into 10 ml LB supplemented with 0.6% glucose, 
and appropriate antibiotics (Chloramphenicol, 34 µg/ml or Ampicillin, 100 µg/ml) and 
were incubated overnight (20-22 hours) at 26°C with shaking at 225 rpm. For induction 
from pACYCF1, 1 ml of the overnight culture was centrifuged for 10 min at 13000 
rpm. Pelleted cells were washed in 1 ml LB at 13000 rpm 10 minutes, resuspended in 
10 ml LB with 10 µg/ml chloramphenicol and thermoinduced at 37°C for 4 hours. For 
induction from pFMA1, a transformant colony was inoculated in 10mL LB with 0.6% 
glucose and 100µg/ml ampicillin for ON at 26°C. The next day, the sample was washed 
and subcultured 1/10 in 10mL LB with 100µg/ml AMP for 1 hour at 37°C followed by 
induction of 0.5 mM IPTG and incubated for further 1.5 hours at 37°C. Stock cultures 
were prepared by adding 700 µl of the 26°C overnight cultures to 300 µl of 50% 
glycerol stock (final concentration 15% w/v glycerol) and stored at -80°C 
2.3 Plasmids and mutants 
Table 2.2 provides details of all plasmids and constructs used in the study. The 
caf operon was expressed from either pACYCF1, pFMA1 plasmid, or derivatives 
thereof. The pACYCF1 plasmid expresses a good level of Caf1 protein and a low level 
of Caf1M which mimics the native caf operon. In pFMA1, there is a high level of 
Caf1M and a slightly lower level of expression of Caf1 from this plasmid.  Expression 
of Caf1 from pFMA1 is toxic to E. coli after 2-3 hours (Kersley et al., 2003).  
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Table 2.2: Plasmids used in this study 
Plasmid 
Description Reading 
stock 
number 
Reference 
pACYCF1 
pACYCDuet with the entire caf 
system, subcloned into NcoI and 
SacI restriction sites of pACYC, 
under control of caf1R. Thermo-
induced for 4 hours at 37°C 
R1122 Mary 
Leonard and 
Dharmender 
Kumar, 
unpublished 
pFMA1 
(R352) 
 
 
Ptrc99a with caf1M caf1A, caf1 
under control of ptrc promoter. 
IPTG induced, 1 hour without 
glucose than 0.5mM IPTG for 1.5 
hours at 37°C 
R352 (Chapman et 
al., 1999)  
pACYCF1-A-F4A 
Derivative of pACYCF1 with N-
terminal domain mutation Phe4 to 
Ala 
R1156 This study 
pACYCF1-A-F4S 
Derivative of pACYCF1 with N-
terminal domain mutation Phe4 to 
Ser 
R1157 This study 
pACYCF1-A-Y240A 
Derivative of pACYCF1 with 
middle domain mutation Tyr240 
to Ala 
R1158 This study 
pACYCF1-A-∆N(T8-
Q131) 
Derivative of pACYCF1 with N-
terminal deletion from Thr8 to 
Gln131. Used as control 
R1159 This study 
pFM1-F1d11 clone 4  
D33N34 of Caf1 replaced with 
GG 
R665 Elham 
Moslehi, 
Unpublished 
pFMA1-F1D12 clone 1  
S76QDGNHH82 of Caf1 
replaced to GGGG  
R784 Elham 
Moslehi, 
Unpublished 
pFM1-F1D13 clone A  
D92SRDF96 of Caf1 replaced to 
GGGG  
R669 Elham 
Moslehi, 
Unpublished 
pFM1-F1D14 clone A) 
K129GGK132 of Caf1 replaced 
with DGGG 
R670 Elham 
Moslehi, 
Unpublished 
pFM1-F1::1 clone 1 
D92SRDF96 of Caf1 replaced to 
ELDKWA  
R899 Elham 
Moslehi, 
Unpublished 
pFM1-F1::2 clone 1  
S76QDGNHH82 of Caf1 
replaced with ELDKWA 
R900 Elham 
Moslehi, 
Unpublished 
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pFM1-F1::3 clone 2  
D33N34 of Caf1 replaced to 
ELDKWA 
R901 Elham 
Moslehi, 
Unpublished 
pFM1-F1::4 clone 2  
K129GGK132 of Caf1 replaced 
to ELDKWA  
R902 Elham 
Moslehi, 
Unpublished 
pACYC-F1D11 
Encodes Caf1 loop 1 mutation 
D33N34→GG InFused from 
R665 into pACYCF1 
R1161 This study 
pACYC-F1D12 
Encodes Caf1 loop 4 mutation 
S76QDGNHH82→GGGG 
InFused from R784 into 
pACYCF1 
R1162 This study 
pACYC-F1D13 
Encodes Caf1 loop 5 mutation 
D92SRDF96→GGGG InFused 
from R669 into pACYCF1 
R1167 This study 
pACYC-F1D14 
Encodes Caf1 loop 7 mutation 
K129GGK132→DGGG InFused 
from R670 into pACYCF1 
R1160 This study 
pACYC-F1::1 
Encodes Caf1 loop 1 mutation 
D92SRDF96→ELDKWA 
InFused from R899 into 
pACYCF1 
R1163 This study 
pACYC-F1::2 
Encodes Caf1 loop 4 mutation 
S76QDGNHH82→ELDKWA. 
InFused from R900 into 
pACYCF1 
R1164 This study 
pACYC-F1::3 
Encodes Caf1 loop 5 mutation 
D33N34→ELDKWA. InFused 
from R901 into pACYCF1 
R1165 This study 
pACYC-F1::4 
Encodes Caf1 loop 7 mutation 
K129GGK132→ELDKWA 
InFused from R902 into 
pACYCF1 
R1166 This study 
pACYCF1_A_Y266A 
Derivative of pACYCF1 with 
middle domain mutation Tyr266 
to Ala 
R1220 This study 
pACYCF1_A_Y266S 
Derivative of pACYCF1 with 
middle domain mutation Tyr266 
to Ser 
R1221 This study 
pACYCF1_A_Q169A 
Derivative of pACYCF1 with 
usher mutation Gln169 to Ala 
R1200 This study 
pACYCF1_A_Q169G 
Derivative of pACYCF1 with 
usher mutation Gln169 to Gly 
R1201 This study 
pACYCF1_F1_N80G 
Derivative of pACYCF1 with 
caf1 mutation Asn80 to Gly 
R1202 This study 
pACYCF1_F1_N81G 
Derivative of pACYCF1 with 
caf1 mutation Asn81 to Gly 
R1203 This study 
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pACYCF1::4_F1_N81G 
Derivative of pACYCF1::4 with 
caf1 mutation Asn81 to Gly 
R1204 This study 
pACYCF1::2_F1_ELDK
WANP 
Derivative of pACYCF1::2 with 
Asn and Pro insertions in Caf1 
insert loop 4 
R1205 This study 
pACYCF1::1_A_Q169A 
Derivative of pACYCF1::1 with 
usher mutation Gln169 to Ala 
R1206 This study 
pACYCF1::1_A_Q169G 
Derivative of pACYCF1::1 with 
usher mutation Gln169 to Gly 
R1207 This study 
pACYCF1_F1_P16A 
Derivative of pACYCF1 with 
caf1 mutation Pro16 to Ala 
R1208 This study 
pACYCF1::3_F1_P16A 
Derivative of pACYCF1::3 with 
caf1 mutation Pro16 to Ala 
R1211 This study 
pACYCF1_F1_R18K 
Derivative of pACYCF1 with 
caf1 mutation Arg18 to Gln 
R1209 This study 
pACYCF1::3_F1_R18K 
Derivative of pACYCF1::3 with 
caf1 mutation Arg18 to Gln 
R1212 This study 
pACYCF1::2_A_ELDK
WANH 
Derivative of pACYCF1::2 with 
Asn and His insertions in Caf1 
insert loop 4 
R1214 This study 
pACYCF1_A_S182A 
Derivative of pACYCF1 with 
usher mutation Ser182 to Ala 
R1215 This study 
pACYCF1::1_A_S182A 
Derivative of pACYCF1::1 with 
usher mutation Ser182 to Ala 
R1216 This study 
pACYCF1_A_Q167S 
Derivative of pACYCF1 with 
usher mutation Gln167 to Ser 
R1217 This study 
pACYCF1_A_Q167A 
Derivative of pACYCF1 with 
usher mutation Gln167 to Ala 
R1218 This study 
pACYCF1::4_F1_N80G 
Derivative of pACYCF1::4 with 
caf1 mutation Asn80 to Gly 
R1219 This study 
pACYCF1D12_GGGGN
NH 
Derivative of pACYCF1D12 with 
Asn, Asn and His insertions in 
Caf1 insert loop 4 
R1222 This study 
pACYCF1::2_ELDKWA
NNH 
Derivative of pACYCF1::2 with 
Asn, Asn and His insertions in 
Caf1 insert loop 4 
R1223 This study 
pACYCF1_plug_E298K 
Derivative of pACYCF1 with 
usher mutation Glu298 to Lys 
R1240 This study 
pACYCF1_plug_E291K 
Derivative of pACYCF1 with 
usher mutation Glu291 to Lys 
R1242 This study 
pACYCF1_plug_E291A 
Derivative of pACYCF1 with 
usher mutation Glu291 to Ala 
R1242 This study 
pACYCF1_plug_R263A 
Derivative of pACYCF1 with 
usher mutation Arg263 to Ala 
R1243 This study 
pACYCF1_hairpin_Y21
5A 
Derivative of pACYCF1 with 
usher mutation Tyr215 to Ala 
R1244 This study 
pACYCF1_hairpin_D21
7A 
Derivative of pACYCF1 with 
usher mutation Asp217 to Ala 
R1245 This study 
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pACYCF1_plug_S289A 
Derivative of pACYCF1 with 
usher mutation Ser289 to Ala 
R1246 This study 
pACYCF1_plug_R258A 
Derivative of pACYCF1 with 
usher mutation Arg258 to Ala 
R1247 This study 
pACYCF1_barrel_K462
A 
Derivative of pACYCF1 with 
usher mutation Lys462 to Ala 
R1248 This study 
pACYCF1_barrel_N144
A 
Derivative of pACYCF1 with 
usher mutation Asn144 to Ala 
R1249 This study 
pACYCF1_barrel_N148
A 
Derivative of pACYCF1 with 
usher mutation Asn148 to Ala 
R1250 This study 
pACYCF1_barrel_N601
A 
Derivative of pACYCF1 with 
usher mutation Asn601 to Ala 
R1251 This study 
pACYCF1_barrel_Q150
A 
Derivative of pACYCF1 with 
usher mutation Gln150 to Ala 
R1252 This study 
pACYCF1_barrel_Q464
A 
Derivative of pACYCF1 with 
usher mutation Gln464 to Ala 
R1253 This study 
pACYCD1_MA_S123 
Encodes E. coli SE11 whole 
operon cloned into pACYCDuet1 
(without upstream and 
downstream). IPTG induce. 
R1193 This study 
pACYCD1_MA_S1 
Derivatives of R1193 encodes E. 
coli SE11 chaperone, usher and 
subunit 1 by deletion of subunit 2 
and 3 (without upstream and 
downstream). IPTG induce. 
R1197 This study 
pACYCD1_MA_S23 
Derivatives of R1193 encodes E. 
coli SE11 chaperone, usher, 
subunit 2 and 3 by deletion of 
subunit 1 (without upstream and 
downstream). IPTG induce. 
R1234 This study 
pTRC99-Mh-S123 
Encodes E. coli SE11 chaperone, 
subunit 1, 2 and 3 cloned into 
pTRC99 with 6 His added at 
chaperone C-terminus. 
R1195 This study 
pTRC99-Mh-S1 
Derivatives of R1195 encodes E. 
coli SE11 chaperone (6 His), and 
subunit 1 by deletion of subunit 1 
and 2 
R1231 This study 
pTRC99-Mh-S23 
Derivatives of R1195 encodes E. 
coli SE11 chaperone (6 His), 
subunit 1 and subunit 2 by 
deletion of subunit 1. 
R1232 This study 
pTRC99-Mh-S3 
Derivatives of R1195 encodes E. 
coli SE11 chaperone (6 His), 
subunit 3 by deletion of subunit 1 
and subunit 2. 
R1198 This study 
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pTRC99-M8h-S123 
Derivatives of R1195 encodes E. 
coli SE11 chaperone, subunit 1, 2 
and 3 with insertion of 2 His 
making 8 His at chaperone C-
terminus. 
R1196 This study 
pACYCF1::1_DS_6His 
Derivative of pACYCF1 with 6 
His insertion at C-terminus of 
Caf1M 
R1225 This study 
pACYCF1::1_DS_4His 
Derivative of pACYCF1 with 4 
His insertion at C-terminus of 
Caf1M 
R1235 This study 
2.4 DNA techniques 
2.4.1 Plasmid isolation 
QIAprep® miniprep kit was used to isolate DNA from cells. There were three 
steps involved in this procedure, preparation and clearing of bacterial lysate, adsorption 
of the DNA onto the spin-column membrane and washing and elution of plasmid DNA. 
Cells from ON cultures (4.5 ml), incubated at 26°C, were pelleted by centrifugation at 
13000rpm for 5 minutes and the supernatant completely removed. The bacterial cells 
were resuspended in 250 µl Buffer P1. P1 buffer contains EDTA which removes Mg2+ 
ion that preserves the cell membrane structure. Then 250 µl of buffer P2 (contain SDS 
for removing the lipids of the cell membrane) was added and the tube was inverted 
gently 6 times. At this point, the mixture turned blue. Then, 350 µl of N3 buffer was 
added to the mixture which was then inverted gently 6 times until the mixture turned 
colorless. This was to neutralize the lysate and adjust it to a high-salt binding condition 
that helps renature the DNA and denature the protein, chromosomal DNA, cellular 
debris and precipitate the SDS. The mixture was centrifuged at 13000 rpm for 10 
minutes and the supernatant was applied to a column followed by centrifugation for 60 
seconds to bind the DNA to the spin-column membrane. PB buffer (500 µl) was added 
to the column which was centrifuged for 1 minute at 13000 rpm to ensure efficient 
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binding of the DNA to the membrane. The supernatant was removed and centrifuged 
again for 1 minute to remove the rest of the PB buffer from the column. Then, 750 µl 
of PE buffer (contains ethanol) was added to the column. The column was placed in a 
new microcentrifuge tube and 30 µl sterilized nH20 was added to the column. After 2 
minutes standing at RT, the plasmid DNA was recovered by centrifugation for 1 minute 
at 13000 rpm. The DNA was then stored at-20°C for later use. 
2.4.2 DNA quantitation 
The NanoDrop spectrophotometer (Thermo Scientific) was used to determine 
the concentration of DNA and quality by measuring the ratio of OD260nm/OD280nm. The 
ratio absorbance at these wavelengths has been used because the maximum absorbance 
of nucleic acid is at 260 nm and 280 nm for protein. A pure DNA sample will have a 
ratio of >1.8   OD260nm/OD280nm. A total of 2 µl DNA was used for quantitation. 
2.4.3 Agarose gel electrophoresis 
To check the DNA quantity and quality, 0.7% w/v agarose gel was used to 
separate the DNA fragments. The gel was prepared by melting 0.35 g agarose powder 
(Melford Labs) in 49.65 ml 1X TAE (40 mM Tris-HCl acetate, 1 mM EDTA pH 8.0). 
GelRed (Biotium, Cambridge Bioscience) (2.5 µl or a 1:20000 dilution) was added 
prior to pouring the gel into a horizontal cast (BioRad) with ten well comb. DNA 
samples were mixed with 2X final concentration of BlueJuice™ Gel Loading Buffer 
(Invitrogen) and loaded onto the gel along with 2µl of HyperLadder I (Bioline). 1X 
TAE was used as running buffer, and the gel was run for 90 minutes at 80 Volts. A 
SYNGENE system (G-Box) was used to image the gels and images were saved in *.tif 
format. 
 63 
 
2.4.4 DNA sequencing and analysis 
A total of 5 µl of plasmid DNA per reaction with a concentration of 50-100 ng/µl 
(from DNA isolation using QIAprep® Miniprep kit) was sent for sequencing with 
appropriate primer to Source Bioscience, Oxford. If the DNA concentration was lower 
than 50 ng/µl, the DNA was sent for sequencing with amplification. Primers were by 
Source Bioscience were sent at a concentration of 3.2 pmol/µl (5µl/reaction). 
Sequences were analysed using DNAdynamo version 1.374 (Blue Tractor Software 
Ltd) and FinchTV version 1.4 (Geospiza). 
2.5 Mutagenesis and Polymerase Chain Reaction (PCR) 
An Eppendorf MasterCycle EP gradient S machine was used to carry out all PCR 
reactions.  
2.5.1 Oligonucleotides 
Oligonucleotides for mutagenesis and sequencing primers are listed in Table 2.3 
and Table 2.4 respectively. For site-directed mutagenesis; the primer size was between 
25 to 45 bases with the desired mutation situated in the middle of the primers and 10 to 
15 correct bases on either side. The GC content was ideally close to 40%, the melting 
temperature at least 78°C (calculated using the Stratagene Quik change formula) and 
primers terminated with 1-3’ C or G bases. 
Clonetech primer design was used to design primers for inverse PCR of 
linearized vector and amplification of gene of interest (insert). When designing primers, 
15bp of overlapping sequence with adjacent segment was included. This 15bp overlap 
sequence in crucial for the InFusion enzyme to work by facilitating the complementary 
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overlapping sequence and create the desire construct. DNAdynamo program was used 
to predict the Tm and GC content of the primer and to check the plasmid is in frame 
after cloning. The melting temperature of the primer pair was aimed to be between 58°C 
to 65°C with a difference of less than 4°C, a GC content of around 40% to 60%, length 
of 18 to 25 nucleotides (excluding 15bp overlap for infusion) and Gs or Cs at the 3’ end. 
Primers were purchased from Eurofin MWG-Biotech, resuspended in nH2O to make a 
stock of 200 pmol/µl, stored at -20°C and used at a working solution of 10 pmol/µl.  
Table 2.3:  Primers used in the construction of mutants. 
Residue in red indicates changes, blue insertion, green substitution, bold indicates 
restriction site and italic indicates 15bp overlap for infusion.
 Primer Sequence (5’-3’) Comment 
Caf1A-F4SFor 
GGGACGCGCATATACT
TCGGACTCTACTATGC
TTG 
Mutates Phe4 of Caf1A to Ser. 
Forward primer. 
Caf1A-F4SRev 
CAAGCATAGTAGAGTC
CGAAGTATATGCGCGT
CCC 
Mutates Phe4 of Caf1A to Ser. 
Reverse primer. 
Caf1A-Y240AFor 
CAGATGAATCGATGGT
CCTGCCTACCAATGGA
ATTTTGCTCC 
Mutates Tyr240 of Caf1A to Ala. 
Forward primer.  
Caf1A-Y240ARev 
GGAGCAAAATTCCATT
GGTAGGCAGGAACCAT
CGATTCATCTG 
Mutates Tyr240 of Caf1A to Ala. 
Reverse primer. 
Caf1A-NdelFor 
TTCCCGGGCAATTGTG
GGATGACGGCATTCC 
Caf1A-∆N with XmaI restriction 
site. Forward primer. 
Caf1A-NdelRev 
ATCCCGGGAGAGTCC
GAAGTATATGCGCGTC 
Caf1A-∆N with XmaI restriction 
site. Reverse primer. 
F1for11 
CCACTGCAACGGCAAC
TCTTG 
Amplification of F1D11, F1D12, 
F1D13, F1::1, F1::2 and F1::3 
inserts (Hybridises to caf1). 
Forward primer. 
F1rev11 
CTGCTGCAAGTTTACC
GCCTTTTG 
Amplification of F1D11, F1D12, 
F1D13, F1::1, F1::2 and F1::3 
inserts (Hybridises to caf1). 
Reverse primer. 
InfFor2 
AGGCGGTAAACTTGCA
GCAGG 
Inverse PCR, to linearize 
pACYCF1 as vector for F1D11, 
F1D12, F1D13, F1::1, F1::2 and 
F1::3 (Hybridises to caf1). 
Forward primer. 
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InfRev2 
ACAAGAGTTGCCGTTG
CAGTGG 
Inverse PCR, to linearize 
pACYCF1 as vector for F1D11, 
F1D12, F1D13, F1::1, F1::2 and 
F1::3 (Hybridised to caf1). 
Reverse primer. 
F1D14insertFOR-2 
GATTTAACTGCAAGCA
CCACTGC 
Amplification of F1D14 and 
F1::4 inserts (Hybridised to caf1). 
Forward primer. 
F1D14insertREV-2 
GGTTAGATACGGTTAC
GGTTACAG 
Amplification of F1D14 and 
F1::4 inserts (Hybridised to caf1). 
Reverse primer. 
F1D14invFOR-2 
TGCTGTAACCGTAACC
GTATCTAAC 
Inverse PCR, to linearize 
pACYCF1 as vector for F1D14 
and F1::4 (Hybridised to caf1). 
Forward primer. 
F1D14invREV-2 
TTGCAGTGGTGCTTGC
AGTTAAATC 
Inverse PCR, to linearize vector 
pACYCF1 as for F1D14 and 
F1::4 (Hybridised to caf1). 
Reverse primer. 
Y287AFor-Caf1A 
GGTAGAGGTTTTAAGA
GATGGCGCCACTGTAA
GTAATGAGTTGGTG 
Mutates Tyr266 of Caf1A to Ala. 
Forward primer. 
Y287ARev-Caf1A 
CACCAACTCATTACTT
ACAGTGGCGCCATCTC
TTAAAACCTCTACC 
Mutates Tyr266 of Caf1A to Ala. 
Reverse primer. 
Y287SFor-Caf1A 
GGTAGAGGTTTTAAGA
GATGGCAGCACTGTAA
GTAATGAGTTGGTG 
Mutates Tyr266 of Caf1A to Ser. 
Forward primer. 
Y287SRev-Caf1A 
CACCAACTCATTACTT
ACAGTGCTGCCATCTC
TTAAAACCTCTACC 
Mutates Tyr266 of Caf1A to Ser. 
Reverse primer. 
F1ins1_Q190Afor 
ACTCTTATTATGCTCAG
TTGGCACCGGGATTAA
ACATAGGGG 
Mutates Gln169 of Caf1A to Ala 
to make pACYCF1_A_Q169A 
and pACYCF1::1_A_Q169A 
constructs. Forward primer. 
F1ins1_Q190Arev 
CCCCTATGTTTAATCCC
GGTGCCAACTGAGCAT
AATAAGAGT 
Mutates Gln169 of Caf1A to Ala 
to make pACYCF1_A_Q169A 
and pACYCF1::1_A_Q169A 
constructs. Reverse primer. 
F1ins1_Q190Gfor 
CTCTTATTATGCTCAGT
TGGGACCGGGATTAAA
CATAGGGG 
Mutates Gln169 of Caf1A to Gly 
to make pACYCF1_A_Q169G 
and pACYCF1::1_A_Q169G 
constructs. Forward primer. 
F1ins1_Q190Grev 
CCCCTATGTTTAATCCC
GGTCCCAACTGAGCAT
AATAAGAG 
Mutates Gln169 of Caf1A to Gly 
to make pACYCF1_A_Q169G 
and pACYCF1::1_A_Q169G 
constructs. Reverse primer. 
D12_N80Gfor 
CATTTACTTCTCAGGAT
GGAGGTAACCACCAAT
TCACTACAAAAGTG 
Mutates Asn80 to Gly of Caf1 to 
make pACYCF1_F1_N80G and 
pACYCF1::4_F1_N80G 
constructs. Forward primer. 
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D12_N80Grev 
CACTTTTGTAGTGAATT
GGTGGTTACCTCCATC
CTGAGAAGTAAATG 
Mutates Asn80 to Gly of Caf1 to 
make pACYCF1_F1_N80G and 
pACYCF1::4_F1_N80G 
constructs. Reverse primer. 
D12_N81Gfor 
GTACTTAACATTTACTT
CTCAGGATGGAAATGG
CCACCAATTCACTAC 
Mutates Asn81 to Gly of Caf1 to 
make pACYCF1_F1_N81G and 
pACYCF1::4_F1_N81G 
constructs. Forward primer. 
D12_N81Grev 
GTAGTGAATTGGTGGC
CATTTCCATCCTGAGA
AGTAAATGTTAAGTAC 
Mutates Asn81 to Gly of Caf1 to 
make pACYCF1_F1_N81G and 
pACYCF1::4_F1_N81G 
constructs. Reverse primer. 
Caf1_P16A_For 
CAACGGCAACTCTTGT
TGAAGCAGCCCGCATC 
Mutates Pro16 to Ala of Caf1 to 
make pACYCF1_F1_P16A and 
pACYCF1::3_F1_P16A 
constructs. Forward primer. 
Caf1_P16A_Rev 
GATGCGGGCTGCTTCA
ACAAGAGTTGCCGTTG 
Mutates Pro16 to Ala of Caf1 to 
make pACYCF1_F1_P16A and 
pACYCF1::3_F1_P16A 
constructs. Reverse primer. 
Caf1_R18K_For 
GCAACTCTTGTTGAAC
CAGCCAAGATCACTCT
TACATATAAGGAAG 
Mutates Arg18 to Lys of Caf1 to 
make pACYCF1_F1_R18K and 
pACYCF1::3_F1_R18K 
constructs. Forward primer. 
Caf1_R18K_Rev 
TTCCTTATATGTAAGA
GTGATCTTGGCTGGTT
CAACAAGAGTTGCC 
Mutates Arg18 to Lys of Caf1 to 
make pACYCF1_F1_R18K and 
pACYCF1::3_F1_R18K 
constructs. Reverse primer. 
F1ins2_ELDKWANH_
for 
CTGAACTGGATAAATG
GGCCAACCACCAATTC
ACTACAAAAGTGATTG 
Inserts His and Asn to create 
pACYCF1::2_ELDKWANH 
construct. Forward primer. 
F1ins2_ELDKWANH_
rev 
CAATCACTTTTGTAGT
GAATTGGTGGTTGGCC
CATTTATCCAGTTCAG 
Inserts His and Asn to create 
pACYCF1::2_ELDKWANH 
construct. Reverse primer. 
Caf1A_S203A_for 
CTTGGCGCTTTCGTAGT
GCAACCTCATGGTGGA
AA 
Mutates Ser182 to Ala of Caf1A 
to make pACYCF1_A_S182A 
and pACYCF1::1_A_S182A 
constructs. Forward primer. 
Caf1A_S203A_rev 
TTTCCACCATGAGGTT
GCACTACGAAAGCGCC
AAG 
Mutates Ser182 to Ala of Caf1A 
to make pACYCF1_A_S182A 
and pACYCF1::1_A_S182A 
constructs. Reverse primer. 
Caf1A_Q188A_for 
TCTCTGGACTCTTATTA
TGCTGCGTTGCAACCG
GGATTAAAC 
Mutates Gln167 of Caf1A to Ala. 
Forward primer. 
Caf1A_Q188A_rev 
GTTTAATCCCGGTTGC
AACGCAGCATAATAAG
AGTCCAGAGA 
Mutates Gln167 of Caf1A to Ala. 
Reverse primer. 
Caf1A_Q188S_for 
GTCTCTGGACTCTTATT
ATGCTTCGTTGCAACC
GGGATTAAACA 
Mutates Gln167 of Caf1A to Ser. 
Forward primer. 
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Caf1A_Q188S_rev 
TGTTTAATCCCGGTTGC
AACGAAGCATAATAAG
AGTCCAGAGAC 
Mutates Gln167 of Caf1A to Ser. 
Reverse primer. 
F1D12_GGGGNNH_F
OR 
CTGGTGGGGGTGGCAA
TAACCACCAATTCACT
ACAAAAGTG 
Inserts His and two Asn to create 
pACYCF1D12 _ELDKWANNH 
construct. Forward primer. 
F1D12_GGGGNNH_R
EV 
CACTTTTGTAGTGAATT
GGTGGTTATTGCCACC
CCCACCAG 
Inserts His and two Asn to create 
pACYCF1D12 _ELDKWANNH 
construct. Reverse primer. 
F1ins2_ELDKWANN
H_for 
CTGAACTGGATAAATG
GGCCAATAACCACCAA
TTCACTACAAAAGTG 
Inserts His and two Asn to create 
pACYCF1::2_ELDKWANNH 
construct. Forward primer. 
F1ins2_ELDKWANN
H_rev 
CACTTTTGTAGTGAATT
GGTGGTTATTGGCCCA
TTTATCCAGTTCAG 
Inserts His and two Asn to create 
pACYCF1::2_ELDKWANNH 
construct. Reverse primer. 
Plug_E298K_For 
GAGCTGAAAGTCATCA
TTCATAAAAGTGATGG
AACAAAGCAAG 
Mutates Glu298 of Caf1A middle 
domain to Lys. Forward primer. 
Plug_E298K_Rev 
CTTGCTTTGTTCCATCA
CTTTTATGAATGATGA
CTTTCAGCTC 
Mutates Glu298 of Caf1A middle 
domain to Lys. Reverse primer. 
Plug_E291K_For 
GGGTGGGGGGAGTGGT
AAGCTGAAAGTCAT 
Mutates Glu291 of Caf1A middle 
domain to Lys. Forward primer. 
Plug_E291K_Rev 
TGACTTTCAGCTTACC
ACTCCCCCCACCC 
Mutates Glu291 of Caf1A middle 
domain to Lys. Reverse primer. 
Plug_E291A_For 
GTGGGGGGAGTGGTGC
GCTGAAAGTCATCAT 
Mutates Glu291 of Caf1A middle 
domain to Ala. Forward primer. 
Plug_E291A_Rev 
ATGATGACTTTCAGCG
CACCACTCCCCCCAC 
Mutates Glu291 of Caf1A middle 
domain to Ala. Reverse primer. 
Plug_R263A_For 
GCCAGGGTAGAGGTTT
TAGCAGATGGCTACAC
TGTAAAG 
Mutates Arg263 of Caf1A middle 
domain to Ala. Forward primer. 
Plug_R263A_Rev 
ACTTACAGTGTAGCCA
TCTGCTAAAACCTCTA
CCCTGGC 
Mutates Arg263 of Caf1A middle 
domain to Ala. Reverse primer. 
Hairpin_Y215A_F 
CGTTTGACATTGGGGG
AAACCGCTTCTGATAG
CAGTATCTTTG 
Mutates Tyr215 of Caf1A hairpin 
loop to Ala. Forward primer. 
Hairpin_Y215A_R 
CAAAGATACTGCTATC
AGAAGCGGTTTCCCCC
AATGTCAAACG 
Mutates Tyr215 of Caf1A hairpin 
loop to Ala. Reverse primer. 
Hairpin_D217A_F 
GGGGGAAACCTATTCT
GCTAGCAGTATCTTTG
ACAG 
Mutates Asp217 of Caf1A hairpin 
loop to Ala. Forward primer. 
Hairpin_D217A_R 
CTGTCAAAGATACTGC
TAGCAGAATAGGTTTC
CCCC 
Mutates Asp217 of Caf1A hairpin 
loop to Ala. Reverse primer. 
Plug_S289A_F 
CTCTGGGTGGGGGGGC
TGGTGAGCTGAAAG 
Mutates Ser289 of Caf1A middle 
domain to Ala. Forward primer. 
Plug_S289A_R 
CTTTCAGCTCACCAGC
CCCCCCACCCAG 
Mutates Ser289 of Caf1A middle 
domain to Ala. Reverse primer. 
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Plug_R258A_F 
CGCACGTACACAAGCC
GCGGTAGAGGTTTTAA
GAG 
Mutates Arg258 of Caf1A middle 
domain to Ala. Forward primer. 
Plug_R258A_R 
CTCTTAAAACCTCTAC
CGCGGCTTGTGTACGT
GCG 
Mutates Arg258 of Caf1A middle 
domain to Ala. Reverse primer. 
Barrel_K462A_F 
GATTATGCTAAACCCA
AAAACGCAGTGCAATT
CAATTTAAGTCAAAGC 
Mutates Lys462 of Caf1A β-
barrel to Ala. Forward primer. 
Barrel_K462A_R 
GCTTTGACTTAAATTG
AATTGCACTGCGTTTTT
GGGTTTAGCATAATC 
Mutates Lys462 of Caf1A β-
barrel to Ala. Reverse primer. 
Barrel_N144A_F 
GGCATTCCTGCTCTGTT
CATGGCTTATAATACG
AACATGCAGAC 
Mutates Asn144 of Caf1A β-
barrel to Ala. Forward primer. 
Barrel_N144A_R 
GTCTGCATGTTCGTATT
ATAAGCCATGAACAGA
GCAGGAATGCC 
Mutates Asn144 of Caf1A β-
barrel to Ala. Reverse primer. 
Barrel_N148A_F 
GCTCTGTTCATGAATT
ATAATACGGCCATGCA
GACAAGAAAATTCAG 
Mutates Asn148 of Caf1A β-
barrel to Ala. Forward primer. 
Barrel_N148A_R 
CTGAATTTTCTTGTCTG
CATGGCCGTATTATAA
TTCATGAACAGAGC 
Mutates Asn148 of Caf1A β-
barrel to Ala. Reverse primer. 
Barrel_Q150A_F 
GAATTATAATACGAAC
ATGGCGACAAGAAAAT
TCAGAGAAGGAGGC 
Mutates Gln150 of Caf1A β-
barrel to Ala. Forward primer. 
Barrel_Q150A_R 
GCCTCCTTCTCTGAATT
TTCTTGTCGCCATGTTC
GTATTATAATTC 
Mutates Gln150 of Caf1A β-
barrel to Ala. Reverse primer. 
Barrel_Q464A_F 
GCTAAACCCAAAAACA
AAGTGGCATTCAATTT
AAGTCAAAGCATACCT
G 
Mutates Gln464 of Caf1A β-
barrel to Ala. Forward primer. 
Barrel_Q464A_R 
CAGGTATGCTTTGACT
TAAATTGAATGCCACT
TTGTTTTTGGGTTTAGC 
Mutates Gln464 of Caf1A β-
barrel to Ala. Reverse primer. 
Barrel_N601A_F 
CCTCCAATGCACTGAA
TTTGGCTTATCGAGGA
ACTTATGGG 
Mutates Asn601 of Caf1A β-
barrel to Ala. Forward primer. 
Barrel_N601A_R 
CCCATAAGTTCCTCGA
TAAGCCAAATTCAGTG
CATTGGAGG 
Mutates Asn601 of Caf1A β-
barrel to Ala. Reverse primer. 
SE11For1  
AGGAGATATACCATGA
ACGGCAGCTATGCGC
CG 
Amplification of E. coli SE11 
MA_S123 inserts (Hybridises to 
pACYCD1). Forward primer. To 
create pACYC_MA_S123 
construct. 
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SE11Rev1 
TGGCTGCTGCCCATG
TGTAAGAACATGCCT
GCAC 
Amplification of E. coli SE11 
MA_S123 inserts (Hybridises to 
pACYCD1). Reverse primer. To 
create pACYC_MA_S123 
construct. 
pACYCD1_MA_S1_F 
GAACTAGTTTATATAC
CAAATGAAAGC 
SE11_∆S23 with SpeI restriction 
site. Forward primer. 
pACYCD1_MA_S1_R 
GAACTAGTAGCAGCC
ATCACCATC 
SE11_∆S23 with SpeI restriction 
site. Reverse primer. 
SE11_Mhis_C2_F 
AGGAAACAGACCATGAT
GAAGTATAGAAAACTA
CAAATCTTAAATTGTG 
Amplification of E. coli SE11 
M6his_S123 inserts (Hybridises 
to pACYCD1). Forward primer. 
To create pTRC99_Mh_S123 
construct. 
SE11_Mhis_C2_R 
GAACACCATTAGTGATG
ATGATGATGATGAAAA
ATTACATTCTTCG 
Amplification of E. coli SE11 
M6his_S123 inserts (Hybridises 
to pACYCD1). Reverse primer. 
To create pTRC99_Mh_S123 
construct. 
pTRC99_Mh_S1_for 
GAACTAGTTTATATAC
CAAATGAAAGC 
SE11_∆S23 with SpeI restriction 
site. Forward primer. 
pTRC99_Mh_S1_rev 
GAACTAGTTTCTAACG
AAGTTTATTGG 
SE11_∆S23 with SpeI restriction 
site. Reverse primer. 
pTRC99_Mh_S23_for 
GAACTAGTACTTCGTT
AGAAATAAGG 
SE11_∆S1 with SpeI restriction 
site. Forward primer. 
pTRC99_Mh_S23_rev 
GAACTAGTCAGACGAT
AACGAGAC 
SE11_∆S1 with SpeI restriction 
site. Reverse primer. 
pTRC99-Mh-S3_for 
GAACTAGTCAGGGGA
ATGATTGTTC 
SE11_∆S12 with SpeI restriction 
site. Forward primer. 
pTRC99-Mh-S3_rev 
GAACTAGTCAGACGAT
AACGAGAC 
SE11_∆S12 with SpeI restriction 
site. Reverse primer. 
SE11_M8his_for 
CGAAGAATGTAATTTT
TCACCACCATCATCAT
CATCATCAC 
Inserts two His of pTRC99-Mh-
S123 to create pTRC99-M8h-
S123 construct. Forward primer. 
SE11_M8his_rev 
GTGATGATGATGATGA
TGGTGGTGAAAAATTA
CATTCTTCG 
Inserts two His of pTRC99-Mh-
S123 to create pTRC99-M8h-
S123 construct. Reverse primer. 
F1ins1_6His_For 
GTGATTGGCAAGCATC
ATCACCATCACCACGAT
ATCTCTCCTAAG 
Substitutes ELDKWA of 
pACYCF1::1 to six His to create 
pACYCF1::1_6His construct. 
Forward primer. 
F1ins1_6His_Rev 
CTTAGGAGAGATATCG
TGGTGATGGTGATGAT
GCTTGCCAATCAC 
Substitutes ELDKWA of 
pACYCF1::1 to six His to create 
pACYCF1::1_6His construct. 
Reverse primer. 
Fi1ns1_DS4his_F 
GATTGGCAAGGATTCT
CATCATCACCACGATA
TCTC 
Substitutes two His of 
pACYCF1::1_6His to Asp and 
Ser to create 
pACYCF1::1_DS_4His 
construct. Forward primer. 
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Fi1ns1_DS4his_R 
GAGATATCGTGGTGAT
GATGAGAATCCTTGCC
AATC 
Substitutes two His of 
pACYCF1::1_6His to Asp and 
Ser to create 
pACYCF1::1_DS_4His 
construct. Reverse primer. 
 
Table 2.4: Sequencing primers 
Primer Sequence (5’-3’) Direction Comment 
DuetDOWN1 
GATTATGCGGCCGT
GTACAA 
Reverse 
Primes within vector, 
downstream Caf1, 
available commercially 
DuetUP1 
GTCCGGGATCTCGA
CGCTCTCCCTTATG 
Forward 
Primes within vector, 
downstream Caf1R, 
available commercially 
F1#1 
ATGTTGGGTCGAAC
ATAAATCG 
Forward 
Primes within vector, 
near Caf1R 
F1#4 
CACAAACATCGTAT
GTTGGCGCTC 
Forward 
Primes from middle of 
Caf1A 
F1#6 
CCTTCTGCTGAATCC
TGAATAC 
Forward 
Primes from beginning 
of Caf1R towards 
intergenic promoter 
region 
F1-7for 
TCAGAGGATCCTTT
CGTGGTCAC 
Forward 
Primes from middle of 
Caf1M 
Caf1Afor-3b 
GAGGAACTTATGGG
GAGATCAGTG 
Forward 
Primes from end of 
Caf1A towards Caf1 
Caf1Afor-4 
AAATCTGGTACAGA
GCAATGTG 
Forward 
Primes from start of 
Caf1A 
Caf1Arev-1 
CTACGAAAGCGCCA
AGCCCCTATG 
Reverse 
Primes from within 
first quarter of Caf1A 
towards Caf1M 
F1rev2 
GATTGGTGTTGCTG
GGTATG 
Reverse 
Primes from start of 
intergenic promoter 
region towards Caf1R 
Caf1Arev1 
CATAGGGGCTTGGC
GCTTTCGTAG 
Reverse 
To sequence 
pACYCF1-Caf1A -F4S 
and –N∆ 
Caf1Arev2 
CCCAGTTACTTTACC
CAATGATGCAGAG 
Reverse 
To sequence 
pACYCF1-Caf1A-
Y240A 
pTRC99A.seq.for 
TGCAGGTCGTAAAT
CACTGC 
Forward 
Primes within vector, 
upstream chaperone of 
pTRC99_Mh_S123. 
Available 
commercially 
pTRC99his reverse 
CTTCTGCGTTCTGAT 
TTAATCTG 
Reverse 
Primes within vector, 
downstream subunit 3 
of pTRC99_Mh_S123. 
Available 
commercially 
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SE11_A_1_Rev 
ACACGGTGATAATG
TATCTTCG 
Reverse 
Primes from beginning 
of usher towards 
subunit 1 
SE11_A_1_For 
AATGGCGAAGATAC
ATTATCACCG 
Forward 
Primes from beginning 
of usher towards 
chaperone 
SE11_A_2_For 
AAATTTGATACACG
TATCGGTGGG 
Forward 
Primes from end of 
usher towards subunit 1 
SE11_A_2_Rev 
TAACAGTCGCCCAC
CGATAC 
Reverse 
Primes from end of 
usher towards 
chaperone 
SE11_S2_3_Rev 
TAGCAGTTATCGCT
GTTCCG 
Reverse 
Primes from beginning 
of subunit 2 towards 
subunit 3 
SE11_S2_3_for 
TTATTCGGAACAGC
GATAACTGC 
Forward 
Primes from beginning 
of subunit 2 towards 
subunit 1 
** See Appendix 13 for approximate location of priming site 
 
 
 
 
2.5.2 Site-directed mutagenesis 
QuikChange II XL Site-Directed Mutagenesis was used to construct all specific 
mutant of Caf1 and Caf1A in pACYCF1 and Histidine insertions of pTRC99-Mh-S123, 
pTRC99-M8h-S123, pACYCF1::1_DS_6His and pACYCF1::1_DS_4His. The 
reaction mixture was prepared, according to the kit instructions and as follows: 2.5 µl 
10X reaction buffer, 50 ng of template plasmid, 0.625 µl of 10 pmol forward and reverse 
plasmid, 0.5 µl of dNTP mix, 1.5 µl of Quick solution agent, 0.5 µl of Pfu Ultra HF 
DNA polymerase (2.5U/µl) and nH2O to make up the final volume to 25 µl. The 
reaction mixture was prepared on ice. The PCR cycling parameter were as follows: 
initial denaturation at 95˚C for 2 minutes (1 cycle), 18 cycles of denaturation (95˚C for 
1 minute), annealing (60˚C for 1 minute) and extension (95˚C for 2 min/Kb) followed 
by final extension at 68˚C for 7 minutes.  The PCR products were treated with DpnI 
enzyme from the kit as follows: 0.5 µl of DpnI was added to 15 µl of PCR reaction, 
incubated for 2 hours at 37˚C and transformed into E. coli competent cells. 
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Transformants were picked and grown overnight at 26°C for plasmid isolation and 
sequencing. 
2.5.3 Deletion mutagenesis 
Inverse PCR was used for construction of the N-terminal deletion mutant, 
pACYCF1-A-∆N. Oligonucleotides (Caf1A-N-delFor and Caf1A-delRev) were 
designed with a XmaI restriction site, for religation of the PCR product. The PCR 
mixture was prepared according to CloneAMP
TM
 HiFi Premix instructions. The mixture 
was prepared in triplicate for three different annealing temperatures to get optimum 
PCR products using the temperature gradient programme of the PCR machine. Then, 
the PCR product was treated with DpnI, purified and digested with XmaI, (New 
England Biolab) to create sticky ends. Then, the restriction enzyme was heat inactivated 
at 20 minutes at 65°C and the PCR product purified. To ligate the product, DNA (50ng) 
was made up to 10µl with nH2O, mixed with Quick ligase (Biolabs) (1 µl) and 10 µl of 
2X Quick Ligase buffer (Biolabs) and incubated at room temperature (25°C) for 5 
minutes. The plasmid was transformed into E. coli DH5α and incubated at 26°C for 48 
hours. Transformants were picked and grown overnight at 26°C for plasmid isolation 
and sequencing. 
Table 2.5: PCR reaction mixture of inverse PCR 
Component Volume 
Clone Amp HiFi PCR Premix 2X (Clonetech) 12.50 µl 
Primer Caf1A-NdelFor (7.5 pmol) 0.75 µl 
Primer Caf1A-NdelRev (7.5 pmol) 0.75 µl 
pACYCF1 template (50 ng) 5 µl 
nH20 6 µl 
Total 25 µl 
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Table 2.6: PCR reaction condition for inverse PCR.  
Different annealing temperatures were used to get optimum PCR product. Annealing 
temperatures were choosen based on annealing temperature of the oligonucleotides. 
Below is an example of PCR condition used to synthesize Caf1A-N-terminal deletion. 
 Step Temperature Time Cycle 
Denature 98°C 10 seconds 
30 cycles Annealing 55.1°C, 57.1°C and 59.7°C 10 seconds 
Extension 72°C 
88 seconds 
(10 sec/kb) 
 
2.5.4 InFusion Mutagenesis 
Plasmid constructs pACYC-F1D11, pACYC-F1D12, pACYC-F1D13, 
pACYC-F1D14, pACYC-F1::1, pACYC-F1::2, pACYC-F1::3, pACYC-F1::4, 
pACYC_MA_S123 and pTRC99-Mh-S123 were designed using In-fusion HD cloning 
kit (Clontech). The CloneAMP
TM
 HiFi Premix was used to linearise vectors and 
amplify inserts.  
2.5.4.1 Linearizing vector 
Inverse PCR or restriction enzyme digestion was used to linearize vector for 
infusion. Inverse PCR was used to linearise vector and prepared according to the 
CloneAMP
TM
 HiFi Premix instructions as follows: 12.5 µl of 2X CloneAmp HiFi PCR 
Premix, 7.5 µl of 10 pmol forward and reverse primer, 50 and 100 ng of template 
plasmid, made up to 25 µl with nH2O. To get optimal PCR products, two different 
template concentrations were prepared. Cycling parameters with three different 
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annealing temperatures were used based on primer melting temperature, which were 
between 2˚C to 5˚C less than melting temperature. The PCR cycling parameters are as 
follows: denature for 10 seconds at 98˚C, annealing for 10 seconds at three different 
annealing temperatures, extension at 72˚C for 30 secs/Kb.  
For linearising vector by restriction digestion, 1µl of restriction enzyme (New 
England Biolabs) and 10X NEBuffer was added to 30µl of DNA. Then, nH2O was 
added up to a final concentration of 50µl. The mixture was incubated for 1 hour at room 
temperature. The reaction was stopped by heat inactivation according to manufacturer 
instruction (i.e. SpeI was heat inactivated at 80°C for 20 minutes). 
After amplification, the linearised vector was verified using agarose gel, DpnI 
treated and purified. The purified linerised vector and insert were then analysed again 
by agarose gel to check the quality and quantity of the purified PCR products. 
2.5.4.2 Amplification of inserts 
CloneAMP
TM
 HiFi Premix was used to amplify the targeted insert. The PCR 
reaction mix was prepared as follows: 12.5 µl of 2X CloneAmp HiFi PCR Premix, 7.5 
µl of 10 pmol forward and reverse primer, 50 ng of template plasmid, made up to 25 µl 
with nH2O. To get optimal PCR products, cycling parameters with three different 
annealing temperatures were used based on primer melting temperature which are 
between 2˚C to 5˚C less than melting temperature. The PCR cycling parameter are as 
follows: denature for 10 seconds at 98˚C, annealing for 10 seconds at three different 
annealing temperatures, extension at 72˚C for 30 secs/Kb. Then, the PCR product was 
DpnI treated, purified and quality and quantity of the product was checked by agarose 
gel. 
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2.5.4.3 InFusion cloning reaction 
InFusion cloning reactions were set up at room temperature as follows: 2µl 5X 
InFusion enzyme premix, 1 volume of vector (100ng), 3 volume of purified insert, made 
up mith nH2O to final volume of 10µl. In-fusion molar ratio calculator was used to help 
calculate the optimal amount of vector and insert for the In-Fusion. 
(http://www.clontech.com/US/Products/Cloning_and_Competent_Cells/Cloning_Res
ources/Online_In-Fusion_Tools). The mixture was incubated for 15 minutes at 50°C, 
and then placed on ice. Finally, 3 µl of the reaction mixture was used for transformation 
of Stellar competent cells (Clonetech) which were incubated for 48 hours at 26°C. 
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Figure 2.1: In-Fusion cloning procedure using In-Fusion HD Cloning kit (Image 
taken from Clonetech  In-Fusion user manual)
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2.5.5 DpnI digestion 
Following PCR, DpnI digestion was used to digest methylated and 
hemimethylated parental template in the reaction mixture. DpnI CutSmart (0.5µl)(New 
England Biolabs) was added to 21µl of the PCR product, 1X CutSmart buffer (New 
England Biolabs) and nH2O was added up to final concentration of 25µl. The mixture 
was incubated for 1 hour at 37°C. 
2.5.6 Purification of PCR products 
QIAquick® PCR Purification Kit was used to purify the PCR products of 
100bp-10Kbp. Sample (usually all PCR product was purified, 25µl) was mixed with 5 
volumes of PB buffer. This buffer helps to increase the negative charge of the DNA so 
that it could bind to the column. The mixture was then applied to a QIAquick column 
and centrifuged for 60 seconds.  PE buffer (750 µl), which contains ethanol, was added 
to the column and centrifuged for another 60 seconds to wash the DNA. Then the 
column was placed in a clean 1.5 ml microcentrifuge tube. Sterilised nH20 (50 l) was 
added to the column and centrifuged to elute the DNA. A Nanodrop spectrophotometer 
was used to quantify the purified DNA which was then stored at -20°C for later use. 
For infusion, inserts and vectors were purified using NucleoSpin® Gel and PCR 
Clean-up kit (MACHERY-NAGEL).  The PCR product was mixed with 2 volumes of 
buffer NT1 (binding buffer). The mixture was applied onto a NucleoSpin column and 
centrifuged for 30 seconds at 10000 rpm. The flow-through was discarded. Then, the 
silica membrane was washed by adding 700µl Buffer NT3 (ethanolic buffer) to the 
column followed by centrifugation for 30 seconds at 10000 rpm. The flow-through was 
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discarded and the silica membrane was dried by centrifugation for 1 minute at 11000 x 
g. Pure DNA was eluted with 30µl Buffer NE, incubated at RT for 1 minute and 
centrifuged for 1 minute at 10000 rpm. The DNA concentration was read using 
Nanodrop spectrophotometer then stored at -20˚C for later use. 
2.5.7 DNA extraction from agarose gels 
NucleoSpin® Gel and PCR Clean-up kit (MACHERY-NAGEL) was used to 
extract DNA from agarose gel. After running 0.7% agarose gel for 90 minutes at 80 
Volts, a clean scalpel was used to excise the DNA fragment. All excess agarose was 
removed and weight of the gel slice was determined. Based on the weight, for each 100 
mg of agarose gel, 200µl Buffer NTI (binding buffer) was added and incubated for 5 to 
10 minutes at 50˚C until the gel slices completely dissolved. The dissolved gel was 
transferred onto a NucleoSpin column, centrifuged for 30 seconds at 10000 rpm. The 
flow-through was discarded. Then, the silica membrane was washed by adding 700µl 
Buffer NT3 (ethanolic buffer) to the column followed by centrifugation for 30 seconds 
at 10000 rpm. The flow-through was discarded and the silica membrane was dried by 
centrifugation for 1 minute at 10000 rpm. Pure DNA was eluted with 30µl Buffer NE, 
incubated at RT for 1 minute and centrifuged for 1 minute at 10000 rpm. The DNA 
concentration was read using a Nanodrop spectrophotometer then stored in -20˚C for 
later use. 
2.6 Making competent cells 
An overnight culture (0.5 ml) was subcultured into 50ml LB in 250 ml flask and 
incubated at 37°C with 225 rpm shaking until the OD600 reached 0.4-0.5, at which point 
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cells were harvested in Falcon tubes by centrifugation at 4000 rpm and 4°C for 15 
minutes. The supernatant was discarded and the pellet was resuspended in 15 ml ice-
cold RF1 buffer. The mixture was incubated for 15 minutes and then centrifuged at 
4000 rpm for 10 minutes at 4°C. The pellet was resuspended in 5ml ice-cold RF2 buffer 
and incubated on ice for 15 minutes. Cells were dispensed in 50 l aliquots in sterile 
microcentrifuge tubes, using cold tips. Finally, the aliquots were snap frozen in liquid 
N2 and stored at -80°C.  
Table 2.7: Preparation of RF1 and RF2 buffer. 
RF1 buffer composition 
(160mM KCl, 50mM MnCl2, 30 mM K 
acetate, 10 mM CaCl2, 15% glycerol, 
pH 5.8) 
RF2 buffer composition 
(10 mM KCl, 75 mM CaCl2, 10 mM 
MOPS, 15% glycerol, pH 6.8) 
KCl 2.4 g KCl 0.3 g 
MnCl2.4H20 1.98 g 0.5 M MOPS (pH 6.8 
adjust with KOH) 
4 ml 
Potassium Acetate 0.6 g 
Glycerol 30 ml Glycerol 30 ml 
CaCl2.2H20 0.3g CaCl2.2H20 2.2 g 
Adjust pH 5.8 with 0.2M acetic acid, 
make up to 200 ml and filter sterilise. 
Store at -20°C. 
Adjust pH 6.8 with KOH, make up 
volume to 200ml and filter sterilise. 
Store at -20°C. 
  
2.7 Transformation 
Competent cells from -80°C stocks were thawed on ice.  DNA from plasmid 
isolation (1 µl), InFusion/ligation mixture (3 µl) or site-directed mutagenesis (1 or 2 µl) 
was added and mixed gently with 25 µl or 30 µl competent cells, respectively. The 
mixture was incubated for 30 minutes on ice, heat-shocked at 42°C on a heating block 
for 1 minute, and then incubated for 2 minutes on ice. Pre-warmed LB (250 µl) with  
0.6% glucose was added to the cells, which were then incubated at 37°C for 1 hour at 
225 rpm shaking. Transformants were spread on LB agar plates with the appropriate 
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antibiotic and incubated for 48 hours at 26°C, inverted. Transformants were stored on 
plates at –4°C until required (generally within 1 or 2 days, within 2 weeks at latest). For 
storage, single transformants were picked and resuspended in 1 ml of LB with 15% 
glycerol. The transformant stock was dispensed into 100 µl aliquots and stored at -80°C 
for subsequent experiments. 
2.8 Cell fractionation 
2.8.1 Analysis of F1 in whole E. coli cells 
E. coli DH5α or E.coli BW25113 carrying pACYCF1 or derivative was cultured 
overnight and induced at 37°C as in section 2.2. After 4 h induction, OD600 was 
measured. Then, 1 ml of cells was centrifuge at 13000 rpm for 20 minutes. Encapsulated 
cells require a longer time to pellet than unencapsulated cells. The supernatant was 
discarded by pipetting and avoiding losing any of the fluffy pellet (F1). The pelleted 
cells were resuspended in PBS to give a final concentration of 5OD cell equivalent/ml 
and stored at -20°C. 
2.8.2 Isolation of surface F1 
E. coli DH5α or E. coli BW25113 carrying pACYCF1, derivative thereof, or 
pFMA1 was cultured overnight and induced for F1 production, as in section 2.2. 
Following induction, 3OD equivalent of cells were recovered by centrifugation at 
13000 rpm for 20 minutes. The pelleted cells were resuspended in 100 µl PBS and heat-
shocked for 1 hour at 57°C, in a heating block or water bath unless otherwise indicated. 
The cells were mixed gently every 15 minutes. Then, the cells were removed at 13000 
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rpm for 10 minutes at 4°C. The supernatant that contained released F1 was stored at -
20°C.  
Preparation of the F1 standard used the same procedure as surface extraction 
except it was done in batch. First, the DH5α containing pACYCF1 plasmid was cultured 
in 10 ml LB, 0.6% glucose, 34 µg/ml CAM at 26°C ON with 225 rpm shaking. The 
next day, 10 ml of the washed cells were subcultured in 100 ml of LB with 10 µg/ml 
CAM and incubated for 4 hours at 37°C with 225 rpm shaking, then the OD600 was 
read. All of the cells from 100 ml LB were recovered by centrifugation at 15000 rpm 
for 30 minutes at 4°C using the Sorvall high-speed centrifuge. The recovered cells were 
resuspended in PBS (1ml of PBS per 10 ODs bacterial cell) and heat-shocked for 1 hour 
at 57°C in a water bath. The cells were mixed gently every 15 minutes. Then the sample 
was centrifuged at 15000 rpm for 10 minutes at 4°C using the Sorvall centrifuge. The 
supernatant was kept at -20°C and quantified to establish a value for the standard. 
2.8.3 Isolation of periplasmic F1 
E. coli DH5α or E. coli BW25113 carrying pACYCF1 or pFMA1 were cultured 
overnight and thermo-induced at 37°C for 4h to induce for F1 production, or with IPTG 
as in section 2.2. Following induction, 3OD cells were recovered by centrifugation at 
13000 rpm for 20 minutes. The pelleted cells were resuspended in 100 µl of 20% (w/v) 
sucrose, in 30mM Tris pH 8.0, 10mM EDTA and incubated for 10 minutes at RT. 
Plasmolysed cells were recovered by centrifugation at 13000 rpm for 10 minutes at RT. 
All supernatant was removed and cells resuspended in 100 µl of cold 10mM MgCl2 and 
incubated for 10 min on ice. The periplasmic fractions were recovered by centrifugation 
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at 13000 rpm for 10 minutes at 4°C.  The supernatant (periplasmic fractions) was stored 
at -20°C for further analysis.  
2.9 Protein techniques 
2.9.1 Bradford assay 
A Quick Start Bradford Protein Assay kit (Bio-Rad) was used to determine the 
concentration of the Caf1 protein in the Caf1 standard. The Microassay protocol was 
used with bovine gamma-globulin as standard (1.25-20µg) prepared as shown in Table 
2.8. Duplicates of 150 µl of each concentration of the standard were pipetted into 
microplate wells and mixed with 150 µl of 1X dye reagent. At the same time, samples 
of the F1 standard (unknown concentration) were also prepared as shown in Table 2.9. 
The mixture was then incubated for 15 minutes at RT before being measured using the 
microplate reader at an absorbance of 595 nm. A standard curve of the gamma-globulin 
was plotted to determine the concentration of F1 standard. 
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Table 2.8: Preparation of microplate gamma-globulin standard dilutions, sufficient for 
duplicates. 150 µl of each dilution is used in microassay.
 Tube 
Standard 
volume (µl) 
Source of 
standard 
Diluent volume / 
PBS (µl) 
Final protein 
concentration 
(µg/ml) 
1 10 2 mg/ml stock 790 25 
2 10 2 mg/ml stock 990 20 
 3 6 2 mg/ml stock 794 15 
4 500 Tube 2 500 10 
5 500 Tube 4 500 5 
6 500 Tube 5 500 2.5 
7 500 Tube 6 500 1.25 
8 (blank) - - 500 0 
 
 
Table 2.9: Preparation of microplate samples of F1.   
The F1 samples were prepared directly in microtitre plate as shown (150 µl final 
volume). Dilutions prepared and run in duplicate.
 F1 standard 
applied (µl) 
Diluent volume / 
PBS (µl) 
10 140 
8 142 
6 144 
4 146 
2 148 
 
2.9.2 Quantitation of Caf1 from Coomassie blue stained SDS-PAGE 
Samples of heat extracted F1 were run in duplicate or triplicate (as indicated) 
Mini-PROTEAN® TGX™ precast gels (Bio-Rad). All gels for one experiment were 
stained (1 hour) and destained (45minutes with two changes of destain) at the same time 
in the same plastic container. A SynGene (G-box) was used to image the gels and 
GeneTools program was used for quantitation by using manual quantitation option. A 
circular drawn and adjusted to match the size of each band. Then, the background was 
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subtracted by using automatic background correction. The raw data of each band from 
the gel was averaged for comparison of mutants; wild-type was assigned as 100%.  
2.9.3 Sodium-dodecyl-sulphate polyacrylamide gel electrophoresis 
A mini-PROTEAN II gel apparatus (Bio-Rad), which is a vertical 
electrophoresis system, was used to resolve the protein sample using sodium-dodecyl-
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970). Samples 
were mixed with 4X sample buffer (62.5 mM Tris HCL, 2% SDS, pH 6.8, 10% glycerol, 
0.0024% bromophenol blue) and boiled for 15 minutes at  >95°C to denature the Caf1 
polymer or used unheated to analyse the Caf1 polymer. The concentrations of the gels 
were 14% acrylamide for separating and 5% acrylamide for stacking gels. Gels used 
were 0.75 mm thick and were run at 200 V for 55 minutes with freshly diluted SDS-
PAGE running buffer (0.25 M Tris HCL, 1.92 M Glycine pH 8.3, 1% SDS). Finally, 
the gels were stained with Coomassie Blue (2.5 g Coomassie Blue R250, 450 ml 
methanol, 450 ml H2O, 100 ml acetic acid) for 1 hour to overnight followed by 
destaining for 1 hour with multiple changes of de-stain solution (30% methanol, 10% 
glacial acetic acid, 60% dH20). For quantitation, SDS-PAGE gels were stained (1 hour) 
and destained (45minutes with two changes of destain) at the same time. A SynGene 
(G-box) system was used to image the gels.  
2.9.4 Immunoblotting 
Hybond ECL nitrocellulose membrane (Life Sciences); 0.45 µm and a Mini-
PROTEAN II Mini Trans-blot module (Bio-Rad) with transfer buffer (0.025 M Tris-
HCL, 0.2 M glycine) were used to identify protein separated by SDS-PAGE. Following 
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blotting, the membrane was blocked overnight at 4°C in 50 ml blocking buffer (Tween 
20 Tris buffer saline (TTBS, 0.05M Tris (pH 7.5), 0.15M NaCl, 0.1% (v/v) Tween 20) 
containing 5% milk powder). The next day, the membrane was incubated for a further 
30 minutes at 25°C prior to washing. The membrane was rinsed twice in TTBS followed 
by three 5 minutes washes in TTBS. Primary antibody was added and the membrane 
incubated for 1 hour rocking at 25°C, using rabbit polyclonal Caf1SC (14685), to detect 
Caf1 at a dilution of 1 in 10000 in TTBS  or rabbit polyclonal Caf1M at a dilution of 1 
in 20,000 to detect Caf1M. After 1 hour, the membrane was rinsed and washed as stated 
before and secondary antibody (anti-rabbit IgG-peroxidase, Sigma-Aldrich) was added 
at 1 in 40000 dilutions and the membrane incubated for another 1 hour, rocking at 25°C.  
Following a quick rinse and three short washes (5 minutes), bound antibody was 
visualised using a ChemiFast chemiluminescence substrate from Syngene. ChemiFast 
luminol (500µl) and ChemiFast stable peroxide solution (500µl) were mixed and 
poured evenly over the membrane. After 5 minutes incubation, the G-Box was used for 
imaging.   
2.9.5 TCA precipitation 
For TCA precipitation, surface extraction procedure was followed. Cells were 
grown overnight at 26˚C with 0.6% glucose and appropriate antibiotic, washed, 
subculture 1/10 with appropriate antibiotic and induced for 4 hours at 37˚C. After 
induction, 1 ml culture was centrifuged for 20 minutes.   The supernatant was kept for 
TCA precipitation. Then, a total of 10% TCA (40% w/v stock) was added to the protein 
sample and incubate on ice for 1 hour followed by centrifugation for 15 minutes at 4˚C, 
13000 rpm. The supernatant was discarded by pipetting. The sample was spun briefly 
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to remove remaining TCA. 1 ml of 90% cold acetone was added, inverted several times 
and incubated for 15 minutes on ice followed by centrifugation at 4˚C, 13000 rpm for 
15 minutes. The supernatant was discarded by pipetting and not losing any pellet. 100% 
acetone (1 ml) was added and the pellet was dried in a desiccator for 15 minutes. The 
pellet was resuspended in 30µl of SDS-PAGE loading buffer, boiled for 5 minutes at 
100˚C and   20µl of the sample was applied on a polyacrylamide gel. 
2.9.6 Protein identification by Mass spectrometry 
Subunits from pACYCD1_MA_S123 were purified from outer membrane using 
a large batch surface extraction procedure as discussed above. Extracted subunits were 
boiled at >95˚C for 10 minutes, run on Mini-protean TGX pre-cast gel(BioRad) at  
200V, stained for 1 hour with Coomassie blue and destain (30% methanol, 10% glacial 
acetic acid, 60% dH20) with multiple changes until no background observed. The 
proteins from the gel were excised, cut into small pieces and put in a 0.5ml 
microcentrifuge tube filled with nH2O. The gels were then destained with 200µl 50% 
acetonitrile (MeCN) (Rathburn, UK) /50% 10mM triethylammonium bicarbonate 
(TEAB) (Sigma, UK) overnight. The next day, the gels were dehydrated by adding 
200µl MeCN. Then, the MeCN was removed with a SpeedVac (ThermoSavant) for 10 
minutes. The gels were hydrated with 200µl TEAB followed by dehydration using the 
SpeedVac for 10 minutes. It was dehydrated again with 200µl MeCN and removed by 
SpeedVac for 10 minutes. The gel pieces were reduced with 200µl dithiothreitol (DTT) 
(Sigma, UK) in 10mM TEAB for 30 minutes at 50˚C. DTT was removed and 200µl of 
50mM iodoacetamide (IAA) in 10mM TEAB was added and incubated for 30 minutes 
at room temperature in the dark to alkalyte the gels. The IAA was removed, and 10mM 
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of DTT was added prior to washing (in the dark). This helps reduce N-terminal peptide 
alkylation. DTT was removed, and gel pieces were washed for three times with 200µl 
10mM TEAB and once with 200µl MeCN. Then, gel pieces were dehydrated in 
SpeedVac for 10 minutes followed by washing with MeCN and TEAB. A total of 200ng 
of Porcine trypsin (Promega) was added to the dehydrated gel pieces and left to re-swell 
on ice for 20 minutes. 30 to 50ul of 10mM TEAB was added to fully cover the gel and 
incubate overnight at 37˚C. The next day, the digests were placed on dry ice for 5 
minutes, allowed to thaw and transferred to new 0.2ml PCR tubes (Bioquote, UK). A 
total of 30µl of 10% ACN/5% formic acid (BDH, UK) was added to the gels and placed 
in a sonicator (Jencons, UK) for 15 minutes and was repeated twice. 30µl of HPLC 
grade water (Rathburn, UK) was added the samples and analysed by mass spectrometer 
by staff (Nicholas Micheal) at the Chemical Analysis Facility (CAF), University of 
Reading. 
2.9.7 Purification of E. coli SE11 subunits 
2.9.7.1 Ni2+ affinity chromatography 
His6-tagged of E. coli SE11 chaperone-subunits bound was prepared in a large 
batch of 400ml culture of pTRC99_Mhis_S1/DH5α and pTRC99_M8his_S123/DH5α 
according to periplasmic extraction procedure. HisTrap HP 1 ml (GE healthcare) was 
fitted on an AKTA purifier system. The AKTA system was washed with degassed nH20 
followed by washing of column with 5 CV (column volume) of elution buffer (20mM 
sodium phosphate, 500mM NaCl, 500mM imidazole, pH 7.4) with flow rate of 1ml/min. 
Then, the column was equilibrated with 5 CV binding buffer (20mM sodium phosphate, 
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500mM NaCl, 20mM imidazole, pH 7.4) with flow rate of 1ml/min. Sample was 
applied with flow rate of 0.5ml/min followed by washing with 10 CV binding buffer.  
The wash fraction and flow-through (FT) fraction were collected. The column bound 
chaperone-subunits were eluted with 5 CV, flow rate of 0.5ml/min, collecting 1ml 
fraction in 1.5ml microcentrifuge tubes each. Eluted fractions were kept on ice and 
analysed by SDS-PAGE. 
2.9.7.2 Size exclusion chromatography 
Surface extracted subunit 1 and -2 polymer of pACYCD1-MA-S123/BL21 (DE3) 
constructs was prepared in large batch of 400ml culture. Culture was grown overnight 
at 26˚C in 40ml LB with 0.6% glucose with appropriate antibiotic. The next day, the 
cells were washed and subcultured into 400ml LB with appropriate antiobiotic and 
grown for 1 hour at 37˚C. Then, the culture was induced with 0.5 mM IPTG and grown 
for another 4 hours at 37˚C. After 4 hours, the OD was read. All cells were recovered 
with Sorvall high-speed centrifuge at 13000 rpm for 30 minutes, 4˚C. The recovered 
cells were resuspend in PBS of 4.5OD/100µl and heat extracted at 55˚C. Then the 
extracted protein was treated with TX114. HiPrep Sepharyl HR S-300 column was 
fitted on an AKTA purifier system. The AKTA system was washed with degassed 20% 
ETOH for 10 minutes with flowrate 1ml/min followed by washing of column with 5 
CV of nH2O at 0.5ml/min. Then the column was equilibrated with 2 CV PBS + 0.01% 
azide at 1ml/min. The proteins were separated with 1.5 CV of PBS at 0.5ml/min and 2 
ml samples fraction were collected. The sample fractions were analysed by SDS-PAGE 
to identify the purified E. coli SE11 subunits.  
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2.10 Bioinformatics analysis 
2.10.1 Basic Local Alignment Similarity Search (BLAST) 
Sequence similarity searches to identify closely related ushers were performed 
using BLAST. Usher from Y. pestis, (WP_012564968) was used as a query. In this 
study, BLASTP was used for similarity search of the protein queries against the non-
redundant database. Default options were used except for the maximum target 
sequences, where the number was increased to 1000. All of the sequences were 
downloaded in FASTA format for further analysis. 
2.10.2 CLUSTALW 2.0 
ClustalW version 2.0 (Larkin et al., 2007) was used to produce multiple 
sequence alignments of divergent sequences. This program will align sequences based 
on the best match. Therefore, the identity, similarity and differences between sequences 
can be identified. The program is available online from the EBI web server: 
http://www.ebi.ac.uk/tools/clustalw2 
2.10.3 PHYLIP 3.695 
A phylogenetic tree was constructed using PHYLIP version 3.695 package 
(Felsenstein, 1993). There are two trees constructed, which are an NJ tree and a 
bootstrap tree. NJ tree is the original tree estimated using the program and used to 
interpret the data. However, the bootstrap tree was used to evaluate the NJ tree. The 
bootstrap tree was constructed by replicating the data set (1,000 replicates for this study) 
and finally generating a bootstrap tree from all 1,000 trees generated in this process.  
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Initially, ClustalW2.0 was used to generate multiple sequence alignment (MSA) and 
the output was saved in *.phy format for used in PHYLIP. For constructing NJ tree, 
PROTDIST and NEIGHBOR programs were used. The PROTDIST program computes 
a distance measure for the protein sequences. Then, the distance measure from 
PROTDIST was used in a distance matrix program, NEIGHBOR. The NEIGHBOR 
program produced an unrooted tree using the distance matrix method. The NJ was used 
because this method is very fast and can handle a large data set. 
To construct a bootstrap tree a thousand datasets were first made using the 
SEQBOOT program. Then, the PROTDIST program was used to compute the distance 
of protein sequences in each dataset. This was followed by producing 1000 trees using 
the NEIGHBOR program. Finally, CONSENSE program was used to compute 
consensus tree by the majority-rule consensus method. The bootstrap tree will give 
values in each node. Node with more than 70% indicates the clade descending from that 
node is reliable. Subsequently, MEGA5 was used to view the result of the phylogenetic 
tree. 
2.10.4 SignalP 
SignalP is a program to predict signal peptide presence and location that 
discriminate from transmembrane regions. There is option of different organism group 
(Gram-positive prokaryotes, Gram-negative prokaryotes, and eukaryotes) can be 
choose in the option. The program can be accessed at 
http://www.cbs.dtu.dk/services/SignalP/ 
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2.10.5 BetaCavityWeb 
BetaCavityWeb is a webserver to predict molecular cavities which are 
important to determine molecular function. This webserver used protein structure to 
compute the cavities and reports their geometrical properties such as boundry area and 
narrowest cavity space.  The server can be accessed at 
http://voronoi.hanyang.ac.kr/betacavityweb 
2.10.6 MEGA 5.2 
MEGA 5.2 (Tamura et al., 2011) is a user-friendly integrated program that can 
help the user to conduct multiple sequence alignments, mining data using the online 
database and infer phylogenetic trees. In this study, the MEGA program was used to 
display the output (newick format) from PHYLIP and to analyse and label the tree. 
2.10.7 I-TASSER 
I-TASSER (Roy et al., 2010) server was used to predict protein structure. In this 
study, the protein sequence was submitted to I-TASSER and a specific template was 
assigned. To estimate the quality of the protein model, confidence score (C-score) was 
used. C-score typically ranges between -5 and 2. Models with a C-score more than -1.5 
are expected to have a correct fold. The server can be accessed at 
http://zhanglab.ccmb.med.umich.edu/I-TASSER/ 
2.10.8 IntFOLD2 
InFOLD version 2.0 (Roche et al., 2011) is a server used to predict protein 
structure and function. It is an independent server that integrates a few programs. The 
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outputs of the server are tertiary structure prediction (nFOLD), 3D model quality 
assessment (ModFOLD), identification of disordered region (DISOclust), domain 
prediction (DomFOLD) and protein-ligand binding residue prediction (FunFOLD). The 
IntFOLD server is available at the following website: 
http://www.reading.ac.uk/bioinf/IntFOLD/. 
2.10.9 TMalign 
TMalign program (Zhang and Skolnick, 2005) was used for comparison and 
alignment of protein structures. This program used dynamic programming iterations to 
generate residue to residue alignment based on structural similarity. In this study, 
TMalign was used to obtain model coordinates relative to the template for assembly of 
the translocon. TM-score was used to assess the reliability of the structure alignment 
where TM-score between 0.5 and 1 indicates same fold of structural similarity and less 
than 0.3 indicates random structural similarity. The TMalign program is available at the 
following website: http://zhanglab.ccmb.med.umich.edu/TM-align/ 
2.10.10 PyMOL version 1.3 
PyMOL is an open-source program for protein visualization. This program can 
produce high-quality 3D images of protein structure and macromolecules for 
assemblies. At the same time, PyMOL has many options available for protein 
manipulation. In this study, PyMOL was used in the visualisation of protein structure, 
model and assembly of Caf proteins. Measurements of the Caf1A barrel were made by 
using the distance measurement option.  
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2.10.11 DiscoTope 2.0 
DiscoTope 2.0 is a structure-based antibody prediction tool from Immune 
Epitope Database (IEDB). It was used to predict-cells epitope in Caf1. The DiscoTope 
2.0 tool is available at the following website: 
http://tools.immuneepitope.org/tools/bcell/iedb_input  
  
94 
 
 
 
 
 
 
CHAPTER 3 ANALYSIS OF F1 
EXPORT IN NEW SYSTEM – 
pACYCF1 
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3.1 Introduction 
In previous studies, the pFMA1 plasmid (Figure 3.1) has been used to study the 
role of chaperone and usher in the assembly of F1. This pTRC99-based plasmid 
expresses the three caf genes (caf1M, caf1A, caf1), in the absence of Caf1R, from the 
LacI repressed Ptrc promoter. The plasmid (pFM1) was initially designed for 
overexpression of the chaperone:subunit complex for structural studies (Chapman et al., 
1999, Zavialov et al., 2003). The usher encoding caf1A gene was then amplified from 
pFS2, a construct containing the caf operon from Y. pestis pFra (Galyov et al., 1990) 
and cloned in between caf1M and caf1 to form the pFMA1 construct (Chapman et al., 
1999). Hence, expression from pFMA1 produces surface assembled F1 but also 
overexpression of both Caf1M and Caf1A. This system has proved ideal for studying 
many aspects of chaperone and usher structure and function, as it efficiently traps any 
nonexported, Caf1 in periplasmic Caf1M:Caf1n complexes (Dubnovitsky et al., 2010; 
MacIntyre et al., 2001; Yu et al., 2009; Yu et al., 2012; Zavialov et al., 2002). However, 
overexpression of usher, in particular, leads to toxicity after 2-3 h induction (Kersley, 
2002). Hence high levels of surface F1 cannot be obtained with pFMA1. 
To study efficiency of translocation mediated by the Caf1A usher, it is important 
to use a system where the relative levels of expression of chaperone, usher and subunit 
closely approximate levels of expression from the native Caf system. One problem with 
using the subcloned native caf operon on a high copy number plasmid, including pFS2 
(Galyov et al., 1990), was instability, due to the very high levels of expression of F1. 
This should be improved with use of a low to intermediate copy number plasmid and 
controlled expression of F1. Thus, pACYCF1 (R1122) (Figure 3.1) was designed with 
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the whole native caf operon amplified from pFS2 and cloned between the NcoI and 
SacI sites of pACYCDuet1 plasmid.  In this plasmid (pACYCF1), expression of caf1M, 
caf1A and caf1 is under control of caf1R regulator. 
Surface assembly of F1 from this plasmid does not lead to toxicity therefore 
higher levels of F1 can be obtained. This Chapter deals with induction of expression 
and quantitation of F1 expressed from this plasmid. 
  
               
Figure 3.1: Comparison of pFMA1 and pACYCF1 plasmid.  
(A) Plasmid used in previous studies (pFMA1), where gene encoding Caf system were 
individually subcloned into pTRC99 plasmid, produces a low level of Caf1 and 
overexpression of caf1M and to lesser extent caf1A, under control of ptrc promoter 
(IPTG induction). (B) Plasmid used in this study (pACYCF1) where the native caf 
operon cloned in pACYCDuet1, expression of caf genes under control of caf1R. 
 
3.2 Comparison of assembled F1 and chaperone from pACYCF1 and pFMA1 
This study began by comparing levels of Caf1M and F1 produced from 
pACYCF1 and pFMA1. Both plasmids were transformed into competent E.coli DH5α 
A B 
pFMA1 8224 bp 
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cells and one transformant from each was induced with 0.5 mM IPTG (pFMA1) for 1.5 
h  or thermo-induced (pACYCF1) for 4 hours as in method 2.8. Chaperone denatures 
at 55°C (Zavialov et al., 2005); hence F1 can be readily extracted from the cell surface 
by heating induced cells at 56°C for 1 hour. Both whole cells and surface extracted F1 
were analysed by SDS-PAGE. F1 is very stable and only denatures at 75°C in SDS or 
at 90°C without SDS. Therefore, samples were applied to SDS-PAGE unheated to 
detect Caf1 polymer (F1) or following heating at >95°C for 15 minutes, in SDS-PAGE 
sample buffer to visualise and quantitate denatured Caf1 subunit. Figure 3.2 shows that 
the level of F1 in whole cells and surface extracted F1 from E. coli DH5α/pACYCF1 
is higher compared to that from cells following induction from pFMA1. This is despite 
the high level of chaperone visible in samples from E.coli/pFMA1 (see Figure 3.2).  
 
 Induced cells of E. coli DH5α /pACYCF1 and E. coli DH5α /pFMA1 were also 
compared for the level of periplasmic Caf1M.  Periplasmic fractions from both were 
isolated by osmotic shock and analysed by SDS-PAGE. Figure 3.3 highlights the much 
lower level of expression of Caf1M (26.3 kDa) from E. coli DH5α/pACYCF1 
compared to pFMA1. Identity of Caf1M was confirmed by immunoblotting (Figure 3.3 
Figure 3.2: SDS-PAGE analysis to 
compare level of surface F1 in E. coli 
DH5 carrying either pACYCF1 or 
pFMA1.  
Following induction for 1.5 hours 
with IPTG for pFMA1 (A) and 4 
hours at 37°C for pACYCF1 (B), 
3ODs of cells were recovered and 
heat shocked in 100µl PBS to isolate 
surface F1. Whole cells were 
resuspended at 1OD/200µl   cells. 
10µl of each sample was loaded in 
well. 
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(B)). In general, therefore, it seems that despite the low level of chaperone in pACYCF1, 
assembly of F1 on the cell surface is more efficient than from pFMA1. With the very 
low level of chaperone produced for pACYCF1, it is likely that non-exported Caf1 
would not accumulate in the periplasm but be degraded.  
 
Figure 3.3: Comparison of level of Caf1M chaperone in induced cultures of E. coli 
DH5 carrying pACYCF1 or pFMA1.  
(A) SDS-PAGE of periplasmic fractions stained with Coomassie Blue. (B) 
Immunoblotting of periplasmic fraction with 1 in 10000 dilution of rabbit anti-Caf1M 
serum. 10µl sample was loaded in each lane. 
 
3.3 Optimisation of induction time and Caf1 extraction temperature 
3.3.1 Thermoinduction of pACYF1 
To test the induction time required for expression of Caf1, pACYCF1 (R122b) 
was retransformed in E. coli DH5α. Six individual colonies were cultured ON at 26°C 
then induced for 4 hours or 6 hours at 37°C. Cells from each culture were resuspended 
at 4 OD equivalent/ml and analysed by SDS-PAGE for F1 production. Figure 3.4 shows 
samples of heat denatured F1 in whole cells. Caf1 is clearly visible and is the most 
prominent band in all samples. Despite the fact that samples induced for 6 hours have 
Caf1M Caf1M 
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more Caf1 compared to samples induced at 4 hours, 4 hours was selected as the best 
time to monitor differences. This is because at 4 hours, the cells are still growing 
(exponential phase).  
 
 
Figure 3.4: Analysis of F1 production in six transformants of E. coli DH5/pACYCF1 
expression from whole cells.  
(A) Production of F1 at 4 hours induction. (B) Production of F1 at 6 hours induction. 1 
to 6 indicate different transformants. 
To establish the optimal induction temperature of F1 from pACYCF1 individual 
colonies were cultured ON at 26°C then subcultured and induced at 26°C, 28°C or 37°C. 
F1 was analysed directly in heat-denatured whole cells and also as surface extracted 
protein by SDS-PAGE (Figure 3.5). In Figure 3.5 (A), there is no Caf1 evident at 26°C 
while it is clearly visible at 28°C. However, in Figure 3.5 (B), very low levels of F1 
were detected following surface extraction of cells cultured at 26°C. The level of F1 in 
whole cells and surface extract of cells induced at 28°C were slightly less than that in 
cells induced at 37°C.  Thus, a temperature of 37°C and induction time of 4 hours was 
used for subsequent experiments in this study. 
A 
4 hours B 6 hours 
Caf1 
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Figure 3.5: SDS-PAGE analysis of thermoregulation of F1 at 26°C, 28°C and 37°C.  
(A) Whole cells of E. coli DH5/pACYCF1 (WT) following 4 hours subculture at 
indicated temperature. (B) Surface extracted F1, red box indicates heat denatured F1. 
-ve indicates, E. coli DH5/pACYCduet1. 
 
3.3.2 Optimisation of F1 heat extraction for quantitation 
Extraction of F1 from whole cells facilitates quantitation. This was routinely 
performed between 55°C-57°C for 1 hour. However, with large amounts of F1, all F1 
was not always completely extracted. Therefore, prior to quantitation, the efficiency of 
extraction of F1 at 65°C was compared to that at 57°C. Two transformants from the E. 
coli DH5α/pACYCF1 were inoculated ON and thermo-induced at 37°C for 4 hours.  3 
ODs of cells were recovered by centrifugation at 13000 rpm for 20 minutes, then heat 
shocked at 57°C and 65°C for 1 hour subsequently to extract surface F1. Extracted F1 
was analysed by SDS-PAGE (Figure 3.6). The level of extracted F1 is higher from cells 
extracted at 65°C compared to 57°C heat shocked samples. It is also clear that there is 
a higher polymer level in the stacking gel of 65°C heat shocked samples compared to 
57°C (Figure 3.6 (B)). SDS-analysis of pelleted cells after surface extraction of F1 
A B 
Caf1 
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shows that a substantial F1 band remained associated with whole cells after heating at 
57C, whereas with the 65°C sample this was greatly reduced (Figure 3.6 (C). In 
conclusion, heat extraction of F1 at 65°C was very efficient and recovered most surface 
F1. Therefore, 65°C was used to isolate surface F1 for quantitation from cells 
expressing loop mutation constructs (refer Chapter 5).  
 
 
 
Figure 3.6: Impact of extraction temperature on recovery of surface F1. F1 polymer 
was extracted from cells of E. coli DH5/pACYCF1, thermoinduced for 4 hour, by 
incubation at 57°C or 65°C for 1 hour  
(A) Heat denatured, extracted F1. (B) Unheated extracted F1 polymer. (C) Heat 
denatured whole cells pelleted after surface extraction. For denaturing, 18µl of sample 
was mixed with 6µl of 4X loding buffer and heated at 99°C for 15 minutes. 20µl was 
loaded onto the well. S indicates F1 standard. 
 
 
3.3.3 Comparison of Caf1 from whole cells, surface extracted and TCA 
precipitation of culture media 
TCA precipitation (see section 2.9.6 for method) was used to assess the amount 
of F1 that was released into the culture media from the cell surface of E. coli 
A B C 
Caf1 
F1 
polymer 
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DH5α/pACYCF1 during thermoinduction for 4 hours. Two transformants were 
inoculated, grown ON (26°C) and thermos-induced. The cells were recovered by 
centrifugation at 13000rpm for 20 minutes for whole cell analysis (4 OD/ml), surface 
extraction of F1 (3 OD/100ul) and TCA precipitation of F1 in spent growth media (~1 
OD/30ul). Samples were heated for 15 minutes at >95°C prior to SDS-PAGE. Figure 
3.7 shows a faint band of F1 that had remained in the supernatant after 20 minutes 
centrifugation. However, the amount of F1 released from the cell surface into the media 
during the 4 hours growth was very low, in comparison to that recovered by extraction 
from the cell surface.  Therefore, it was concluded that surface extraction was the most 
effective method for efficient recovery and quantitation of F1.  
 
Figure 3.7: SDS-PAGE analysis of F1 in whole cells, surface extraction and TCA 
precipitate from culture media.  
All samples were heated at >95°C for 15 minutes. 10µl of whole cells and surface 
extracted F1 were applied to the gel while 20µl of the TCA precipitate from spent 
culture media was applied. The level of Caf1 in WT-B of whole cells extracted was 
higher because the amount of cells applied was more compared to WT-A. 
 
3.4 Caf1 quantitation following SDS-PAGE 
As accumulation of F1 in the periplasm cannot be used to monitor efficiency of 
surface assembly with expression from pACYCF1, a reliable method of quantitation of 
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surface F1 was required. Because of the high levels of Caf1 visible in both whole cells 
and surface extracts, quantitation by imaging denatured Caf1 resolved by SDS-PAGE 
offered a direct quantitative assay. Initially, a large batch of F1 was prepared by heat 
extraction, as standard. This preparation contained primarily F1 but also a low level of 
cell contaminants (Figure 3.8). The total protein concentration in the original F1 
standard was calculated as 345.03µg/ml using the Bradford assay and gamma globulin 
as standard (Table 3.1).  The F1 concentration was calculated by imaging and 
quantitation following SDS- PAGE and average percentage of F1 band on each lane 
was 85%. Therefore,  the concentration of F1 from each lane was estimated at 
293.25µg/ml.                                                                                                                                                                                                                                                                                                                                                                                                                                   
Table 3.1: Estimated concentration of total protein in F1 standard. 
Duplicate samples (4-8 µl) were made up to 150µl with PBS for the Bradford 
microassay. Protein concentration in this 150µl was calculated from the standard curve. 
The dilution factor for preparation of the 150µl test sample was then used to calculate 
the estimatec total protein concentration in the original F1 standard preparation.  
Sample 
Applied 
(µl) 
OD595 OD595 Mean 
OD595 
Standard 
deviation 
Concentration 
(µg/ml) 
Dilution Original 
concentration 
(µg/ml) 
8 0.28 0.265 0.2725 0.011 23 18.75 430.1 
6 0.209 0.189 0.199 0.014 14 25 350 
4 0.11 0.115 0.1125 0.003 6.8 37.5 255 
Average 345.03 
 
To accurately compare levels of F1 produced under different conditions or from 
different mutants, the sensitivity of the imaging and quantitation assay was assessed by 
quantitating different levels of F1. GeneTools was used to calculate the amount of F1 
applied based on intensity of band and subtraction of background (See section 2.9.2). 
A graph was plotted based on the exact amount of F1 applied against Caf1 band raw 
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data (gel imaged) to determine the reliability and proportionality of quantitation of the 
F1 band with increasing sample concentrations.  
Figure 3.9 shows that the assays were not proportional. High levels of applied 
samples give proportionally slightly lower readings for denatured Caf1 than low levels. 
Therefore, an amount of F1 standard of 2.5-3.75 µl was used to apply on a gel for 
quantitation because this range is the most linear point in the graph. 
 
Table 3.2: The raw data of F1 standard from each lane of SDS PAGE.   
The percent was calculated from the raw data to get the concentration of Caf1 protein 
(F1) within the crude F1 preparation standard. 
 
Lane 
Exact 
amount 
applied (µl) 
F1 band 
raw data 
F1 band raw data 
(average) 
Total F1 protein (µg) 
1 1.25 4229.13 
4277.76 0.431 
2 1.25 4326.4 
3 2.5 7074.42 
7280.27 0.863 
4 2.5 7486.13 
5 3.75 10211.5 
9753.4 1.294 
6 3.75 9295.32 
7 5 11633.9 
11213.9 1.725 
8 5 10794.00 
9 6.25 13102 
13023.4 2.156 
10 6.25 12944.8 
Caf1 
 
 
Figure 3.8: Standard gel for F1 
quantitation.  
Increasing amount of F1 from 2l to 10µl 
were made up with dH20 to12µl and 
mixed with 4µl of 4X sample loading 
buffer, denatured and 10µl was applied for 
SDS-PAGE. µl indicates volume of 
original F1 standard in each sample 
applied to the gel and g indicates the total 
protein applied, based on the Biorad 
estimated protein concentration of the F1 
preparation (0.345 µg/µl). 
 
Cut off 
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Figure 3.9: F1 standard concentration graph for determination of F1 standard reliability. 
 
3.5 Conclusions 
In this chapter, it is clear that the expression of recombinant caf1 from pACYCF1 
in E. coli is thermoregulated as has previously been noted from Y. pestis (Brubaker, 
1972; Perry and Fetherston, 1997) and other recombinant constructs (Chapman et al., 
1999; MacIntyre et al., 2001). In this system, production of F1 polymer was ‘on’ above 
28°C and ‘off’ below 26°C. Therefore, throughout this study, to ensure stability, E. coli 
cells carrying pACYCF1 were always cultured at 26°C until expression was required 
and growth was switched to 37°C.  
Accumulation of periplasmic Caf1 has been used as an assay to monitor 
inefficiency of export across the outer membrane (Zavialov et al., 2002). However, non-
exported periplasmic Caf1 subunit is mainly degraded (Chapman et al., 1999; 
MacIntyre et al., 2001). Therefore, with pACYCF1 and the low levels of chaperone, it 
is likely that most non-assembled Caf1 would be degraded. Hence, accurate direct 
quantitation of extracted surface F1 is required.  Chaperone denatures at 55°C (Zavialov 
y = -155.37x2 + 2879.3x + 982.91
0
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et al., 2005) and heat extraction of bacterial cells coated in F1 polymer at this 
temperature effectively releases F1 from the cell surface. Here, it is shown that 
increasing the extraction temperature to 65°C for 1 hour enhances F1 surface extraction 
resulting in a very efficient extraction. TCA precipitation of the spent culture media 
demonstrated that very little F1 was released into the growth medium within the first 4 
hours induction. Hence, monitoring F1 levels in whole cells and surface extracts is a 
valid assay for comparisons of F1 production.  
A reliable F1 quantitation assay, based on imaging following SDS-PAGE and 
comparison to an F1standard has been established. However, the assay is not directly 
proportional. Therefore, two levels of standard were routinely used for subsequent 
quantitation – 2.5µl (0.863µg) for comparison with poorly functioning mutants and 
8.5µl (2.59µg) for production closer to wildtype. 
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CHAPTER 4 MODELLING AND 
PROPERTIES OF THE CAF 
TRANSLOCON 
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4.1 Introduction 
This chapter is focused on understanding details of the structure and function of 
the Yersinia pestis translocon of the Caf system.  The N-terminal domain of Caf1A had 
previously been shown to participate as the primary binding site of the Caf1M:Caf1 
complex (Phan et al., 2011; Di Yu et al., 2012; Ng et al., 2004).  Deletion of Caf1A N-
terminal domain results in accumulation of Caf1:Caf1M complexes in the periplasm 
and completely abolished export of F1 to the cell surface (Di Yu et al., 2012; Yu et al., 
2009). The Caf1A middle domain is important in plugging the pore (Remaut et al., 
2008; Yu et al., 2009) and Caf1A C-terminal domain is crucial in assembly of Caf1 
polymer (Dubnovitsky et al., 2010). Two hydrophobic clusters from Caf1A C-terminal 
domain (Cluster 1: Phe740, Iso743, and Iso755, and Cluster 2: Phe727, Tyr763, and 
Ala800) were demonstrated as essential for assembly. Double mutations of these 
residues resulted in accumulation of Caf1 polymer in the periplasm.  
Structures of Caf1A usher N-terminal, C-terminal and middle domains have been 
solved (refs). Other available structures of the Caf system include, wild type and mutant 
complexes of Caf1M:Caf1:Caf1 complexes (Zavialov et al., 2003, Zavialov et al., 2005, 
Yu Di et al 2012), subunit-free Caf1M (Di Yu et al., 2012), Caf1A N-terminal domain 
in complex with Caf1M:Caf1 as well as alone  (Di Yu et al., 2012). The only remaining 
unsolved structure in the Caf system is the Caf1A usher barrel.  To advance our 
understanding of usher function and facilitate strategic applications of the F1 assembly 
system, structural information of the Caf1A usher and the Caf translocon is very 
important. Therefore, the structure of FimD (Phan et al., 2011; Geibel et al., 2013) was 
used to model open Caf1A and the structure of PapC (Remaut et al., 2008) to model 
  
109 
 
closed Caf1A using homology modelling. The model of open Caf1A usher was then 
assembled with the available structure of Caf1:chaperone complex (Zavialov et al., 
2003) to create the Caf translocon. Potentially important interacting residues were 
identified from alignments and location of conserved residues within the modelled 
translocon. The importance of identified residues for F1 polymer assembled was 
addressed by mutagenesis.  This modelled translocon was also used in Chapter 5 to 
optimise export of F1 with short peptide inserts. 
4.2 Extension of γ3 family of fimbrial usher protein 
A previous publications identified 15 members of the γ3 family of fimbrial usher 
proteins with the closest relative of Caf1A usher as Y. pestis CO92 (PsaC) and Y. 
enterocolitica (MyfC) (Nuccio and Baumler, 2007). Availability of sequence 
information of closer relatives might aid in identifying key residues in usher proteins 
of this family. Therefore, the BLASTP programme from NCBI was used to search the 
non-redundant database for additional members of γ-3 family of ushers and in particular 
for close relatives of Caf1A. The number of hits in the search was increased to 1000, 
identical entries were excluded and results downloaded and summarised in an excel file 
(Appendix 1). From the similarity results in Appendix 1, there are 34 new sequences 
that had not already been assigned to the γ fimbrial group (Nuccio and Baumler, 2007). 
These include usher proteins from E. coli SE11, S. enterica, E. coli, Klebsiella 
pneumonia, Klebsiella oxytoca, Serratia marcescens, Serratia odorifera, Y. 
enterocolitica, Enterobacter cancerogenus, Providencia rustigianii, Cronobacter 
dublinensis, Klebsiella Sp., Cronobacter sakzakii, Serratia fonticola, Edwardsiella 
piscicida and  Enterobacter hormaechei. By compiling the 34 new sequences together 
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with previously identified proteins in the γ fimbrial group, a phylogenetic tree was 
constructed to expand the γ group.  
Figure 4.1 shows that of the 34 newly identified ushers, the γ3 fimbriae group 
contained eight new putative ushers annotated as follows; AafC from E. coli 042, 
AAD27810 (confirmed with 100% bootstrap), an usher protein from E. coli 1-250-
04_S1_C3, EZJ94256 (confirmed with 96% bootstrap), a fimbrial usher protein from 
E. piscicida, GAJ67292  (confirmed with 100% bootstrap), an usher protein from E. 
coli SE11, WP_000877656.1 (confirmed with 100% bootstrap) and four putative 
fimbrial usher proteins from S. enterica (WP_001750818, WP_023222330, 
WP_001750512, WP_023222950) (confirmed with 100% bootstrap value). The whole 
γ3 fimbriae group was confirmed with 87% bootstrap value. This excludes a type I 
fimbriae anchoring protein FimD (WP_021806158.1) from Serratia fonticola which 
was identified with bootstrap value of only 37%. For this protein the bootstrap value 
was only 47% which indicates that it is unreliable to include this usher in the γ3 fimbriae 
group.  It is clear that the usher from the commensal E. coli SE11 grouped with γ3 
fimbriae. It is also clear that from the phylogenetic tree that the usher from E. coli SE11 
(Oshima et al., 2008) lies next to Y. pestis Caf1A indicating a close evolutionary 
relationship with 70% identity within 99% sequence coverage. They are likely to share 
common functional features with respect to assembly via the chaperone-usher system. 
The new S. enterica clade that grouped in γ3 also clustered close to Caf1A from Y. 
pestis. This is interesting in view of the recognition that Y. pestis pMT1/pFra plasmid 
shares common ancestry, but not the caf locus, with a cryptic plasmid of S. enterica 
(Prentice et al., 2001). This interesting relationship between the Y. pestis Caf locus, the 
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related chaperone-usher loci from E. coli SE11 and S. enterica loci is investigated in 
more depth in Chapter 6. Based on the previous publication (Nuccio and Baumler, 
2007), the most distant ushers in the γ3 fimbriae group are the CS3 and CSSD  usher 
proteins. This was confirmed in this expanded γ3 fimbriae group.  
A new clade was also identified in the γ fimbriae group (see Figure 4.1, grey 
clade). This clade was only supported with a bootstrap value by 25%. Therefore, a new 
phylogenetic tree was constructed along with members of all fimbriae usher family to 
identify the group to which these usher proteins belong. To construct the phylogenetic 
tree, three members from each fimbrial usher family were picked randomly, and along 
with the ushers from the undefined group (grey clade), a phylogenetic tree was 
constructed using PHYLIP package. Based on Figure 4.2, it is clear that this undefined 
group belongs to the Gamma fimbriae family, however, this group of ushers form a 
distinct clade. Thus, further analysis must be done to this clade to characterise the ushers.    
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Figure 4.1: Phylogenetic tree of Gamma fimbriae group of 
usher proteins.  
(A) Coloured in yellow is γ, orange is γ1, green is γ2, blue 
is γ3, pink is γ4 and grey is undefined group. (B) γ3 
fimbriae subtree. Type 1 fimbriae anchoring protein FimD 
(S. fonticola) was excluded from the γ3 fimbriae group 
because the bootstrap value was only 47%. All other 
proteins in γ3 were supported with 87% bootstrap value. 
Pale blue, dotted line indicates newly identified proteins 
that cluster in the γ3 usher clade (refer Appendix 1) and 
blue, linear line indicates proteins previously identified as 
belonging to γ3 group (Nuccio and Baumler, 2007) 
 
100% 
A B 
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Figure 4.2: Phylogenetic tree of fimbrial usher protein family. 
Colured in yellow is γ, orange is γ1, green is γ2, blue is γ3, pink is γ4, red is π, brown is κ, 
cyan is β, maroon is σ, purple is α and grey is undefined group. Number indicates bootstrap 
percentage for each family of 1000 replicates.  
γ: 62  
γ1: 100 
γ2: 100 
γ3: 100 
γ4: 65  
π: 100 
κ: 100 
β: 100 
σ: 100 
α: 100 
undefined group: 81 
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4.2.1 Structural proteins loci of the γ3 family members. 
Generally, γ3-fimbriae consist of one major subunit that forms the fibre while some 
members of this group contain a second subunit (Nuccio and Baumler, 2007; Zav'yalov et 
al., 2010). The γ3 fimbriae operons encode a subunit(s) that is assembled into thin, flexible 
fimbriae, in contrast to the rigid multi-subunit fimbriae of the γ1 group, for example Type I 
fimbriae assembled by FimD usher. The γ1-fimbriae, in addition, include a terminal adhesin, 
approximately twice the size of subunit proteins. Therefore, to provide detailed 
consideration of usher function of the extended γ3-fimbriae group, the entire gene cluster 
was documented, initially using the NCBI database. For some new members of the γ3 group, 
only putative ushers were identified, the remainder of the operon was not annotated.  The 
core structure for a functional operon in this group would be genes encoding at least one 
subunit, an usher and a chaperone. Some operons encode one regulator for example caf 
system, some two very different regulatory proteins for example psa; while others have no 
associated regulator gene, including the gene cluster from E. coli SE11. The operon from E. 
coli SE11 consists only of one chaperone, one usher and two subunits.  (See Chapter 6 for 
detailed analysis). While both chaperone and usher can be readily identified by BLAST 
analysis, identification of subunits is more difficult and generally awaits experimental 
confirmation. However, based on size and location in the operon, it is possible to predict 
genes encoding structural subunits.  
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Table 4.1: Locus structure of updated γ3 fimbriae group CU systems.  
Red arrow represents regulator, blue chaperone, green usher, yellow subunit and grey 
unknown protein. Protein with asterisk (*) is newly identified usher in γ3 fimbriae group. 
 
4.3 Operon analysis and domain analysis of E. coli SE11 caf like genes 
The most similar protein to Caf1A was an usher from E. coli commensal SE11 
(accession no WP_000877656.1) (Oshima et al., 2008) with an E-value of 0 and 70% 
identity. This gene lies on plasmid pSE11-2 DNA (NC_011413.1). This is remarkably close 
to Caf1A; the next closest was E. coli AfaC, found to have an E-value of 0 and 44% identity. 
Because of the very close identity of this E. coli SE11 usher to Y. pestis Caf1A this 
chaperone usher locus was studied in more detail. The context of this usher gene within the 
E. coli SE11 plasmid as recorded in the Entrez database is shown in Figure 4.3. The usher 
from this bacterium was clustered with a chaperone and three putative structural subunits. 
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Figure 4.3: E. coli SE11 plasmid encoded chaperone-usher cluster (pSE11-2 
(NC_011413.1)).  
The upstream and downstream sequences next to this cluster encode hypothetical proteins 
and do not identify any domain when checked for domain in Interpro.  The data was obtained 
from Entrez database. 
 
Protein analysis of proteins within this SE11 CU cluster was performed by using 
Interpro to confirm domain identification and BLASTP to look for sequence similarity 
against the non-redundant database. As expected and as shown in Table 4.2, E. coli SE11 
chaperone had a PapD-like domain predicted from CATH and Superfamily database, PapD-
N domain predicted from Pfam and NCBI CDD (Conserve Domain Database), and PapD-
C domain predicted from CATH, Superfamily and Pfam database. Caf1M is also predicted 
to have these domains. As for similarity search, the closest relative to the chaperone from 
E. coli SE11 was Caf1M from Y. pestis with an E-value of 2E-109 and 59% identity.  
 
As expected from the annotation, E. coli SE11 usher from this locus 
(WP_000877656.1) exhibits high similarity to Caf1A usher protein from Y. pestis with an 
E-value of 0 and 70% identity. Domain search predicted the same domain structure as 
Caf1A with PapC_N, usher and PapC_C from both NCBI CDD and Pfam database. The 
first subunit (WP_000721504.1) was predicted to have an antigen_Caf1 domain and similar 
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to Caf1 from Y. pestis with an E-value of 4E-04 and identity of 34% over the whole protein. 
The second (WP_000734263.1) also shared similarity with Caf1 with identity of 31% and 
E-value of 6E-04. Interestingly, subunit 2 was also predicted to have a Sef14_adhesin 
domain (Pfam).  Neither this subunit nor Sef14 have the two domain structure and size of 
the terminal adhesins as seen in Pap and Fim pili. Hence, these can be predicted to have the 
single Ig-domain pilin fold.  Due to the small size of the third gene ((WP_024210470.1, 
only 58 amino acids), it would not be capable of forming a typical pilin-fold and is unlikely 
to be important as a structural component of this operon (see Table 4.2). Chapter 6 discusses 
of E. coli SE11 plasmid 2 (pSE11-2) encoded chaperone-usher system in more detail. 
 
Table 4.2: In silico analysis of E. coli SE11 pSE11-2 chaperone-usher cluster.  
Pairwise alignments were performed against mature Caf1 and mature E.coli SE11 subunits 
by EMBOSS Needle programme.  
E. coli SE11 CU 
cluster proteins 
Domain analysis 
(Interpro) 
Similarity search (BLASTP) 
Chaperone  (254 aa) 
(WP_012564967.1) 
PapD_N (NCBI CDD) 
PapD-like (CATH, 
Superfamily) 
PapD-N (Pfam) 
PapD-C (CATH, 
Superfamily and Pfam) 
F1 chaperone protein, Y. pestis 
(WP_002211762.1) 
E-value: 2E-109 
Identity: 59% 
Query cover: 100% 
Usher (835 aa) 
(WP_000877656.1) 
Usher (Pfam, Panther, 
NCBI CDD) 
PapC_N (Pfam, NCBI 
CDD) 
PapC_C (Pfam, NCBI 
CDD) 
Fimbrial usher protein, Y. pestis 
(WP_002211763.1) 
E-value: 0 
Identity: 70% 
Query cover: 99% 
Subunit 1 (159 aa) 
(WP_000721504.1) 
Capsule antigen, Caf1 
(NCBI CDD , CATH and 
Pfam) 
Capsule protein F1 (precursor), Y. 
pestis (AGX27780.1)  
E-value: 5E-04 
Identity: 34%  
Query cover: 99% 
Pairwise alignment of mature 
subunits 
Identity: 30.4% 
Similarity: 45.6% 
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Subunit 2 (159 aa) 
(WP_000734263.1) 
Capsule antigen, Caf1 
(NCBI CDD , CATH and 
Pfam) 
Sef14_adhesin (Pfam) 
Capsule protein F1 (precursor), Y. 
pestis (AGX27780.1) 
E-value: 6E-04 
Identity: 31% 
Query cover: 100% 
Pairwise alignment of mature 
subunits 
Identity: 29.1% 
Similarity: 48.3% 
Subunit 3 (58aa) 
(WP_024210470.1) 
Capsule antigen, Caf1 
(NCBI CDD , CATH and 
Pfam) 
Capsule protein F1 (precursor), Y. 
pestis (AGX27780.1) 
E-value: None 
Identity: None 
Query cover: None 
Pairwise alignment of mature 
subunits 
Identity: 14.1% 
Similarity: 22.8% 
4.4 Modelling of the Caf translocon 
Following review of available sequences of the γ3 fimbrial usher protein family, 
protein modelling of Caf1A was performed. Availability of related sequences should aid in 
determining key residues that are involved in the function and assembly of F1. Available 
crystal structures of the Caf system include, wildtype (PDB:1Z9S, 2.2 Å) and mutant 
(PDB:1P5U, 1.99 Å) of Caf1M:Caf1:Caf1 complexes, (Zavialov et al., 2005), the Caf1A C-
terminal domain (PDB:2XET, 1.6 Å) (Dubnovitsky et al., 2010), recombinant Caf1A plug 
or soluble middle domain (PDB:3FCG, 2.85 Å) (Yu et al., 2009) and recently subunit-free 
Caf1M (PDB:4AY0, 1.52 Å) as well as the Caf1A N-terminal domain alone (PDB:4B0E, 
2.0 Å) and in complex with Caf1M:Caf1 (PDB: 4B0M, 1.8 Å) (Di Yu et al., 2012). The 
only remaining unsolved structure in the Caf system is the Caf1A usher barrel.   As reviewed 
in the introduction, the most extensively studied fimbrial usher proteins are type I pili 
(FimD) and P pili usher (PapC). The structure of PapC is in the closed state (PDB: 2VQI, 
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3.2 Å) and for FimD, structures are available for the closed usher (PDB: 3OHN, 3.01 Å) 
and in two different open states; one is FimD:FimC:FimH (PDB: 3RFZ, 2.8 Å) 
accommodating FimH adhesion in the pore with solved resolution of 2.8Å and the other 
subunit complex is FimD:FimC:FimG:FimH (PDB: 4J3O, 3.8 Å)  accommodating FimG in 
the pore, with resolution of 3.80Å. 
4.4.1 Modelling of closed and opened Caf1A 
To start modelling the Caf translocon, a 3D model of Caf1A usher was produced using 
IntFOLD2 and I-TASSER servers. IntFOLD2 was initially used to model the open Caf1A 
based on FimD with bound FimC:FimH (chaperone:adhesin) complex and the FimH 
adhesin located within the pore (3RFZ:B) Figure 4.4.  As IntFOLD2 cannot model a protein 
based on the assigned template, the alternative way is to use I-TASSER. Therefore, I-
TASSER was used to build closed Caf1A based on 3OHN:A and opened Caf1A based on 
4J3O:D (FimD:FimC:FimG: FimH complex with FimG located in the pore). 
The C-score was used to estimate the quality and confidence level of each model. The 
C-score in I-TASSER ranges from -5 to 2 where the higher score signifies a model with a 
high confidence. The C-score for I-TASSER modelled closed Caf1A was 0.50 and for the 
open Caf1A model based on FimD accommodating FimG, the score was -0.23. In IntFOLD2, 
model quality is assessed by global model quality score where the score ranges between 1 
and 0. A model with a score of less than 0.2 indicates the model might be incorrect and a 
score more than 0.4 indicates that the model is more complete and confident. The global 
model quality score of the Caf1A based on FimD accommodating FimH was 0.6928. These 
results signified that while all Caf1A models are confident, the open Caf1A based on FimD 
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accommodating FimH was more reliable than that with FimG. This may be related to the 
lower resolution (3.80Å) of the crystal structure of FimD with FimG which was used as 
template.  
 
Figure 4.4: Quality and reliability assessment of Caf1A models based on ModFOLD4.  
The colour of the models were based on B-factor where blue indicates residues closest to 
the native structure and red residues furthest from the native structure (temperature scheme). 
(A) Caf1A model based on FimD accommodating FimH (IntFOLD2). (B) Caf1A model 
based on FimD accommodating FimG (I-TASSER). Yellow indicates solved C-terminal 
domain structure (PDB: 2XET, 1.6 Å) and pink indicates solved plug domain structure 
(PDB: 3FCG, 2.85 Å) superposed on the model structure. 
A 
B 
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To further assess the quality and reliability of the models, ModFOLD4 was used. With 
ModFOLD4, quality of the model is reflected in colour of the modelled barrel. The B factor 
of Caf1A based on FimD accommodating FimH (total barrel β strands are 24, in both) is 
better than that of Caf1A based on FimD accommodating FimG (total barrel β strands of 
Caf1A are 23, where one β-strand at β19-strand is not assigned - see Figure 4.5 (C) below). 
The whole Caf1A model based on FimD accommodating FimH is in blue, indicating that 
the model is close to the native structure, but the C-terminus of the Caf1A model based on 
FimD accommodating FimG was coloured in cyan. Figure 4.4 shows model to structure 
superpositions for Caf1A barrel models and the Caf1A plug domain crystal structure. Caf1A 
model based on FimD accommodating FimH superposition has an RMSD=1.070 where the 
β-strands were aligned properly in the model, indicating that the model is a close 
representation of the native structure (see Figure 4.4 (A)). For Caf1A model based on FimD 
accommodating FimH superposition has RMSD=0.912 and all β-strands of the structure and 
the model were aligned.  
The Caf1A model based on FimD accommodating FimG superposition has an 
RMSD=1.128 (PyMOL align) where one β-strand was not assigned in the model (strand-D) 
and β1-strand is very short (see Figure 4.4 (B)). For the C-terminal domain of the Caf1A 
model based on FimD accommodating FimG (see Figure 4.4 (B)), superposition with the 
structure of Caf1A-C has RMSD=1.174 with four unassigned β-strands (strand-B, -C, -E 
and -H). Thus, because the Caf1A model based on FimD accommodating FimH appears to 
be more reliable than Caf1A model based on FimD accommodating FimG, it was used to 
assemble the translocon.  
  
122 
 
As reviewed in the introduction, for FimD the dimensions of the pore vary 
substantially between opened and closed pore (Phan et al., 2011). To predict the size of the 
pore of predicted Caf1A protein at different conditions, the Caf1A models were 
superimposed. As would be expected, this was also the case for modelled Caf1A (Figure 
4.5). Dimensions changed from 27.4 Å by 55.2Å in the closed modelled pore of Caf1A to 
52.7 Å by 34.9 Å in the opened pore based on FimD accommodating FimH and 51.2 Å by 
37.2 Å in the opened pore based on FimD accommodating FimG.  As shown in Figure 4.5 
(D), there is some conformational change on the predicted model of Caf1A based on FimD 
accommodating FimH (coloured in cyan) and FimG (coloured in pink) involving strand β1, 
β2, β3, β4 and β24. This might be because the Caf1A model based on FimG is not reliable.  
However, the conformational changes between closed and open pore suggest flexibility 
within the barrel. Flexibility of the barrel is a promising feature for utilisation of the F1 
translocon as a scaffold for export of heterologous peptides.  
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Figure 4.5: Measurement of Caf1A pore modelled on FimD.  
(A)(B)(C) Change in dimensions of the Caf1A pore modelled on closed FimD 
(PDB: 3OHN, 3.01 Å) (A, purple); FimD accommodating the adhesin FimH 
(PDB: 3RFZ, 2.8 Å)(B, cyan) and FimD accommodating pilin subunit FimG in 
the pore (PDB: 4OHJ, 3.8 Å) (C, pink). (D) Superposed Caf1A models shown in 
B and C. Measurements were performed in PyMOL. All 3 model structures of 
Caf1A are available in attached CD (see Appendix 14). 
D 
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Having modelled Caf1A, Caf1M:Caf1:Caf1 complex was assembled into Caf1A 
using TMalign and PyMOL.  To start, TMalign was used to carry out superposition of the 
Caf1A based on FimD, 3RFZ chain B (TM-score=0.91412, where TM-score between 0.5 
and 1 indicates same fold of structural similarity and less than 0.3 indicates random 
structural similarity (Zhang and Skolnick, 2005)). This step is crucial to obtain model 
coordinates relative to the template. Then, Caf1M (1Z9S chain A) was superposed with 
FimC (3RFZ chain C) to gain coordinates for Caf1M relative to FimC (TM-score=1.0).  
Then, the models of Caf1A, Caf1M:Caf1:Caf1 complex structure (PDB:1Z9S, 2.2 Å) and 
TMalign files were loaded into PyMol to view the models for assembly. In PyMol, Caf1A 
model was aligned with the TMalign file of Caf1A based on FimD. The Caf1M:Caf1:Caf1 
complex (PDB: 1Z9S, 2.2 Å) was then aligned with the TMalign file of Caf1M based on 
FimC. The completed translocon (Figure 4.6) was saved as *.pse format for viewing and 
manipulation for later use (available in attached CD). Construction of the translocon using 
Caf1A model based on FimD accommodating FimG was also attempted. However, there 
was a clash between Caf1 and this Caf1A model even on trying to dock the subunit and 
chaperone one by one.  This might be a consequence of the poor model with a number of 
unassigned β-strands possibly due to the low resolution of the template, and inability of 
Pymol to assign these strands or both. Therefore, the F1 translocon modelled on 
FimD:FimC:FimH was used in all further studies. 
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Figure 4.6: Model of assembled Caf translocon.  
In green is Caf1A model, orange is top Caf1 subunit, yellow is bottom Caf1 subunit and 
blue is Caf1M chaperone. Caf1M:Caf1:Caf1 is solved crystal structure (PDB: 1Z9S, 2.2 Å). 
Pink, plug (PDB: 3FCG, 2.85 Å) in open position. 
 
4.4.2 Modelling of E. coli SE11 translocon 
The usher encoded in E. coli SE11 pSE11-2 was the only usher closely related to 
Caf1A. It shares 70% sequence identity with Caf1A. Therefore, this usher was also 
modelled to assist characterisation of Caf1A barrel. IntFOLD2 was used to model the usher 
based on multiple templates; 3RFZ:B (FimD), 2XET:A (Caf1A CTD), 3BWU:D (FimD 
NTD). The global model quality score of the usher based on FimD accommodating FimH 
was 0.6446, a value just marginally lower than that for the Caf1A model, which signifies a 
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high confidence model. In the model of this E. coli SE11 usher, the barrel was composed 
of 24 β-strands with a similar topology to the FimD structure.  The superpose of E. coli 
SE11 usher, Caf1A and FimD revealed slight differences in the modelled conformation of 
β-strand 1, 2, 4, 21, 22, 23, and 24 (See Figure 4.7). Interestingly, these are the β-strands 
close to the subunit during translocation of polymer. 
 
Figure 4.7: Superposition of modelled E. coli SE11 usher (pink) and Caf1A (green) with 
structure of FimD (blue).  
 
4.5 Characterisation of Caf barrel 
4.5.1 Residues interacting with conserved residues in the plug domain 
The usher models of Y. pestis Caf1A and E. coli SE11 usher were used to localise 
residues that might be directly involved in F1 assembly and in particular the nature of 
residues facing the translocating subunit in the barrel. Previous studies had identified 
residues in the plug that are conserved within all fimbriae usher families. Selected 
conserved residues between Caf1A and PapC middle domain were shown experimentally 
to have an impact on F1 assembly when mutated (Mycroft, 2011; Yu et al.,2009). The 
translocon model permits analysis of how both plug and subunit might interact with the 
usher barrel. Multiple sequence alignment (MSA) of the mature usher of Caf1A, FimD, 
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usher from E. coli SE11, and other members of the γ3 fimbrial usher protein family 
identified conserved residues (Figure 4.8). There are a total of 14 conserved residues within 
the plug domain (Figure 4.8).  
The translocon models were then used to identify conserved residues in the plug that 
interact with either Caf1 subunit or with the β-barrel in the closed usher. An absolutely 
conserved Tyr residue (Tyr266) that lies at the beginning of β-strand D of the plug, was 
found to make a polar interaction with subunit Asn81 with a distance of 3.0 Å. (See Figure 
4.8 (B)). Asn81 is notable for its conservation between Caf1 and SE11subunits (see Chapter 
6).  
Glu298 was also absolutely conserved in the alignment and mutation of Glu298 had 
previously been shown to have a negative impact in production of Caf1 (Mycroft, 2011). 
In this previous study, mutation of E298K and E298R, led to a 2.9 and 2.3 times increase, 
respectively, in accumulated periplasmic Caf1. Arg263 was found to interact with the barrel.  
Arg263 is located at the end of β-strand C in a highly-conserved R/KQ sequence, but which 
is different in both Caf1A (LR) and the SE11 usher (QQ). In Caf1A Arg263 interacts with 
Tyr215 in the hairpin loop at a distance of 3.2 Å. Based on the crystal structure of closed 
PapC, Remault and co-workers (Remault, 2008), suggested that residues residing in the 
hairpin loop interact with and hold the plug in place. Previous mutation of R263D increased 
accumulation of periplasmic Caf1, 1.77 times and R263E increased accumulation of 2 times 
and 2.3 times in periplasmic and surface respectively (Mycroft, 2011). This suggested that 
these residues may not only be essential in correct positioning of the plug in closed usher, 
but also in correct orientation in the open usher.   
  
128 
 
                   
 
Figure 4.8: Multiple sequence alignment and interaction of middle domain (plug) with β-barrel and subunit.  
(A) Multiple sequence alignment of γ3 fimbrial usher protein with focus on plug region, plug β-strands indicated with red arrow. Black boxes indicate highly conserved region in between strand-C to strand-F of plug 
domain modelled to interact with Caf1A barrel.  For whole alignment see Appendix 2. FimD was also added in this alignment for comparisons. Identified conserved region is boxed in black. Jalview was used to 
visualise the alignment. (B)  Interaction between subunit Asn81 with plug domain Tyr266 in opened Caf1A. (C) Interactions of plug residues with barrel residues, respectively, in closed Caf1A; Glu291 with Tyr483, 
Lys462 and Gln464; Ser289 with Asp217; Arg263 with Tyr215; and Arg258 with Asn148 and Gln150 in closed Caf1A. 
A 
B C 
419 187 
Tyr266 
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Some additional non-conserved residues were also found to interact with β-barrel 
residues in the closed Caf1A. As shown in Figure 4.8 (C), Glu291 (a conserved negatively 
charged residue within β-strand E) was found to interact with barrel residues Tyr483, 
Gln464 and Lys462 with a distance of 2.8Å, 3.2Å and 3.5Å respectively. Arg258 (beginning 
of β-strand C) is mainly conserved within γ3 family ushers, but not in FimD (γ1). This 
residue interacts with Asn148 (barrel) and Gln150 (barrel) with a distance of 3.3Å and 2.8Å, 
respectively, while the non-conserved Ser289 (between β-strand D and -E) interacts with 
Asp217 in the hairpin loop with a distance of 2.6Å. As all six residues identified above 
might be important in correct localisation of the plug, these were included in the 
mutagenesis strategy (below) to determine if there was any impact on production and 
assembly of Caf1. The two residues, Arg263 and Glu298 that were identified as important 
in the previous study (Mycroft, 2011) were also mutated in this study for comparison of the 
impact of all mutants together using the pACYCF1 vector. 
 
4.5.2 Localisation of key residues within Caf1A barrel 
Analysis of the barrel started with prediction of the topological properties of the 
usher cavity. A programme called BetaCavityWeb was used to predict the cavity using the 
modelled E. coli SE11 usher and Caf1A structures and the solved crystal FimD structure. 
The programme cannot calculate cavity volume; other information was used to interpret 
usher cavity. Based on the results (depicted in Figure 4.9), FimD has 365 atoms that 
contribute to the channel boundary, Caf1A has 370 atoms and E. coli SE11 usher has 330 
atoms. The most important information that this programme produced was the ‘neckbottle’ 
where it gives a value of the cavity at the narrowest point. At the narrowest cavity, Caf1A 
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has a pore width of only 32Å, while the narrowest measurement is 34Å for the E. coli SE11 
usher and 40Å for FimD. This suggests that Fim has a larger cavity due to the size of the 
terminal adhesin, FimH which contains two domains and may require more space for export 
compared to Caf subunit. Although there is no structure of the E. coli SE11 subunits yet, 
these preliminary results suggest that E. coli SE11 subunits may be of similar dimensions 
to the Caf1 subunits and that γ3 family ushers in general may have a slightly smaller channel.  
The cavity of the closed Fim barrel, that would accommodate the plug domain, was 
also checked to compare the size of the narrowest cavity with that of the open usher. The 
result shows that closed FimD has 321 atoms that contribute to the channel boundary which 
is lower than in the open FimD structure. The size of the narrowest cavity was only 30Å 
consistent with the proposal (Geibel et al., 2013) that ushers have a flexible barrel structure. 
An usher with flexible cavity dimensions that do not change the fold or export function of 
the usher, is ideal for applications of Caf1A as a scaffold for export of short peptides.  
.  
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Figure 4.9: Usher cavity predicted by BetaCavityWeb.  
Cavity for (A)(D) model of open Caf1A barrel, (B)(E) open FimD barrel structure from 
3RFZ (2.8 Å) (C)(F) model of open E. coli SE11 usher model and (G)(H) closed FimD 
structure. Red indicates predicted cavity in the barrel and(A)(B)(G)(H) show β-barrel in 
stick and (D)(E)(F)(H) show β-barrel in surface. 
 
In order to identify residues facing the barrel cavity that might be important for 
translocation and polymerisation of Caf1, the barrel segments of Caf1A, E. coli SE11 usher 
and FimD were analysed by MSA for conserved residues which were then located within 
the modelled Caf1A usher (Fig 4.10). This was done to identify conserved residues that 
might be required for interaction with fibre subunits within the barrel. Figure 4.10 (B) shows 
all residues facing inwards throughout the β-barrel and (Figure 4.10) (A) and (C) highlight 
the 33 conserved residues facing inwards with red highlight and red dots, respectively. The 
Caf translocon model was also used to identify any modelled interactions of these residues 
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with Caf subunit.  In total eight of these 33 conserved residues (six in the β-barrel wall and 
2 in the hairpin loop) were modelled interacting with Caf1 or the plug.  Six of these residues 
Tyr215, Asp217, Asn148, Gln150, Lys462 and Gln464 interact with the plug in the closed 
position as shown in Figure 4.8.  Interestingly, residues Asn148 and Gln150 (both located 
in β1) and shown to interact with plug residue Arg258 (Figure 4.8 C), are also modelled 
interacting with 2 subunit residues in the open usher during Caf1 assembly.  Caf1 subunit 
Thr166 interacts with Caf1A Asn148 and Caf1 Thr53 interacts with Caf1A Gln150 at a 
distance of  2.7 Å and 5.2 Å respectively (see Figure 4.10(C)).  The two additional conserved 
residues of Caf1A barrel, Asn144 and Asn601 also interact with subunit in the modelled 
translocon. Asn144 is located in Caf1A β1 and interacts with Caf1 loop residue Ser93 with 
a distance of 1.7 Å. Asn601, located in Caf1A β22, interacts with subunit, Ser168 with a 
distance of 2.9 Å.  As these residues (summarised in Table 4.3) might have an important 
role in F1 assembly each residue was independently mutated and the impact on production 
of Caf1 assessed. 
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Figure 4.10: Analysis of important residues in Caf1A β-barrel.  
(A) Multiple sequence alignment of barrel and plug domains of E. coli SE11 usher, Caf1A and FimD. Black arrows indicate β-strands forming the barrel. Numbering starts at the first residue of β1 strand of the usher barrel;. therefore, add 
139 to account for residues of the N-termianl domain and adjust residue number to that of intact matureCaf1A as used in images. Asterisk (*) indicates conserved residues and red dot indicates conserved residues facing inwards towards the 
barrel cavity. (B) Modelled Caf1A, E. coli SE11 usher and FimD structure highlighting alternating residues facing inside the barrel, labelled turquoise, red or purple. (C) Caf translocon, showing conserved residues, labelled in red (residues 
facing inwards) and yellow (residues facing outwards).  Cyan spheres are Caf1A Asn148 and Gln150 that are modelled interacting with Caf1 subunit during F1 assembly and also with the plug in closed Caf1A usher (see Fig 4.8 C). In green 
is Caf1A model, orange is top subunit, yellow is bottom subunit and blue is Caf1M. The numbering for the alignment was exclude the N-terminus sequences. Therefore, add 139 to get the correct number of residue as in the model. 
A 
B 
C 
Caf1A E. coli SE11 usher FimD 
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Table 4.3: Summary of Caf1A residues with potential importance on Caf translocon 
function. 
 
4.6 Characterisation of important residues in Caf1A by mutagenesis 
As discussed above, six residues within the plug were modelled as being involved 
in interactions that might be important to usher function and export of F1 polymer (see 
Table 4.3 and section 4.5.1). These residues, Arg258, Arg263, Tyr266, Ser289, Glu291 
and Glu298, were mutated individually to the smaller hydrophobic residue, Ala. This 
change would disrupt any specific interaction formed by these charged and polar 
hydrophilic residues. Site-directed mutagenesis (Quickchange II XL kit) with 
pACYCF1 as a template, was used to construct the mutated usher within the complete 
caf locus. As described, (see section 2.4.4) mutated plasmid DNA was initially 
recovered and sequenced from E. coli Top10 and confirmed mutated plasmid then 
Residue Location 
Interaction in 
opened model 
Interaction in close model 
Glu291 Plug - 
Caf1A_Lys462 (β14), 
Caf1A_Gln464 (β14) and 
Caf1A_Tyr483(β15) 
Glu298 Plug - - 
Arg258 Plug - 
Caf1A_Asn148 (β1) and 
Caf1A_150 (β1) 
Tyr266 Plug Caf1_Asn81 
Caf1A_Tyr198 (β4) and 
Caf1A_Tyr215 (β-hairpin) 
Arg263 Plug - Caf1A_Tyr215 (β-hairpin) 
Ser289 Plug - Caf1A_Tyr217 (β-hairpin) 
Tyr215 Hairpin - Caf1A_Arg263 (plug) 
Asp217 Hairpin - Caf1A_Ser289 (plug) 
Asn144 Barrel (β1) Caf1_Ser93 - 
Asn148 Barrel (β1) Caf1_Thr166 Caf1A_Arg258 (plug) 
Gln150 Barrel (β1) Caf1_Thr53 Caf1A_Arg258 (plug) 
Lys462 Barrel (β14) - Caf1A_Glu291 (plug) 
Gln464 Barrel (β14) - Caf1A_Glu291 (plug) 
Asn601 Barrel (β22) Caf1_Ser168 - 
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transformed into E. coli BW25113 for analysis and quantitation. F1 production was 
induced at 37°C for 4 hours, surface F1 recovered by heat shock at 65°C for 1 hour and 
the level of F1 polymer produced quantitated following heat denaturation and SDS-
PAGE. 
4.6.1 Investigating the role of Tyr266 and Glu298 
One of the residue among the highly conserved residues in multiple sequence 
alignment of γ3 fimbrial usher protein is Tyr266. This plug residue is not only 
conserved but was also modelled to interact with Asn81 in the subunit when the usher 
is in the active translocating state (see Figure 4.8 (B)). Notably, this Asn81 is also 
adjacent to a conserved GlyAsn in alignment of Caf1 and the E. coli SE11 CU subunits 
(See Chapter 6 below). This suggests that the plug residue Tyr266 might play a role in 
stabilising F1 translocation via transient interaction with Caf1. Two point mutants 
within Caf1 subunit were created. In Y266S, Tyr was replaced by a smaller polar 
residue and in Y266A by a small hydrophobic residue that would interfere with any 
natural interaction that Tyr266 might form. As showed in Figure 4.11 Tyr266 is not 
absolutely required for F1 assembly. There might be an indication of decrease in surface 
assembly of F1 with Y266A, but confirmation of this would requires analysis and 
quantitation of triplicate samples.  
The closed Caf1A model was also assessed to look for any interaction of Tyr266. 
When PapC is superposed with Caf1A, Caf1A Tyr266 corresponds to PapC Arg281. 
This PapC plug residue (Arg281) is predicted to undergo repulsion with Arg210 in the 
β-barrel (Remaut et al., 2008). When checked in the Caf1A closed model, Tyr266 
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interacts with Tyr195 (corresponding to Arg210 in PapC) and with Tyr215 in the β-
hairpin (Figure 4.12). These extensive hydrophobic interactions between plug, β-barrel 
and β-hairpin form a hydrophobic patch and might be important in positioning the plug 
inside the pore. Mutation of Tyr 215 might be predicted to destabilise the triple Tyr 
interaction. With this mutation the F1 level was slightly reduced to 86.37% ± 9.09 
compared to wildtype (see Figure 4.14). Ideally, impact of these residues would be 
further investigated by double and triple mutation of all three Tyr to test the impact on 
F1 assembly and Caf1A assembly and permeability. 
Glu298 is also conserved throughout the γ3 fimbrial usher. Glu298 was mutated 
to Lys (large and oppositely charged residue) in the previous study, using the pFMA1 
expression system (Mycroft, 2011).  This mutation resulted in an accumulation of 2.87-
fold Caf1 in the periplasmic compared to 5.4 fold of the N-terminal deletion mutant 
which acted as a non-exporting control. It was concluded that Glu298 is important in 
translocation of F1 but not critical. As pACYCF1 is a much more efficient system, 
Glu298 was mutated to Lys to test the impact in pACYCF1. As shown in Figure 4.14 
below, the level of F1 in E298K was decreased to 84.03%±6.42, consistent with the 
observed accumulation of Caf1 in the pFMA1 system carrying the E298K mutation. 
This new system, pACYCF1 confirmed an effect on translocation of F1 to the cell 
surface while the earlier pFMA1 system, recorded Caf1 accumulation in the periplasm 
due to overexpression of chaperone. 
  
137 
 
 
Figure 4.11: SDS-PAGE of surface F1 extracted from E. coli BW25113 from 
pACYCF1_Y266A and pACYCF1_Y266S constructs.  
4 OD cells (for whole cells) and 3 OD cells (for surface extraction) after 4 hour 
thermoinduction. For surface extraction cells were suspended in 100µl PBS. 10µl of 
samples were loaded onto each lane. Two separate transformants processed for each 
construct. 
 
Figure 4.12: Superpose of closed PapC structure (3FIP, white) and Caf1A closed model 
(yellow).  
Interaction between Arg281 (plug) and Arg210 (β-barrel) in PapC - residues coloured 
in cyan. Interaction between Caf1A Tyr266 (plug), Tyr195 (β-barrel) and Tyr215 (β5-
6 hairpin) - residues coloured in pink. 
 
4.6.2 Mutation of residues predicted to be involved in pore gating 
Four additional plug residues (Arg258, Arg263, Ser289, and Glu291) were 
found to interact with the β-barrel in the closed Caf1A model suggesting that these 
residues may contribute to holding the plug in the pore (refer figure 4.8). These four 
residues were mutated to Ala to disrupt any interactions that occurred naturally in the 
pACYCF1 
Y266A 
pACYCF1 
Y266S 
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translocon. R263A was shown to have a slight increase the level of F1 (111.71% ± 6.39) 
compared to wildtype (Figure 4.14). Based on the translocon model, Arg263 interacts 
with Tyr215 from β5-6-hairpin (between β5 and β6) (refer Figure 4.10).  Mutation of 
Arg263 to Ala, a hydrophobic residue that will bury inside the protein core, should 
disrupt the predicted interaction between Arg263 with Tyr215 in Caf system, thus 
potentially increasing opening of the pore. However, mutation of Tyr215 to Ala showed 
a decreased level of surface F1, 86.37% ± 9.09 compared to wildtype Caf1A. 
Mutation of R258A resulted in a similar level of surface F1 (95.71% ± 7.71) 
compared to wildtype (refer Figure 4.14). In the translocon model, Arg258 interacts 
with Asn148 and Gln150. To validate this interactions is not critical, Asn148 and 
Gln150 were mutated individually to Ala. Quantitation of surface F1 of N148A and 
Q150A showed F1 level of 98.26% ± 9.44 and 82.05% ± 8.05, respectively compared 
to wildtype. Asn144, Asn148 and Gln150, however, were also interacting with subunit. 
Thus, loss of Gln150 might have an impact on translocating the F1 fibre, or simply 
correct orientation of the plug   This suggests that Arg258 might not be important alone 
but that loss of this Arg might have a greater impact if mutated together with Gln150 
as Arg258 is mostly conserved throughout γ3 fimbrial usher system. 
The plug residue Glu291, was modelled to have an interaction with the barrel 
residue Lys462, and was therefore mutated to the small uncharged residue Ala and also 
to the positively charged Lys. The mutation of E291K would be predicted to cause 
repulsion with Lys462 in the β-barrel and weaken the plug interaction leading to an 
opened usher, while the mutation E291A would completely abolish any interaction with 
Lys462 (refer Figure 4.10 for interaction of Glu291).  These changes resulted in a slight 
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increase in F1 level of 116.85% ± 6.2 (E291A) and 111.46% ± 2.87 (E291K) compared 
to wildtype respectively.  These results are consistent with weakening of the plug 
interaction facilitating removal of the plug and opening of the usher. Mutation of 
K462A also showed a slight increase in surface F1 level of 109.54% ± 3.29 which 
further supports the suggestion that destabilisation of the Glu291-Lys462 interaction 
facilitates F1 export. Glu291 corresponds to Arg305 in PapC (Figure 4.13). Point 
mutation of R305A was shown to increase pore opening by disrupting the salt bridge 
interaction between Arg305 with Glu467 (Volkan et al., 2013). These results with 
Caf1A are consistent with an ionic interaction between Glu291 and Lys462 helping to 
hold the plug in position in the pore.  
Based on the closed translocon model, Ser289 in the plug interacts with Asp217 
from the β5-6 hairpin. Mutation of Ser289 had the most profound effect on surface F1 
level, of any of the single point mutations tested Figure 4.14. The level of surface F1 
decreased to 70.81% ± 3.0 and 91.03% ± 1.31 with the Caf1A mutations, S289A and 
D217A respectively. The superpose of the closed Caf1A model and PapC located 
Caf1A-Ser289 corresponding to PapC-R303, a key residue that forms a salt bridge with 
D234 and contributes to correct positioning of the plug inside the pore (Figure 4.13) 
(Volkan et al., 2013).  This suggests that Ser289 and Asp217 may similarly be important 
in orientation of the plug. 
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Figure 4.13: Superpose of closed PapC structure (3FIP, white) and Caf1A closed 
model (yellow).  
(A) Interaction between Glu291 (plug) and Lys462 (β-barrel) in Caf1A. Glu291 
corresponds to Arg305 in PapC. (B) Interaction between Ser289 (plug) and Asp217 
(β5-6 hairpin) in Caf1A. Ser289 corresponds to Arg303 in PapC. Pink indicates residue 
from Caf1A and cyan from PapC. 
 
 
4.6.3 Investigating the role of conserved residues in β-barrel 
Based on the in silico analysis in section 4.5.2, two conserved residues in the 
barrel, Asn144 (located in β1) and Asn601 (located in β22) were identified as 
interacting with subunit. Single point mutations of N144A and N601A had no apparent 
effect on the level of accumulated surface F1  (100.81% ± 5.97 and 93.22% ± 7.37 of 
wild-type levels of surface assembled F1, respectively). This suggests that single 
mutations within the barrel are likely not to have a great impact on the level of surface 
F1. Multiple point mutations would be more likely to have an impact.  
A B 
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Figure 4.14: SDS-PAGE of extracted surface F1 from E. coli/pACYCF1 with point mutations in Caf1A. 
Following 4 hour thermoinduction, F1 was extracted at 65°C for 1 h from 3 OD cells in 100µl PBS.  Extracted samples (12µl) were mixed with 
4µl SDS loading dye, heated at >95˚C for 10 min to ensure complete denaturation of F1 fibre. Denatured sample (10µl) was loaded on SDS-PAGE. 
Following electrophoresis, protein was stained with Coomassie blue, imaged and bands of denatured Caf1 monomer (black arrowhead) quantitated. 
S1 and S2 indicate 2.59µg and 0.863µg respectively of the F1 standard applied. A, B and C are biological repeats, 3 separate transformants 
processed for each construct.
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4.7 Conclusions 
In this chapter, a plasmid encoded usher (pSE11-2) from E. coli SE11 was 
identified as a closely related usher to Caf1A with 70% sequence identity within 99% 
sequence coverage. A phylogenetic tree was constructed and this confirmed that the E. 
coli SE11 usher belongs to γ3 group, and is the closest currently identified neighbour 
to Caf1A. This was validated with bootstrap value of 100% from 1000 replicates. The 
usher from E. coli SE11 and Caf1A are likely to share common functional features with 
respect to assembly via the chaperone-usher system, despite the fact that the E.coli 
usher assembles two different subunits while the Caf1A usher assembles only one. 
Despite the high similarity between E. coli SE11 usher and Caf1A, this usher couls not 
be used as template for homology modelling of Caf1A as there is no solved structure.  
Therefore, PapC (PDB: PDB:2VQI, 3.2 Å)) was used to model closed Caf1A  and the 
structures of FimD:FimC:FimH accommodating FimH within the usher (PDB: 3RFZ, 
2.8 Å) and FimD:FimC:FimF:FimG:FimH accommodating FimG in the usher (PDB: 
4J3O, 3.8 Å) were used to model open Caf1A. However, modelling of Caf1A based on 
FimD:FimC:FimG:FimH gave a poor model where β-strands were poorly predicted 
with missing β-strands in the plug domain, C-terminal domain and the β-barrel. Thus, 
for open Caf1A, the model based on FimD:FimC:FimH combined with the solved 
structure of Caf1M:Caf1:CAf1 (PDB: 1Z9S, 2.2 Å) was used for assembly of the Caf 
translocon. 
Both closed Caf1A usher and the modelled Caf translocon together with multiple 
sequence alignments were used to identify any interactions that might be important in 
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the functions of Caf1A to export F1 polymer. Residues predicted to have interactions 
within Caf1A were mutated to test the impact on surface F1 assembly. One important 
residue is the plug residue Tyr266 as it was predicted to interact with subunit Asn81 in 
the active state of Caf1A and to form an extensive hydrophobic interaction with Tyr195 
(β-barrel) and Tyr215 (β5-6 hairpin) in the closed usher. Mutation of Tyr266 and Tyr 
215 individually each appeared to lead to slight reduction in the level of surface F1. 
Whether this is a consequence of loss of interaction with the subunit or interference 
with plug opening remains to be seen. As identified in Chapter 5 subunitAsn80 appears 
to be more important for F1 assembly. The triple Tyr interaction may be important in 
positioning the plug inside the pore or even as a subunit recognition site. With PapC 
several ionic interactions have been proposed to hold the PapC plug within the 
translocation pore (Remaut et al., 2008).  
Superpose of PapC and Caf1A revealed that plug residues in PapC involved in 
these ionic interactions (Arg281, Arg303, Arg305 and Arg316) correspond with Caf1A 
plug residues also identified as interacting residues. PapCArg281 corresponds to 
Caf1ATyr266, PapCArg303 to Caf1ASer289 and PapCArg305 to Caf1AGlu291. 
Among these residues, only Glu291 forms a typical salt bridge, forming an ionic 
interaction with the β-barrel residue Lys462 and loss of this interaction led to an 
apparent increase in the level of surface F1. This would be consistent with (i) closure 
of the plug within the barrel, via the ionic interaction between Glu291 and Lys462, 
being the primary role of this residue  and (ii) that loss of this interaction facilitates 
opening of the plug without interfering with Caf1 assembly and in fact enhances 
translocation to the surface. Following polymerisation, as shown in Chapter 3, F1 
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remains anchored to the bacterial cell surface at least initially and this is assumed to be 
via its interaction with chaperone. Additional interactions of subunit with usher could 
stabilise surface association of F1. However, in this study extraction for quantitation 
was via heating at 65C for 1h in PBS. This completely denatures Caf1M releasing 
subunit and it is unlikely that any interaction with usher would have an impact on levels 
of F1 polymer released following this treatment. Thus, loss of anchoring interaction 
within the usher is unlikely to be the explanation for apparent enhanced recovery of 
surface F1 from cells expressing the E291A or K mutated usher.  In contrast, mutation 
of Ser289 showed a significance reduction in surface F1. This could be due to a 
requirement for direct interaction with subunit or through an additional interaction 
within the open pore. Much more detailed investigation is required to establish 
involvement of these residues in opening and closing the pore. The models presented 
and preliminary mutagenesis provide a solid background for further study. 
 In this study, the residues that were tested were based on conserved residues 
facing inside the barrel and residues shown to have interaction in the translocon model. 
A systematic approach might involve mutation of all inward facing residues. 
Alternately, a mutagenesis based assay selecting for non-exporters would be another 
approach. However, none of the single mutations tested had a dramatic effect on the 
export of surface F1 and double mutations are likely to have a greater effect in 
highlighting key interactions. Therefore, a targeted approach focusing on interacting 
residues may remain a good direction for future study. This study also highlights 
flexibility of usher barrel residues facing the subunit, a fact used in the next stage of the 
investigation to optimise export of modified F1.  
  
145 
 
 
 
 
 
 
CHAPTER 5 CAF1 AS A 
SCAFFOLD FOR EXPORT OF 
HETEROLOGOUS EPITOPES 
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5.1 Introduction 
E. coli and other Gram negative bacteria coat themselves in remarkably stable 
protein fibres assembled via the well-recognised chaperone-usher (CU) pathway. The 
simplest of these are long polymers, like the F1 fibres of Yersinia pestis. The F1 antigen, 
a polymer of the 15.6 kDa subunit Caf1 is produced at higher temperatures of 35-37oC 
and covers the bacterial surface making the bacteria more resistant to phagocytosis. 
Naturally, F1 fibre only disassociates into oligomers and polymers if exposed to a high 
temperature of 87.5°C (Zavialov et al., 2005). In 0.5% SDS, the fibre begins to 
dissociate at 75°C. This represents an appealing scaffold structure to display short 
foreign peptides.  This chapter demonstrates the flexibility of the Caf CU pathway for 
surface display of different peptides and the ability to use the translocon model to 
identify problem areas and optimise export. 
Earlier unpublished studies in this laboratory had investigated the flexibility of 
Caf1 subunit for periplasmic polymerisation following alteration of 4 different surface 
loops, using the pFM1 vector (expresses chaperone and subunit only, under ptrc 
control). In all cases, surface loops could be readily exchanged for Gly with little effect 
on polymerisation, but replacement with a short well-characterised epitope of HIV 
GP41 led to variable results (see Appendix 3 for detail). Transfer of the inserted 
sequences to the surface expression vector pFMA1 gave less clear results due to the 
lower level of surface F1 assembled with this system. Therefore, in this study, the 
ability to export foreign epitopes was tested using the pACYCF1 vector, under thermo-
induction controlled by the native Caf1R regulator. Initial studies focused on 
requirement of native Caf1 sequences of these four surface loops for surface assembly. 
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Export of the short characterised viral epitope was then monitored.   Having identified 
the optimum insertion site, the ability to decorate surface F1 with polyhistidine inserts 
was assessed. During this study, some key features of the usher and assembly process 
were also identified. 
5.2 Prediction of B-cells epitopes in Caf1 
To design vaccines and diagnostic kits, knowledge of B-cell epitopes are 
important because B-cell epitopes are the sites that are recognised by antibodies of the 
immune system. As B-cell epitopes are frequently located in loops they also represent 
short sequences that can be replaced without disruption of the core protein structure. 
For example, they might be replaced by heterologous epitopes to induce protection 
against other microbes. In 1988, Huges and Gillel induced protective immunity in mice 
against P. aeruginosa using linear B-cell epitopes (Gilleland et al., 1988).  
In a previous study, four different loops of Caf1 that were not involved in β-
strands had been replaced by either glycine residues or a charged epitope of HIV gp41 
(Figure 5.1) to test the impact on subunit polymerization using the plasmid pFM1 
(results are shown in Appendix 3). In this study, export of these modified Caf1 subunits 
through the translocon was tested using pACYCF1. DiscoTope Prediction (Kringelum 
et al., 2012) was used to review prediction of all linear B-cell epitopes of F1. Three 
loops (TIMDNGN (loop 1), TSQDGNNHQ (loop 4) and GSKGGKLAAGK (loop 7)) 
had strong epitope predictions, all of which had been included in the previous study 
(Figure 5.2 The second (KTG) and fifth loops (DSRDF) were also predicted as 
additional epitopes. However, the region between residues 100 and 120 were weaker 
  
148 
 
predictions and shorter sequences. Therefore, the four predicted epitope sites used in 
the previous study were also used here to assess surface assembly of F1 with mutated 
loop. Figure 5.3 shows locations of replacements with Gly or ELDKWA epitope within 
the Caf1 structure. 
           
  
Figure 5.2: Epitope prediction in F1.  
The output from DiscoTope Prediction programme, a structure based antibody prediction. In 
red are segments of each epitope previously identified and that were replaced by Gly residues 
or HIV gp41 core epitope, in pFM1 to monitor the impact of polymerisation. The default 
threshold, -7.7 was used where residues above the threshold were predicted as B-cell epitopes. 
1Z9S (2.2 Å) (Caf1:Caf1:Caf1M) structure was used for prediction. 
 
TIMDNGN 
F1D11/::3(Loop 1) 
KTG 
TSQDGNNHQ 
F1D12/::2 (Loop 4) 
DSRDF 
F1D13/::1 (Loop 5) 
 
D 
GSKGGKLAAGK 
F1D14/::4 (Loop 7) 
V 
TG 
Figure 5.1: Location of Gly and 
ELDKWA replacements within Caf1 
sequence.  
(A) Sequence of Caf1. (B) Caf1 replaced 
with G;y. (C) Caf1 replaced with charge 
epitope, ELDKWA.  Red indicates regions 
involved in loop mutations, -strands are 
underlined, loop as defined. Mutated 
constructs carry only a single replacement, 
as labelled.  Residues coloured in yellow 
indicate α-helix. 
 
A 
B 
C 
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5.3 Generation and phenotype of constructs with glycine and charge epitope 
inserts 
To test the efficiency of surface assembly of F1 with each of the loop mutations, 
DNA fragments of caf1 encoding loop changes were amplified from the eight respective 
pFM1 constructs (Appendix 3) and inserted into pACYCF1, by Infusion technology. 
Figure 5.4 (A) shows the profile of each plasmid preparation used as template for 
amplification of inserts. There was some concern about the appearance of two bands of 
supercoiled pACYCF1 (Figure 5.4 (A), lane A). Therefore, two preparations of 
pACYCF1 (5) and (6) were obtained, transformed into E.coli DH5α and TOP10. 
Plasmid was prepared from 4 transformants of each. All were the same size (Figure 5.4 
(B)). Therefore, all were stored for subsequent use. 
Figure 5.3: Caf12:Caf1M complex 
(PDB: 1Z9S, 2.2 Å) showing surface 
loops tested for epitope replacement.  
Yellow, Caf1M; blue, bottom 
subunit; cyan, top subunit. Sequences 
in brackets indicate residues replaced 
by glycine (F1D11, F1D12, F1D3, 
FD14) and HIV gp41 core epitope, 
ELDKWA (F1::1, F1::2, F1::3, 
F1::4).  
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Figure 5.4: Plasmid source of mutated loop sequences 
(A) Electrophoresis gel of undigested plasmids used as templates for constructing loop mutants. 
The size of pFM1 is 5703bp and the size of pFMA1 used for F1D12 is 8224bp (there was no 
stock from pFM1 plasmid for F1D12). pACYCF1 A and B were from two individual 
tarnsformants. (B) Electrophoresis gel displaying multiple preparation of pACYCF1 plasmid 
extraction of vector templates for constructing loop mutants. No variation in plasmids from 
sixteen different transformants. 
 
Table 5.1: Caf1 loop mutation in pACYCF1. 
Loop mutant 
Caf1 residues 
replaced 
Inserted 
residue 
Insert source 
pACYC-F1D11 D33N34 GG pFM1-F1D11 (R665 clone 4) 
pACYC-F1D12 S76QDGNNH82 GGGG pFMA1-F1D12 (R784 clone 1) 
pACYC-F1D13 D92SRDF96 GGGG pFM1-F1D13 (R669 clone A) 
pACYC-F1D14 K129GGK132 DGGG pFM1-F1D14 (R902 clone 2) 
pACYC-F1::1 D92SRDF96 ELDKWA pFM1-F1::1 (R899 clone 1) 
pACYC-F1::2 S76QDGNNH82 ELDKWA pFM1-F1::2 (R900 clone 1) 
pACYC-F1::3 D33N34 ELDKWA pFM1-F1::3 (R901 clone 2) 
pACYC-F1::4 K129GGK132 ELDKWA pFM1-F1::4 (R902 clone 2) 
 
Table 5.1 lists details of the Caf1 loop mutants constructed, pACYC-F1D11, -
F1D12, -F1D13, -F1D14, -F1::1, -F1::2, -F2::3 and -F1::4 and the pFM1 constructs 
A 
B 
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used as source of mutations. Figure 5.5 overviews the strategy. Because inserts with 
mutations were amplified from caf1 and Infused back into caf1 within the pACYCF1 
vector, amplification primers were identical to the vector (Table 2.3). The same primers 
F1for11 and F1rev11 were used to amplify fragment of caf1 for most constructs. Only 
–F1D14 and –F1::4 amplified a different caf1 fragment using primers 
F1D14insertFOR-2 and F1D14insertREV-2. 
Amplification of inserts and linearization of vector was done using CloneAmp 
HiFi premix. Different annealing temperatures were used to generate linearized 
pACYCF1 and at the same time delete the relevant region of caf1. For F1D11, F1D12, 
F1D13 F1::1, F1::2 and F1::3 annealing temperatures of 55.4°C, 57.7°C and 59.7°C 
were used  and for F1D14 and F1::4 temperatures of 57.2˚C and 59.2˚C were used to 
generate linearized pACYCF1. For amplification of inserts, three different temperatures 
(55.4°C, 57.9°C and 59.9°C) were used to amplify F1D13 to optimise PCR conditions. 
After verifying the PCR product by gel electrophoresis, 57.9°C was selected as the 
optimum temperature to amplify F1D11, F1D12, F1::1, F1::2 and F1::3 inserts. Again, 
the annealing temperatures of 57.2°C and 59.2°C were used to amplify F1D14 and F1::4, 
to optimise the PCR conditions as these inserts used different primers. PCR products of 
inserts and linearized vector were DpnI treated, purified and analysed by gel 
electrophoresis to check the quality and quantity of the purified PCR products (refer 
Figure 5.6). Then the inserts were InFused into linearized pACYCF1 and transformed 
into Stellar competent cells (Clonetech). The correct constructs were identified by gel 
electrophoresis and sequencing. All constructs were confirmed to carry the required 
loop mutations (Appendix 5-16). Correct constructs were then tested for F1 expression.   
  
152 
 
 
 
Figure 5.5: Workflow of In-fusion HD protocol.  
(1) Appropriately mutated pFM1 constructs and pACYCF1 were obtained as source of inserts 
and vector, respectively (2) Four sets of primers were designed, two sets used to amplify vector 
and inserts for F1D11, F1D12, F1D13. F1::1, F1::2 and F1::3. Another two sets were used to 
amplify vector and inserts for F1D14 and F1::4. (3) Inserts were generated by standard PCR 
and vectors were linearised by inverse PCR. (4) InFusion reactions were setup to generate all 
eight constructs (5). Yellow and dark green indicate caf gene; bright green, pACYCF1; red, 
purple, orange and blue, inserts within caf1. 
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Figure 5.6: Electrophoresis analysis of DpnI digested and 
purified linearised vector, and purified inserts.  
(A) Lane 1 and 2 display DpnI digested and purified 
linerised vector PCR product from 55.4°C, first elution 
and second elution respectively. Lane 3 and 4 display 
DpnI digested and purified vector PCR product from 
57.7°C, first elution and second elution respectively. Lane 
5, 6 and 7 display purified F1D11, F1D12 and F1D13 
inserts respectively. (B) Lane 1, 2 and 3 display purified 
F1::1, F1::2 and F1::3 inserts respectively. (C) Lane 1 
displays DpnI and purified linerised vector for F1D14 and 
F1::4 where the PCR products from annealing 
temperature of 57.2˚C and 59.2˚C that were pooled. Lane 
2 and 3 display purified F1D14 and F1::4 inserts 
respectively. 
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5.3.1 Effect of F1 loop mutations on bacterial cell phenotype, initial screen 
Following construction of all loop mutants, three transformants of each 
construct, with the correct insert, were screened to monitor the level of F1 expression. 
Cell pellets were initially screened for the characteristic diffuse white pellet formed on 
recovery of cells assembling large amounts of F1 (Figure 5.7 (A)). Whole cells were 
also screened by SDS-PAGE for the prominent band of denatured Caf1 of 15-16 kDa. 
Transformants carrying plasmid pACYC-F1D11, -F1D13, F1D14 or F1::1 have 
slightly less F1 compared to wildtype as shown in phenotypic analysis of cell pellets 
and SDS-PAGE of whole cells. However, transformants carrying the plasmids pACYC-
F1D12, F1::2, F1::3 and F1::4 all showed a reduced level of surface F1 (Figure 5.7). To 
confirm that no additional spontaneous mutation had occurred that could interfere with 
F1 expression, each of the plasmids resulting in reduced F1 expression was sent for 
whole caf operon sequencing. Seven sequencing primers were used (refer Appendix 13 
(E)) and the sequencing results were assembled using SeqMan Pro tool from DNAstar 
programme. As shown in Appendix 13, the complete caf operon in pACYC-F1D12, 
F1::2, F1::3 and F1::4 constructs were confirmed to have the correct loop mutation and 
no other spontaneous mutation. 
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Figure 5.7: Comparison of F1 production from E. coli Top10 carrying pACYCF1 encoding different loop mutations.  
(A)  Visual inspection of cell pellet, after 24 hour thermo-induction at 37˚C. The culture (1 ml) was centrifuged at 13000 rpm for 20 minutes. F1 
production (WT) is visible as an extensive white fluffy pellet. (B) SDS-PAGE analysis of whole cells (WC). 4 OD cells after 4 hour 
thermoinduction were recovered, resuspended in 100µl PBS and samples denatured in sample buffer prior to electrophoresis. Replicates are 3 
different transformants, each confirmed for the correct insert. WT, pACYCF1; control, pACYCduet1; S, F1 standard.
A 
B 
A A 
A A 
B B 
B B 
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5.3.2 Impact of loop mutations on surface assembly of Caf1 
Following the preliminary screen of F1 loop mutants, confirmed plasmid from 
one transformant for each construct was transformed into E. coli BW25113 to assess 
the impact on surface assembly. This strain was used as it does not carry a mutation in 
the recA gene and high levels of F1 can be recovered. A transformant colony from each 
construct was induced for 4 hours, and then heat extracted F1 (65C/1 hour) was 
analysed by SDS-PAGE (Figure 5.8). F1 was present in all constructs with loops 
replaced with glycine. E.coli/pACYC-F1D13 produced approximately the same level 
of F1 as wild type.  E.coli/pACYCF1-D11 produced slightly less than wildtype and 
pACYCF1-D12 and -D14 produced the lowest level although, still at a good level of 
F1 production. In constructs where loops were replaced with ELDKWA, pACYC-F1::1 
led to accumulation of reasonably high levels of F1, roughly comparable to that 
produced from pACYC-F1D12, but much lower than the Gly replacement in the same 
position (F1D13). Transformants carrying pACYC-F1::2 had a very lower level of F1 
and those carrying pACYC-F1::3 or pACYC–F1::4 had a low level of F1. It is also clear 
that the Caf1 protein produced from pACYC-F1::3 is larger than the other loop mutants. 
This correlates with the respective changes in the size of the loop, larger for F1::3 
compared to wildtype. Efficient polymerisation of all Gly replacement mutants and that 
of F1::1 (Figure 5.8 (B)) was evident from the recovery of Caf1 as very high molecular 
weight (HMW) polymer in the stacking gel of unheated extracts (Yu et al., 2009). No 
HMW polymer could be seen in CB stained gels of samples F1::3, although bands 
corresponding to oligomers of Caf1 were clearly visible, suggesting problems with 
polymerisation or stability. Similar putative oligomers and denatured Caf1 were 
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observed with F1D11 (same position) and F1D12. In fact only F1D13 appeared to 
behave like wild-type F1 with little visible denatured Caf1 in unheated preparations 
(Figure 5.8 (B)). 
            
 
 
Figure 5.8: SDS-PAGE of surface F1 with loop replacements.  
(A) F1 extracted from whole cells at 65°C for 1 hour (B) F1 polymer (stack gel) and 
Caf1 oligomer (separating gel) in unheated samples.  Surface extracts were prepared 
from 3.5 OD cells after 4 hour thermoinduction recovered and resuspended in 100µl 
PBS. 
  
A 
B 
Caf1 
F1 polymer 
Oligomer 
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5.3.3 Impact of loop mutations on stability of the F1 polymer 
From phenotypic analysis of loop mutants, it is clear that five constructs 
(pACYC-F1D11, -F1D12, -F1D13, -F1D14 and -F1::1) assemble Caf1 into high 
molecular weight polymers, but that some may either polymerise less efficiently or 
form less stable polymers. To assess the impact of each mutation on stability of these 
F1 polymers, surface extracted F1 was subjected to heat denaturation in SDS from 65°C 
to 95°C (see Figure 5.9 for detail). As shown in Figure 5.9 (A), wildtype F1 was stable 
in SDS up to between 70°C-75°C. At 75°C both oligomers and denatured Caf1 
monomer were visible. At 80°C and 85°C, F1 appears to be completely denatured to 
the monomer. Thus, to ensure complete denaturation of F1 polymer in SDS, 
temperatures of more than 85°C for 10 minutes should be used to for denaturation.  
From Figure 5.9 (B), it is evident that surface F1 of the F1D11 and F1::1 
constructs were less stable than wildtype. Both were completely denatured at 75°C. 
This was confirmed by western blotting (Figure 5.10) where, only monomemr and 
minor badn of dimer (30 kDa) was present for F1D11 or  dimer (30 kDa) and trimer 
(40 kDa) with F1::1. The constructs F1D12, F1D13 and F1D14 were all more stable. 
Coomassie blue stained oligomers can clearly be observed after heating at 75°C, and 
fully denatured at 85°C. This was confirmed by western blotting for all three constructs 
(Figure 5.10).  However, while the F1D13 construct behaved in a similar manner to 
wildtype with primarily high molecular weight polymer and little monomer after 
heating at 75°C, F1D12 and F1D14 were clearly less stable. Both of these constructs, 
contained a higher proportion of denature Caf1 after heating at 75°C for 10 minutes, as 
well as prominent oligomers.  
  
159 
 
 
 
Figure 5.10: Western blot of temperature stability of extracted F1 from loop mutation 
constructs.  
Samples prepared as for Figure 5.9. 20µl was loaded onto the well. L indicates ladder 
(Thermo Scientific pre-stained protein ladder - 26616). Due to high level of wildtype 
and F1D13 polymer, spill over was detected by western blot in neighbouring lanes.  
 
 
 
A 
B 
Figure 5.9: Temperature stability  
(A) Wild type surface extracted F1. Extracted 
F1 (18µl) was mixed with 6µl of 4X SDS-
loading buffer and heated for 10 minutes at 
65°C, 70°C, 75°C, 80°C, 85°C in an Eppendorf 
Master Cycle PCR machine. (B) Extracted F1 
from loop mutation constructs. Extracted F1 
(18µl) was mixed with 6µl of 4X SDS-loading 
buffer and heated for 10 minutes at 75°C, 85°C, 
95°C in an Eppendorf Master Cycle PCR 
machine. 3.5 OD cells after 4 hour 
thermoinduction were recovered, resuspend in 
100µl PBS and 20µl was loaded onto the well 
for all samples. 
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5.3.4 Quantitative comparison of mutated F1 polymers on the cell surface  
To quantitate differences between the constructs, three fresh transformants of 
each mutated plasmid in E. coli BW25113 were cultured and thermoinduced for 4 hour 
at 37°C. Surface F1 was then, heat extracted at 65°C for 1 hour and analysed by SDS-
PAGE. GeneTool programme was used for quantitation of the Caf1 band by averaging 
the raw data of the triplicate samples and subtracting the background. The average for 
wildtype F1 was assigned as 100 % and the efficiency of surface assembly of each 
mutant expressed as a percent of wild-type (Figure 5.11 and Figure 5.12).  
Results confirmed the preliminary phenotype shown in Figure 5.7. 
Transformants carrying insertions in loop 1, pACYC-F1D11 (Gly insertion) and 
pACYC-F1::3 (ELDKWA insertion), produced surface F1 but at slightly lower levels 
with an average of 70.9%±3.56 and 30.2%±4.18 surface F1, respectively, compared to 
the wildtype surface F1 (100%). Analysis of unheated preparations of both constructs 
revealed accumulation of oligomers in addition to some HMW polymer (Figure 5.8 and 
Figure 5.10). Hence, insertions within loop 1 are likely to interfere with the rate of 
polymerisation and this is exaggerated with the larger charged insertion.  
Quantitation of extracted F1 from cells carrying pACYC-F1D12 (Gly insertion) 
and pACYC-F1::2 (ELDKWA insertion), insertions in loop 4, revealed assembly of 
only 42.1%±1.93 and 6.9%±1.45 surface F1, respectively, compared to wildtype. Cells 
carrying pACYC-F1D14 (Gly insertion) and pACYC-F1::4 (ELDKWA insertion), 
insertions in loop 7, showed an equally reduced level of polymer formation with values 
of 45.2%±2.14 and 8.9%±1.15 respectively, compared to surface F1 from the wild type. 
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Again, the unheated surface F1 (refer to Figure 5.8 (B)) from both constructs revealed 
oligomers consistent with interference with the assembly of Caf1. 
In contrast, insertions in loop 5, had much less impact on surface assembly. 
Cells carrying pACYC-F1D13 (Gly insertion) or pACYC-F1::1 (ELDKWA insertion) 
produced 97.6%±3.66 and 47.9%±2.14 of surface F1, respectively, compared to 
wildtype.  Moreover, F1D13 polymer was as stable as wild type F1.  Despite the lower 
level of high molecular weight polymer produced from construct pACYCF1::1, this 
construct produced the most F1 of all the constructs carrying a charged epitope insertion. 
From this data, loop 5 would appear to be an optimum site for insertion of foreign 
epitope. 
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Figure 5.11: Quantitation of surface F1 extracted from E. coli BW25113 expressing F1 with loop mutations (pACYC-F1D11, -F1D12, -F1D13, 
-F1D14 and -F1::1).  
Top images, SDS-PAGE of F1 extracted at 65°C/1 hour in triplicate for each construct as shown. Lower images, quantitation of imaged F1 band 
using Syngene programme. WT indicates wildtype F1 assigned as 100% for each gel. S indicates F1 standard (5µl applied). 
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Figure 5.12: Quantitation of surface F1 extracted from E. coli BW25113 expressing F1 with loop mutations (pACYC-F1::2, -F1::3 and -F1::4).  
Top images, SDS-PAGE of F1 extracted at 65°C/1 hour in triplicate for each construct as shown. Lower images, quantitation of imaged F1 band 
using Syngene programme. WT indicates wildtype F1 assigned as 100% for each gel. S indicates F1 standard (5µl applied). 
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5.4 In silico analysis of F1 loop insertions 
To assess the reason for poor F1 fibre assembly in some construct, the Caf 
translocon accommodating subunits with loop replacements were modeled. IntFOLD2 
was used to model the fiber inserted subunit where the best template selected by this 
server was 1Z9S:C (Caf1M:Caf1:Caf1 complex). I-TASSER was used to model the 
bottom subunit with 1Z9S:B  assigned as template. There was a need to model the 
modified bottom and top subunits as the cleft in the top subunit is filled with the N-
terminal Gd strand from the bottom subunit; and the cleft in the bottom subunit, is filled 
with the chaperone G1 donor strand from chaperone.  Each FASTA sequence used as 
input in I-TASSER can be seen in Appendix 4. 
Table 5.2 shows that all 16 Caf1 subunits with loop mutations modelled as 
chaperone bound (IntFOLD2) or as fibre inserted (I-TASSER) have a very high 
confidence value indicating that they were correctly modelled.  Small loops are likely 
to be unstructured but to assess any conformational differences at the regions with 
insertions, the Caf1 models (from IntFOLD2) were superimposed with Caf1 structure 
(1Z9S:B) using PyMOL (Figure 5.13). No conformational changes were predicted in 
Caf-F1D11, F1D14, F1::2 and F1::4. The size of loop was reduced in F1D12 where 
residues in loop 4 were reduced from seven to four amino acids and in F1::3 loop 1 was 
converted from two to six amino acids, making a bigger loop. In F1D13, where residues 
in loop 5 were reduced from five to four amino acids. This construct was modeled with 
a shorter loop and missing a β-strand, yet produced the highest level of surface F1 and 
the most stable modified F1 polymers.  F1::1 where residues in loop 5 were converted 
from five to six amino acids, possessed a bigger loop missing the α-helix.   
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Figure 5.13: Superimposed Caf1 mutated model with Caf1 wild type structure to compare the size of insertion in each loops.  
Coloured in red is the replacement either glycine or ELDKWA; cyan, mutated model; and green, Caf1 WT structure (1Z9S:B, chaperone bound 
subunit).   
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Caf1 with loop 
mutation model 
Global model quality score 
(chaperone bound subunit, 
bottom subunit) 
C-score (N-terminal 
extension inserted subunit, 
top subunit) 
F1D11 0.9511 1.55 
F1D12 0.9416 1.53 
F1D13 0.9500 1.49 
F1D14 0.9586 1.57 
F1::1 0.9507 1.52 
F1::2 0.9492 1.50 
F1::3 0.9324 1.40 
F1::4 0.9485 1.58 
Table 5.2: Quality and confidence level of each mutated Caf1 model.  
The confidence value of IntFOLD2, Global model quality score (range 0-1, value >0.4 
indicates a more complete and confident model) and I-TASSER, C-score (range 
between -5 and 2, higher value signifies high confidence model). 
Models of the mutated subunits (fibre inserted and chaperone bound for each of 
the 8 mutated subunits) were then assembled with the Caf1A model to form the 8 
different translocons; thus, permitting analysis of required interactions or clashes 
between the mutated residues and the usher that might affect F1 assembly. To assemble 
each translocon, TMalign was used to superpose Caf1A on FimD, 3RFZ chain B (TM-
score=0.91412). Caf1M (1Z9S chain A) was then superposed with FimC (3RFZ chain 
C) to gain coordinates for Caf1M relative to FimC (TM-score=1).  In PyMol, the Caf1A 
model was aligned with the TMalign file of Caf1A based on FimD. Then, Caf1M:Caf1 
complex (1Z9S:A and B) was aligned with the TMalign file of Caf1M based on FimC. 
Subsequently, the bottom Caf1 mutated model was aligned to the Caf1M:Caf1 bottom 
complex to assemble the bottom Caf1 at this position. The process was repeated for the 
top Caf1 mutated model. The Caf1M structure was aligned to Caf1M:Caf1 complex to 
complete the translocon. Finally, The Gd strand from 1Z9S chain B (residue 1 to 20) 
was loaded into PyMOL and aligned to the bottom subunit model to replace the 
disordered N-terminal Gd extension. The entire process was repeated to assemble all 
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eight translocon models each with two mutated subunits. All are available in the 
attached CD (see Appendix 14 for file details). 
Each translocon was checked for any change in interaction between the 
modified Caf1 subunit and usher. For Caf-F1D11, there is no interaction between the 
inserted glycines with any residues in the translocon  Figure 5.14 (Caf1-F1D11) (A)(iii). 
However, with the longer charged insert in the same loop (Caf1-F1::3), Gln33 and 
Leu34 of the inserted epitope clash with Arg18 and Pro16 in the Gd strand of the 
incoming, chaperone-bound Caf1 (Figure 5.14 (Caf1-F1::3)(B) (iii)). This would be 
consistent with the observed interference in polymerisation of Caf1 carrying the 
inserted epitope.  This was validated by the low level of F1 produced (refer to section 
5.3.4) where pACYCF1::3 produced 30.2%±4.18 surface F1. The inability to 
polymerise efficiently had also been observed earlier when Caf1-F1::3 was expressed 
from pFM1 and oligomers of only 1-8 subunits were recovered (pFM1 encodes 
chaperone and subunit only and results in polymerisation in the periplasm). This was 
in contrast to wildtype and Caf1-F1D11, which assembled high molecular weight 
polymer (refer Appendix 3). Thus, changes to loop 1 are likely to interfere with subunit: 
subunit interaction, decreasing efficiency of polymerisation.  
For Caf-F1D12 and Caf-F1::2 (loop 4 inserts), two interactions are lost, 
Tyr266(plug) with Asn81(subunit) and Thr267(plug) with Gly131(subunit) (Figure 
5.11 and Figure 5.12). In addition, for Caf1-F1::2, the inserted Trp80 within the epitope 
clashed with Tyr266 in the plug. A comparison of both modelled translocons in Figure 
5.14, would suggest that there is nothing hindering Caf1-F1D12 from passing through 
the Caf1A barrel while entrance of Caf1-F1::2 into the usher barrel would be blocked 
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by the additional epitope. This would explain the exceptionally low level of surface 
F1::2 recovered (6.9%±1.45 compared to wildtype). The poor recovery of F1D12 (45 % 
of wild type) might be attributed to loss of required interactions with usher. This is 
supported by the fact that when expressed from pFM1, wildype levels of F1D12 
polymer are produced (Appendix 3) while less surface F1 is produced from 
pACYCF1D12, it still forms relatively stable polymer. The Asn80 residue is conserved 
in multiple sequence alignment of Caf1 and subunits from E. coli SE11. It was also lost 
with insertions in loop 4. Thus, possession of either Asn80 or Asn 81 might be critical 
in translocation of Caf1. 
Figure 5.14 identifies an interaction of 3.5Å in Caf1:F1D13 between Gly92 
(inserted glycine in subunit) and Gln169 (Caf1A barrel). When checked in the wild type 
translocon, Gln169 does not interact with any residue. However, there is an interaction 
of 3.6Å in the wild type translocon between Ser93 (subunit) and Gln167 (Caf1A barrel). 
Based on the quantitation, pACYCF1D13 construct produced essentially wildtype 
levels of assembled polymer (97.6%±3.66). Thus, if the Ser93-Gln167 interaction is 
important for assembly of F1 the new Gly92 - Gln169 interaction may replace this 
requirement to maintain efficient export of F1 fibre to cell surface. The stability of the 
F1 fibre from this construct was also shown to be as stable as wildtype. With the 
changed epitope in this site, pACYCF1::1, there is a clash between Leu93 (inserted 
epitope of top subunit) and Gln169 (Caf1A barrel) and an interaction of 3Å between 
Asp94 (inserted epitope of top subunit) with Ser182 (Caf1A barrel) (refer to Figure 
5.14). However, the interaction between Ser93 and Gln167 that occurred in the wild 
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type was also loss with this epitope insertion. The loss of interaction and clash in this 
construct could explain the reduced level of surface F1 expressed of only 47.9%±2.14.  
Figure 5.14 also shows an interaction of 3Å of Caf1-F1D14 Gly131 (subunit) 
with Thr267 (Caf1A plug) and interaction of 2.4Å between Asn81 (subunit) with 
Tyr266 (plug). This latter interaction is the same as seen in wildtype. However, in Caf1-
F1::4, Asn80 and Asn81 interact with Tyr266 by 2.1Å and 3.1Å, respectively. In the 
wildtype translocon, Asn81 interacts with Tyr266 by 3Å and Gly131 interacts with 
Thr267 by 2.6Å. In Caf1-F1D14, both interactions remained and this predicts that the 
assembly and export of F1 will not be abolished. This was confirmed by quantitation 
where the level of surface F1 was 45.2%±2.14 and shared typical wildtype heat-stability 
properties: after heating at 75˚C in SDS, partially denatured polymer was observed as 
a ladder of oligomers (refer to Figure 5.9). The interactions that are lost in F1::4 remain 
in F1D14 which would correlate with the much higher level of exported F1 with this 
construct, where only 8.9%±1.15 exported outside of the cells carrying pACYCF1::4. 
The very low level of F1 from Caf-F1::4 transformants can be explained as the 
interaction between the subunit (Gly131) and plug (Thr267) was lost (see Figure 5.14) 
and interfering with the opening of the pore. 
In conclusion, transformants carrying pACYC-F1D11 and -F1D13 give a very 
good level of surface F1. This indicates that changes in these regions do not interfere 
with the assembly or export of F1. However, for loop mutations inserted with 
ELDKWA, only pACYC-F1::1 gives a reasonable level of surface F1. Therefore, loop 
5 would be a good to target for future loop replacements. Also, it is possible that genetic 
manipulation of pACYC-F1::1 could be performed to enhance export.
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Figure 5.14: Translocon of loop mutation.  
(A) Translocon with Caf1changed to gly. (B) Translocon with Caf1 changed to charged epitope, ELDKWA (i)Model of whole translocon. Coloured in blue is top Caf1, cyan is bottom Caf1, yellow is Caf1M, green is Caf1A 
and red is changed residues. (ii) View of the translocon from top. (iii) Interaction or clashes between residues in translocon with mutated Caf1. (iv) Corresponding interaction or clashes between wild type protein in 
translocon. Caf1-F1D11, no additional interaction or clash. Caf1-F1::3; circled in black, clashes between Gln33(inserted epitope in the top Caf1) with Arg18 (Gd strand of the bottom subunit), Leu34(inserted epitope in the  
top subunit) with Pro16(Gd strand of the bottom subunit). Caf1-F1D12, loss an interaction of Arg81 with Tyr287. Caf1-F1::2; clashed between Trp80 (inserted epitope) clashed with Tyr287 (plug). Caf1D13, new interaction 
occurred between Gly92 (inserted glycine in subunit) and Gln169 (Caf1A barrel) and loss interaction between Ser93 (subunit) with Gln188 (Caf1A barrel). Caf1-F1::1,  clashed between Leu93(inserted epitope of top 
subunit) with Gln169 (Caf1A barrel) and loss interaction between Ser93 with Gln188. Caf1-F1D14, no additional interaction or clash. Caf1-F1::4, new interaction between Asn80 with Tyr266 and loss interaction between 
Gly131 and Thr267.  
Gly131 
Gly131 
Gly131 Gly131 
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5.5 Increasing surface production of F1 with loop insertions by site-directed 
mutagenesis  
Following in silico analysis of the F1 loop mutant translocons, usher residues 
identified as clashing with subunit residues were mutated to a smaller residue. In 
addition, residues that were involved in interactions in the wild-type translocon but lost 
in the mutated constructs were also tested for their requirement and if appropriate were 
added back to the modified loop to test for improved export.  Table 5.3 lists residues 
that were mutated and their location in the caf operon. 
Table 5.3: List of  point mutation and insertion to improve F1 export in loop mutation 
constructs. 
  Name of mutation Location 
Mutation 
position 
REMARKS 
Mutation to 
improve export 
of pACYCD11 
and 
pACYCF1::3 
pACYCF1_F1_P16A 
Subunit  
(Gd strand) 
P16A 
To validate if the residue is important 
in polymerising Caf1 (clash with 
added Leu34 in loop mutation F1::3) 
pACYCF1::3_F1_P16A 
Subunit  
(Gd strand) 
P16A 
To improve polymerisation/export of 
F1 (export 30.2% inF1::3) 
pACYCF1_F1_R18Q 
Subunit 
(Gd strand) 
R18Q 
To validate significance in 
polymerising Caf1 (clash with added 
Gln33 in loop mutation F1::3) 
pACYCF1::3_F1_R18Q 
Subunit  
(Gd strand) 
R18Q 
To improve polymerisation/export of 
F1::3 (export 30.2% inF1::3) 
pACYCF1_F1_R18K 
Subunit  
(Gd strand) 
R18K 
To validate significance in 
polymerising Caf1 (clash with added 
Gln33 in loop mutation F1::3) 
pACYCF1::3_F1_R18K 
Subunit  
(Gd strand) 
R18K 
To improve polymerisation/export of 
F1::3 (export 30.2% inF1::3) 
Mutation to 
improve export 
of pACYCD12 
and 
pACYCF1::2 
pACYCF1_A_Y266A Plug Y266A 
To validate potential influence in 
opening and closing the pore (clash 
with added Trp80 in F1::2 -  export 
only 6.9%) 
pACYCF1_A_Y266S Plug Y266S 
To validate potential influence in 
opening and closing the pore (clash 
with added Trp80 in F1::2 - export 
only 6.9%) 
pACYCF1_F1_N80G 
Subunit 
(loop) 
N80G 
To validate if this residue/interaction 
important in binding with Tyr266 in 
plug/ opening and closing pore in WT 
pACYCF1_F1_N81G 
Subunit 
(loop) 
N81G 
To validate if this residue/interaction 
important in binding with Tyr266 in 
plug/ opening and closing pore in WT 
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pACYCF1D12_GGGGNNH 
Subunit 
Loop 
Add NH 
making 
GGGGNNH 
insert 
To validate if shift GGGG three 
residues backwards can increase the 
export (export 6.9%). 
pACYCF1::2_ELDKWANNH 
Subunit 
Loop 
Add NNH 
making 
ELDKWANNH 
insert 
To validate if shift ELDKWA three 
residues backwards and avoiding a 
clash between Tyr266 and added Trp 
can increase the export (export 
42.1%). 
pACYCF1::2_A_ELDKWANH 
Subunit 
Loop 
Add NNH 
making 
ELDKWANH 
insert 
To validate if shift ELDKWA two 
residues backwards and avoiding a 
clash between Tyr266 and added Trp 
can increase the export (export 6.9%). 
Mutation to 
improve export 
of pACYCD13 
and 
pACYCF1::1 
pACYCF1_A_Q169A Barrel Q169A 
To validate significance for F1  export 
(clash with added Leu in loop 
mutation F1::1) 
pACYCF1_A_Q169G Barrel Q169G 
To validate significance for F1  export 
(clash with added Leu in loop 
mutation F1::1) 
pACYCF1::1_A_Q169A Barrel Q169A 
To improve export of F1::1 by 
replacing with smaller residue (export 
47.9%) 
pACYCF1::1_A_Q169G Barrel Q169G 
To improve export of F1::1 by 
replacing with smaller residue (export 
47.9%) 
pACYCF1_A_S182A Barrel S182A 
To validate significance for F1  export. 
Ser182 interacts with inserted Asp94 
in F1::1 
pACYCF1::1_A_S182A Barrel S182A 
To validate if removal of Ser203 
interaction improves F1::1 export. 
Ser182 interacts with inserted Asp94 
in F1::1 
pACYCF1_A_Q167S Barrel Q167S 
 To validate importance of Gln167 – 
Ser93 interaction, interaction is lost in 
F1D13 and F1::1 
pACYCF1_A_Q167A Barrel Q167A 
 To validate importance of Gln167 – 
Ser93 interaction, interaction is lost in 
F1D13 and F1::1 
Mutation to 
improve export 
of pACYCD14 
and 
pACYCF1::4 
pACYCF1::4_F1_N81G 
Subunit 
(loop) 
N81G 
To validate if this residue/interaction 
important in binding with Tyr266 in 
plug/ opening & closing pore in loop 
mutations 
pACYCF1::4_F1_N80G 
Subunit 
(loop) 
N80G 
To validate if this residue/interaction 
important in binding with Tyr266 in 
plug/ opening&closing pore in WT 
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5.5.1 Attempt to repair clashes from loop 1 in the F1::3 construct 
With the pACYCF1::3 construct, only 30.2% of  F1::3 was exported and this 
was attributed to a clash between residues of the inserted charge epitope with Arg18 
and Pro16 in the Gd strand from the bottom subunit. The nature of Gd strand residues 
is critical to subunit polymerisation (Yu et al., 2012; Zavialov et al., 2002). However, 
Arg18 and Pro16 both face outwards and hence, are less likely to be critical for donor 
strand exchange. Thus, these residues were mutated in wildtype pACYCF1 to assess 
any impact on production of wild-type F1. Arg18 was mutated to Lys (smaller residue 
in the same polar group) and Gln (smaller residue), while Pro16 was mutated to a 
smaller residue, Ala.  Neither of the Arg mutations had a negative impact on assembly 
of  F1, R18K, and R18Q 104.24%±10.43 and 117.9%3±15.37, compared to wild-type, 
respectively (Figure 5.15).  In contrast, a small reduction in production of surface 
polymer, 77.13%±6.12 of wildtype F1, was observed with the Caf1P16A mutation. 
When the same point mutations were created in pACYCF1::1, there was no marked 
stimulation in production of surface polymer. The levels of mutated F1 were 
34.24%±2.97, 19.45%±2.11 and 37.26±%3.38 compared to WT for F1::3_R18K, 
F1::3_R18Q and F1::3_P16A, respectively. It can be concluded that none of these 3 
additional mutations showed a marked enhanced export of F1::3. The reason why 
F1::3_R18Q was lower, is not clear, but the background staining suggests cell lysis.  
Whole operon sequencing would exclude any additional mutation. Despite the lack of 
impact of additional mutation on export of F1::3, this experiment has identified that the 
outward facing Gd strand residue Arg18 does not appear to be critical in polymerisation.  
It is possible that the large change from Pro16 to Ala had a negative effect on the 
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structure of the Gd strand, thus slightly decreasing the efficiency of polymerisation. 
Additional mutations would be required to assess if the Pro itself is important. 
 
Figure 5.15: SDS-PAGE of extracted surface F1 from E. coli/pACYCF1 with point 
mutations in Caf1A.  
Following 4 hour thermoinduction, F1 was extracted at 65°C for 1 h from 3 OD cells 
in 100µl PBS.  Extracted samples (12µl) were mixed with 4µl SDS loading dye, heated 
at >95˚C for 10 min to ensure complete denaturation of F1 fibre. Denatured sample 
(10µl) was loaded on SDS-PAGE. Following electrophoresis, protein was stained with 
coomassie blue, imaged and bands of denatured Caf1 monomer (black arrowhead) 
quantitated. S1 and S2 indicate 2.59µg and 0.863µg, respectively, of the F1 standard 
applied. A, B and C are biological repeats, 3 separate transformants processed for each 
construct.  
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5.5.2 Replacement of required Asn residue in loop 4 of pACYCF1D12 and 
pACYCF1::2 constructs 
The attempt to enhance export of the loop 4 mutant F1::2 focused on loss of the 
interaction between Tyr266 (plug) and Asn81 (subunit). As discussed in chapter 4, 
mutation of Caf1A Tyr266 to Ser or Ala, in pACYCF1 resulted in only a slight decrease 
of surface F1. Therefore, despite the fact that this Tyr-Asn interaction may still be 
important for efficient F1 assembly, Tyr266 was mutated in the pACYCF1::2 construct 
to minimise the clash with Trp80 of the inserted sequence in loop 4. However, recovery 
of surface extracted polymer from cells with either pACYCF1::2_Y266A or 
pACYCF1::2_Y266S remained extremely low (Figure 5.16). It is possible that this is 
in part attributable to the importance of Tyr266 in gating the pore (see Figure 4.12 in 
Section 4.6.1) as well as its interaction with subunit (via Asn81). 
 
  
Figure 5.16: SDS-PAGE of surface F1 extracted from 
E. coli BW25113 from construct pACYCF1::2_Y266A 
and pACYCF1::2_Y266S.  
3 OD cells after 4 hour thermoinduction were 
recovered, extracted and resuspend in 100µl PBS. 10µl 
of samples were loaded onto each lane. 
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As removal of the Tyr266 clash did not improve export, focus turned to the Asn 
residues. Caf1 Asn81 was mutated to the smaller residue from the same polar group, 
Gly in pACYCF1 (wildtype). There was no impact on export of surface F1. Referring 
back to the multiple sequence alignment of Caf1 and CU subunits from E. coli SE11 
(Figure 4.4, section 4.3.2), Asn80 was conserved rather than Asn81. Thus, Caf1Asn80 
was also mutated to Gly in pACYCF1 and surface F1-N80G extracted. Surprisingly, 
the production of F1-N80G in cells carrying pACYCF1_N80G decreased dramatically 
to 18.4%±2.18 of wild-type, suggesting that Asn80 may be essential in the export of F1 
to the cell surface (Figure 5.17 and Figure 5.18).  In F1D12, the loop size had been 
reduced from seven residues to four residues and included loss of both Asn residues. 
Therefore, to test the ability of Asn residue(s), to restore export F1 with modified loop 
4, the three residues NNH were reintroduced  to pACYCF1D12 and to pACYCF1::2 , 
creating the loop sequences GGGNNH and ELDKWANNH, respectively. Cells 
carrying pACYCF1D12NNH exhibited a dramatic increase in F1 production 
(145.19±4.92% of wild-type) compared to pACYCF1D12 (42.71%±2.25 of wild-type). 
However, for cells carrying the pACYCF1::2NNH construct, the level of mutated F1 
was slightly reduced to 11.51±1.53% compared to cells carrying F1::2 (17.13%±2.32). 
This might be explained by the increased size of the loop interfering with export. 
Therefore, the construct pACYCF1::2_NH was made by deleting one Asn. This small 
change increased mutated F1 assembly to 43.63±2.44% (Figure 5.17 and Figure 5.18). 
The small decrease in size, correct orientation of Asn, avoiding clashes of other residues 
with Tyr266 and Thr288 in the plug could each have contributed to improved export.  
This study provides strong evidence that Asn80 in subunit is essential to export F1to 
the cell surface. 
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Figure 5.17: SDS-PAGE of surface F1 extracted from E. coli BW25113 to assess and 
improve export of loop 4 mutation. 
 
Figure 5.18: SDS-PAGE of extracted surface F1 from E. coli/pACYCF1 with point 
mutations in Caf1A.  
Following 4 hour thermoinduction, F1 was extracted at 65°C for 1 h from 3 OD cells 
in 100µl PBS.  Extracted samples (12µl) were mixed with 4µl SDS loading dye, heated 
at >95˚C for 10 min to ensure complete denaturation of F1 fibre. Denatured sample 
(10µl) was loaded on SDS-PAGE. Following electrophoresis, protein was stained with 
Coomassie blue, imaged and bands of denatured Caf1 monomer (black arrowhead) 
quantitated. S1 and S2 indicate 2.59µg and 0.863µg, respectively, of the F1 standard 
applied. A, B and C are biological repeats, 3 separate transformants were processed for 
each construct. 
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5.5.3 Repairing clash and new interaction involving loop 5 of F1D13 and F1::1  
Loop 5 gives the most promising level of modified F1 export for insertion of 
other epitopes. As shown in Figure 5.11, cells carrying F1::1 were estimated to export 
47.9%±2.1 of surface polymer compared to wildtype, the highest of any of the 
constructs carrying the charged epitope, ELDKWA. Modelling identified loss of an 
interaction between Ser93 (subunit) and Gln167 (Caf1A) (Figure 5.14). The 
significance of this was assessed by mutating Caf1AGln167 to a smaller residue Ala or 
Ser in wildtype F1. As shown Figure 5.19, mutation of this residue did not affect F1 
export to the cell surface, suggesting that the interaction between subunit Ser93 and 
usher Gln167 alone is not critical. Hence, if need be Gln167 could be manipulated to 
improve F1 export. 
Additionally, there was a clash between Caf1 Leu93 from the inserted epitope 
with Q169 in the Caf1A barrel. This was initially assessed by mutating Q169 to the 
smaller residues Ala and Gly with wild-type subunit. The cells carrying 
pACYCF1_Q169G or pACYCF1_Q169A both produce a similar level of F1 as 
wildtype usher, 112.10%±5.88and 100.42%±8.2, respectively (Figure 5.19). This 
indicates that this residue is not essential and can be manipulated in an attempt to 
improve F1::1 production. The same mutations were prepared in pACYCF1::1. Both 
constructs showed dramatically improved production of F1::1; 86.54%±3.86 ftom 
pACYCF1::1_Q169G and 78.71%±1.47 from pACYCF1::1_Q169A compared to only 
37.41% ±1.26 from pACYCF1::1 (Figure 5.11). Thus, in this case, a clash of residue 
was repaired by mutating Gln169 to a smaller residue. To confirm that the charged 
epitope insert was still in this construct, pACYCF1::1_Q169G was sent for whole 
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operon sequencing and both the sequence encoding the charged epitope with Caf1 
subunit and the Q169G codon within caf1A were confirmed on this plasmid. 
In the F1::1 usher translocon, a new interaction between Asp94 of inserted 
epitope and Ser182 of the usher β-barrel was modelled. To determine if this new 
interaction in the F1::1 translocon has any impact on the level of F1::1, Ser182 was 
mutated to Ala in pACYCF1 and also in pACYCF1::1. Cells carrying 
pACYCF1_S182A showed no impact on the level of surface F1, but cells carrying 
pACYCF1::1_S182A produced the same level of F1 as wildtype. This mean that the 
production of surface F1::1 increased from only 37.41%±1.26 in cells carrying 
pACYCF1::1 to 110.68%±10.76 in cells carrying pACYCF1::1_S182A. Time 
limitation, has not permitted whole operon sequencing of this construct.  But based on 
the evidence provided, in contrast to Gln169 which appears to hinder export via a clash 
of residues, Ser182 appears to hinder export by interacting with a loop residue.   
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Figure 5.19: SDS-PAGE of extracted surface F1 from E. coli/pACYCF1 with point mutations in Caf1A.  
Following 4 hour thermoinduction, F1 was extracted at 65°C for 1 h from 3 OD cells in 100µl PBS.  Extracted samples (12µl) were mixed with 4µl SDS 
loading dye, heated at >95˚C for 10 min to ensure complete denaturation of F1 fibre. Denatured sample (10µl) was loaded on SDS-PAGE. Following 
electrophoresis, protein was stained with Coomassie blue, imaged and bands of denatured Caf1 monomer (black arrowhead) quantitated. S1 and S2 
indicate 2.59µg and 0.863µg respectively of the F1 standard applied. A, B and C are biological repeats, 3 separate transformants processed for each 
construct. 
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5.5.4 Repairing loss of interaction in loop 7 of pACYCF1D14 and pACYCF1::4 
constructs 
F1::4 is produced from pACYCF1::4 at very low levels, only 8.9%±1.15 of the 
WT level of F1. Therefore, with F1::4 (loop 7), the focus was to remove the additional 
interaction that occurred between Asn80 and Asn81 with Tyr 287 and maintain an 
interaction between Asn80 and Tyr266. Asn81 was mutated to a smaller residue, Gly 
in pACYCF1::4. As shown in Figure 5.20, it can be seen that cells carrying 
pACYCF1::4_N81G abolished the production of surface F1 and no high molecular 
weight polymer was observed. Therefore, no further mutation was done to improve this 
construct as loop 5 had already been identified as the most promising loop to insert 
foreign epitope. 
 
Figure 5.20: SDS-PAGE of surface F1 containing F1::4_N81G.  
F1 extracted at 65°C for 1 hour and run on SDS-PAGE showing unheated sample with 
high molecular weight polymer in stacking gel. The heated sample was mixed with SDS 
loading dye and heated at>95˚C for 15 minutes to denature all F1 fibre to Caf1 
monomer. 3 OD cells after 4 hour thermoinduction were recovered, extracted and 
resuspend in 100µl PBS. 
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5.6 Histidine insertion in loop 1 
In this study, loop 5 was also modified to insert six or four histidine residues, to 
develop a His tag within the surface assembled polymer. A His-tag within the fibre 
could have many applications, including detailed microscopy analysis of the fibre 
assembly. A construct was made by replacing the charged epitope residues from 
pACYCF1::1 with six His codons to create pACYCF1_DS6His. The Asp and Ser 
residues were also included to optimise loop flexibility for affinity labelling. InFusion 
HD cloning was used, by undergraduate students under my supervision, to make this 
and additional constructs. 
The efficiency of assembly of F1::DSH6 was tested by transforming 
pACYCF1_DS6His into E. coli Top10. As shown in Appendix 15 (A), F1::DSH6 was 
produced and assembled into HMW polymer, but levels were substantially lower than 
that with wild-type F1. Production of his tagged F1 from cells carrying 
pACYCF1_DS6his was also evidently toxic after 4 hours thermoinduction. From the 
translocon model, this inserted epitope also clashed with Gln169. Therefore, Gln169 
was mutated to Ala in this construct making pACYCF1_DS6his_Q169A. The level of 
F1 was tested by surface extraction and as shown in Figure 5.21 below the level of 
surface F1 did not improve after repairing the clash and the cells were still toxic after 4 
hours induction at 37˚C. The bulky His residues and number of  inserted residues (extra 
3 residues, from DSRDF to DSHHHHHH) was likely to be toxic. Thus, two histidine 
residues were deleted using Quickchange II XL kit making pACYCF1_DS4his to test 
the for cell toxicity and ability of binding to the Ni-NTA fluorescence probe.  
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Figure 5.21: SDS-PAGE of surface F1::1DS6His.  
E. coli Top10/ pACYCF1_DS6his_Q169A or pACYCF1 (WT) were thermoinducted 
for 4 h. F1 was extracted at 65°C for 1 h from 3 OD cells in 100µl PBS. Samples were 
mixed with SDS loading dye and heated at>95˚C for 15 minutes to fully denature F1 
fibre. Arrowhead, denatured Caf1M monomer. 
 A growth curve of pACYCF1_DS6his_Q169A and pACYCF1_DS4his 
constructs were tested for cell toxicity. The cells carrying these constructs were grown 
overnight at 26˚C and then following 1 in10 subcultured were thermoinduced at 37˚C. 
The OD600 was monitored and whole cells sampled for F1 extraction, hourly.  
Cells carrying pACYCF1_DS6his_Q169A grew more slowly and appeared 
toxic after 4 hours thermoinduction (Figure 5.22). The level of His tagged F1 from cells 
carrying pACYCF1_DS6his_Q169A, was very low initially - at 2, 3 and 4 hours. 
However, after 5 hours thermoinduction, the F1::DSHis level was almost the same as 
wildtype. This suggests that cells were recovering. For cells carrying 
pACYCF1_DS4his, the production of F1 was high compared to 
pACYCF1_DS6his_Q169A and this was supported by surface extraction (Appendix 15 
(B)).  
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Figure 5.22: Growth curve of pACYCF1_DS6his_Q169A and pACYCF1_DS4his.  
(A) Graph showing groth curve of cells carrying control (pACYCDuet1), wildtype 
(pACYCF1), pACYCF1_DS6his_Q169A and pACYCF1_DS4his based on OD600/ml 
taken every hour. (B) SDS-PAGE of F1 extracted from whole cells. 1 ml of cells of 
every hour thermoinduction were recovered and resuspended in PBS of 4OD/ml. Note 
that spilled over of Caf1 monomer occurred in negative control lane. 
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5.7 Conclusions 
To test the ability of Caf1 to act as a scaffold for surface epitope, epitopes of the 
Caf1 subunit were predicted and loops 1, 4,  5 and 7 identified with strong B-cell epitope 
prediction. These loops were used to insert the charged epitope, ELDKWA and at the 
same time, the residues in this region were replaced with Gly to test the requirement of 
residues in each loop for efficient assembly through the translocon. The studied showed 
that all Gly loop replacements were exported and polymerised.  However, F1D12 (loop 
4) and F1D14 (loop 7) resulted in  lower levels of modified surface F1 and F1D11 was 
less stable, already fully denatured at 75°C in SDS. Temperature stability tests showed 
that only F1 fibre from Gly replacement in loop 5 (F1D13) was fully stable, produced 
in high levels and behaved similarly to wildtype, and fully denatured after heating at 
80-85˚C in SDS. It is clear that insertion of the charged epitope, ELDKWA caused 
problems. The loop 5 insertion, expressed from pACYCF1::1 was the most permissive, 
accumulating 47.9% the level of wildtype F1. This construct produced high molecular 
weight polymer and represents the most promising site for insertion of short foreign 
epitopes.  
 In order to optimise the export of surface F1, translocon models were prepared 
for each modified F1. Each of the translocons was assessed to identify any residues that 
might interfere with polymerisation and export, with the aim of repairing problems to 
enhance export. One of the most striking outcomes of this was repair of the clash 
between Caf1A Gln169 and Leu of the ELDKWA sequence in F1::1 (loop5). By 
decreasing the size of Caf1AGln169, the level of surface F1::1 increased from only 
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37.41%±1.26,  compared to wildtype F1, to 78.71%±1.47 and 86.54%±3.86 from cells 
carrying pACYCF1::1-Q169A and pACYCF1::1-Q169G, respectively.  
A second important finding was the requirement of a correctly located Asn 
residue in loop 4. While the translocon model identified Asn81 as interacting with 
Tyr266 and mutation of Tyr266 led to a slight decrease in F1 assembly, subunit 
mutagenesis identified Asn80 as being the critical residue. In the F1 loop 4 mutations 
encoded on pACYCF1D12 and pACYCF1::2, Caf1Asn80 had been replaced with Gly 
or the charged epitope.  F1D12 and F1::2 assembly was only 42 % and 6.9 %, 
respectively compared to wildtype F1. Unheated surface extracts of Caf1-F1D12 and 
Caf1-F1::2 showed a low level of high molecular weight polymer for Caf1-F1D12 and 
none in Caf1-F1::2. By replacing the Asn residues, modified F1 assembly, was restored 
to 145.19%±4.92 of wild-type F1, for pACYCF1D12.  With F1::2 the size of the loop 
or orientation of residues was clearly important. Insertion of NH yielding the loop 
sequence ELDKWANH enhanced assembly from 17.13%±2.32% of wildtype to 
43.63% ±2.44; whereas, insertion of NNH did not improve assembly. Location of an 
Asn residue (Asn80 in wildtype) is clearly essential for efficient surface assembly of 
Caf1. 
Having demonstrated the ability to modify surface loops and achieve efficient 
export, an attempt was made to create an F1 polymer decorated with a 6His tag. As 
loop5 had been identified as the best loop to modify and loop4 clearly carried a required 
Asn, loop 5 was used for replacement with the polyhistidine tag. While 4 His residues 
were efficiently assembled, surface localisation of 6His residues were less successful 
and toxic to the cells. 
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CHAPTER 6 CHARACTERISATION OF 
E. COLI SE11 
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6.1 Introduction 
E. coli SE11 is a commensal, non-pathogenic gram negative bacteria that was 
isolated from stools of a healthy adult. It has one chromosome (Genebank: AP009240) 
and six plasmids (Genebank: AP009241, AP009242, AP009243, AP009244, 
AP009245, AP009246) (Oshima et al., 2008). In chapter 4, an identity of 70% between 
an usher from E. coli SE11 and Caf1A was identified. This usher belongs to a fimbrial 
operon encoding a chaperone (ECSE_P2-0001), an usher (ECSE_P2-0002) and three 
putative subunits (ECSE_P2-0003, ECSE_P2-0004, ECSE_P2-0005) (see Figure 4.3). 
The operon is located on a 91.1 Kbp plasmid, pSE11-2 plasmid (AP009242). As 
discussed in Chapter 4, subunit 1 and subunit 2 from this operon have an identity of 
30.4% and 31%, respectively, to Caf1. This was unexpected as Caf1 is considered 
unique to the pMT1/pFRA plasmids of Y. pestis and no close relatives had previously 
been identified on BLAST searches. This is particularly interesting for 3 reasons. Firstly, 
the backbone of pMT1 plasmid is already known to be related to other plasmids in the 
Enterobacteriaceae. Understanding the relationship between pMT1 and this SE11 
plasmid may shed light on the acquisition of the caf operon by the early Y pestis ancestor. 
Secondly, as both usher and subunits of the Y. pestis Caf locus and this E. coli SE11 
CU system are more closely related than any other CU system, comparison of both sets 
of gene products should be advantageous in understanding CU assembly via the γ3 
subgroup. Finally, because of the sequence similarity between Caf1 and the putative 
subunits of these E. coli SE11 fibres, the possibility that there may be an immunological 
cross reaction between the two needs to be investigated. Any false positive in screening 
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for previous exposure to plague, could seriously interfere with assessment. This chapter 
outlines fundamental properties of proteins from the operon that are similar to Caf.  
6.1.1 Comparison of Y. pestis pMT1/pFRA plasmid with commensal E. coli 
pSE11-2 
Progressive MAUVE algorithm was used to compared plasmids between Y. 
pestis KIM5, Y. pestis CO92, E. coli SE11 and S. enterica serovar Typhi.  S. enterica 
was included based on data in a publication in 2001. There is 57.6% and 56.2% 
similarity, respectively, between plasmid pFra (96.2 Kbp) from Y. pestis CO92 and 
pMT1 (100.9 Kbp) from Y. pestis KIM5 and pHCM2 (106.5 Kbp) from S. enterica. 
More than 90% of the similar regions shared 96% DNA identity (Prentice et al., 2001). 
To start, plasmid sequences were downloaded from the ftp site NCBI in genebank 
format for each plasmid. Based on the MAUVE results shown in Figure 6.1, pHCM2 
does not shown any similarity with caf operon. Despite the low similarity of ECSE_P2 
plasmid from E. coli SE11, there is a region (lime block in Figure 6.1) that is similar to 
caf operon. The white area in the yellow block of ECSE_P2 plasmid (91.1 Kbp) are the 
three subunits which are less similar and only have less than 35% identity with caf1. 
However, chaperone and usher shown to have a high similarity, as discussed above.  
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Figure 6.1: Comparison of plasmids.  
(A) Y. pestis KIM5 (pMT1, AF053947), (B) Y. pestis CO92 (pFra, (NC_003134), (C) S. enterica (pHCM2, NC_003385) and (D) E. coli SE11 
(ECSE_P2 plasmid, NC_011413). Colors depict conserved and highly related genomic regions and white areas identify unique or low identity 
regions. Blocks shifted below the centre line indicate regions that align in the reverse complement (inverse) orientation relative to reference Y. 
pestis KIM5.    
A 
B 
C 
D 
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6.1.2 Pairwise alignment with Caf1 and multiple sequence alignment of 
subunits 
Analysis was performed on mature subunits. Therefore, SignalP programme 
was used to predict signal peptide cleavage. An unequivacal SP cleavage site was 
identified for both subunits. This was between Ala25 and Ala26 of subunit 1, leaving a 
mature protein of 134 amino acids and between Ala22 and Ala 23 of subunit 2 leaving 
a mature protein of 136 amino acids (Figure 6.3). The signal sequences were removed 
to compare mature subunits in pairwise alignments. The identity and similarity 
percentage of mature Caf1 (mCaf1) to mature E. coli SE11 subunit 1 is 30.4% and 
45.6%, respectively; to subunit 2 it is 29.1% and 48.3%, respectively; and to subunit 3, 
14.1% and 22.8% respectively.  
Multiple sequence alignment of mature Caf1, subunit 1 and subunit 2 was 
performed, omitting subunit 3 due to it’s short size (58 amino acids instead of 149 
amino acids in subunit 1 and 2). This alignment (Figure 6.2 (A)) identified 11 conserved 
residues in β-strands and seven in the loops with high conservation in the Gd and F β-
strands which are critical for polymerisation (MacIntyre, 2001; Zavialov et al., 2002; 
Yu et al., 2012).
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Figure 6.2: Multiple sequence alignment (ClustalW) and pairwise sequence alignment (EMBOSS) of 
E. coli SE11 subunits with Caf1. 
(A) Arrow indicates beta strands in Caf1. An asterisk (*) indicates conserved residues, colon (:) 
indicates conservation between residues with strongly similar properties, period (.) indicates 
conservation between residues with weakly similar properties. Mature Caf1 is aligned with precursor 
of all three subunits from E. coli SE11. (B) Pairwise sequence alignment. Top sequence is E. coli 
SE11 subunit and bottom sequence is Caf1, Y.  pestis. 
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Interestingly, the important residue for stabilization of F1 polymer, Ala9 in Gd 
strand and surrounding residues are conserved between subunit 2 of E. coli SE11 and Y. 
pestis Caf1; whereas, the extreme N-terminus of subunit 1 is conserved. Notably, the P5 
position (Gd strand Leu 13 in Caf1) is not present in either of the 2 SE11 subunits and is 
replaced with a conserved Val in both. This residue is important in initiating polymerisation 
(Yu et al., 2012). Both of these subunits were predicted to have capsule antigen Caf1 domain 
and hence would be predicted to form polymers of immunoglobulin-like modules via donor 
strand complementation.  
 
           
Figure 6.3: Prediction of signal peptide cleavage using SignalP.   
(A) Subunit 1 (ECSE_P2-0003) from E. coli SE11 where the cleavage is between Ala25 
and Ala26. (B) Subunit 2 (ECSE_P2-0004) where the cleavage is between Ala22 and Ala23. 
The C-score was used to distinguish signal peptide cleavage site, S-score to distinguish 
positions of signal peptides from the mature part of the proteins and from proteins without 
signal peptides and Y-score is combination of C-and S-score for better prediction. 
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6.1.3 Homology modelling of E. coli SE11 subunits and identification of conserved 
residues compared to Caf1 
Following analysis of the E. coli SE11 subunit protein sequences, homology 
modeling was done for an in-depth comparison with the Caf1 subunit. I-TASSER was used 
for homology modeling using Caf1 (PDB:1Z9S:B) as template. The subunit models of E. 
coli SE11 and structure were then superposed using TM-align to compare the size and the 
shape. The model was used to locate conserved residues in the protein. As shown in figure 
6.4, five of the 18 conserved residues, Gly50, Asn80, Gly90, Thr143 and Gln149,  are surface 
located and facing outwards. Furthermore, Asn80 have been mutated in Caf1 and shown to 
be important for efficient export of F1 (Chapter 5). 
 
Figure 6.4: Modelled E.coli SE11 fibre subunits. 
(A) Subunit 1 (ECSE_P2-0003), (B) Subunit 2 (ECSE_P2-0004). Both models are 
superimposed on structure of chaperone-bound Caf1 (PDB:1Z9S:B) Blue, Caf1; Green, E. 
coli SE11 Subunits; residues in red, conserved residues, facing inside; residues in pink are 
five conserved residues facing out and might be interacting with β-barrel Caf1A.  
 
  
A B 
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Table 6.1: Summary of conserved residues in Caf1 based on MSA of Caf1 and E. coli  
SE11 subunit 1 and 2. 
 
 
 
 
 
 
 
 
 
6.1.4 Prediction of B cell epitopes in E. coli SE11 fimbrial subunits 
In section 5.2, four epitopes in Caf1 subunits were predicted using DiscoTope. 
Discotope was also used to predict B cell epitopes in E. coli SE11 subunits 1 and 2 and  
MSA to compare location of predicted epitopes  in Caf1 and each E. coli SE11 subunit. 
Based on Figure 6.5, subunit 1 has 8 regions predicted as epitope in the mature protein. 
Three of these, in loops 1, 4 and 5 correspond to locations of predicted epitope in Caf1 and 
loop 5, possessed the conserved residues, Gly79 and Asn80.  In contrast, subunit 2 shared 
no location of predicted epitope with Caf1. In fact, subunit 2 has only a single predicted 
epitope corresponding to loop 1 and a weak prediction for the Gd strand. This would suggest 
Residue Location 
Thr4 Gd 
Thr10 Gd 
Thr12 Gd 
Tyr23 A 
Gly44 B 
Leu48 B 
Gly50 Loop 4 
Asp64 Loop 5 
Gly79 Loop 6 
Asn80 Loop 6 
Gly90 D 
Asn103 Loop 8 
Gly104 Loop 8 
Gly136 F 
Tyr138 F 
Asp140 F 
Thr143 F 
Gln149 Loop 9 
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that, if there is any cross-reaction between F1 and polymers from this E. coli SE11 CU 
system, then there is a greater chance of subunit 2 cross reacting with antibody against F1.  
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Figure 6.5: B cell epitope prediction using DiscoTope.  
(A) Prediction of subunit 1 precursor and (B) prediction of subunit 2 precursor. Black underline indicates predicted B cell epitope, red arrow 
indicates β-strands and black arrowhead above residues indicates predicted B cell epitope in Caf1. 
A 
B 
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6.2 Construction and characterisation of recombinant E. coli SE11 CU operon 
6.2.1 Cloning E. coli SE11 caf-like operon for recombinant fibre assembly and 
tagged chaperone-subunit complex 
To experimentally test functionality and any cross-reaction between CU fibres of the 
E. coli SE11 locus and Y. pestis F1, the complete pSE11-2 CU operon was cloned into 
pACYCDuet1 to test for surface assembly of an SE11 fibre.  Chaperone and subunits, 
without usher, were also cloned into pTRC99 to test for recovery of periplasmic polymer. 
The constructs pACYCD1-MA-S123 and pTRC99-MHis-S123 (Figure 6.6) were created 
using InFusion Cloning (Takara). For construction of pACYCD1-MA-S123, pACYCDuet1 
was linearised by restriction digestion, NcoI (NEB). The complete E. coli pSE11-2 fimbriae 
sequence from chaperone to subunit 3 (4997 bp) was amplified using CloneAMP
TM
 HiFi 
Premix and primers . The Infusion Cloning kit (Takara) was used to InFuse the insert into 
the linearised vector, which was then transformed into E. coli Stellar ultra competent cells. 
Plasmid DNA was analysed for the correct size of 8.9 Kbp for pACYCD1-MA-S123 and. 
The entire insert and fusion joints confirmed by sequencing. 
pTRC99-MHis-S123 was created by linearising pTRC99 by restriction digestion with 
NcoI (NEB). Two inserts were used to make this construct; fragment one contained DNA 
encoding the chaperone with a C-terminal 6Histag and fragment two contained DNA 
encoding, subunits 1, -2 and -3 (Figure 6.6). Both were amplified from E. coli SE11 genomic 
DNA using CloneAMP
TM
 HiFi Premix and SE11For1 and SE11Rev1 primers. The 
amplified inserts and linearised vector were InFused and transformed into E. coli Stellar 
ultra competent cells. Individual transformants were picked, plasmid (6.7 Kbp) extracted 
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and the correct insert confirmed by sequencing. The CU system encoded in pACYCD1-
MA-S123 is under control of the T7 promoter and the chaperone and subunits in pTRC99-
Mhis-S123 are under control of the pTRC promoter. Both require induction with IPTG for 
expression. 
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Figure 6.6: pACYCD1-MA-S123 and pTRC99-MHis-S123 constructs.  
pACYCD1-MA-S123 was used for recombinant surface expression of E. coli SE11 fimbriae, 
expressed from T7 promoter using plasmid SD sequence upstream of chaperone gene. pTRC99-
MHis-S123 was used to trap the fimbriae in the periplasmic. The map was generated using 
SnapGene 3.2.1 tool. 
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6.2.2 Lack of toxicity of cloned CU operon and identification of expressed protein 
To test for toxicity of expression of the recombinant CU system, pACYCD1-MA-
S123 was transformed into E. coli BL21 (DE3) and growth monitored over 6 h induction. 
The cells were grown overnight at 26˚C in LB with 0.6% glucose and 34 ug/ml CAM. The 
next day, the culture was washed and subcultured 1/10 into LB with 10 ug/ml CAM and 
grown at 37˚C for 1 hour. The cells were then induced with 0.5 mM IPTG. The culture was 
sampled every two hours; the OD600 was read and whole cells (1 ml) recovered and 
resuspended in PBS to a concentration of 4 OD cells/ml. Denaturated cells were then 
analysed by SDS-PAGE. Based on Figure 6.7, it is clear that cells carrying pACYCD1-MA-
S123 grew at a similar rate to pACYCF1 and in fact better than the control, pACYCduet1. 
Expression of recombinant protein was confirmed by SDS-PAGE. In samples of cells 
carrying pACYCD1-MA-S123 recombinant protein was clearly visible even after 2 hours 
induction and the level increased at 4 and 6 hours induction. Two bands migrating slightly 
faster than Caf1 were observed. These were absent from the control and could be assigned 
as subunits from E. coli SE11. These results indicate that expression of the recombinant SE11 
CU operon is not toxic to the E. coli cells, under the conditions tested. The amount of 
recombinant subunit was similar at 4 hours and 6 hours induction thus, 4 h induction with 
0.5 mM IPTG at 37˚C was used for further studies.  
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Figure 6.7: Growth curve of recombinant E. coli BL21 (DE3)/pACYCD1-MA-S123  
(A) Growth curve of E. coli carrying pACYCDuet1 (empty vector), pACYCF1 
(recombinant Y. pestis caf locus) and pACYCD1-MA-S123 (recombinant CU system from 
E. coli SE11). OD600 were taken from each culture every 2 hours, after IPTG induction (0 
hour, time) (B) SDS-PAGE of whole cells. Cell samples (1 ml) were recovered, every 2 
hours after induction and resuspended in PBS, at a concentration of 4 OD cells/ml PBS and 
analysed by SDS-PAGE. Arrow indicates subunits from E. coli SE11 or Caf1. Note that at 
6 hours, pACYCDuet1 sample was missed. 
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6.2.3 Comparison of  recombinant production of periplasmic chaperone-subunit 
complexes and surface assembled subunit from the E. coli SE11 fimbriae 
operon 
Expression of the recombinant E. coli SE11 fimbriae operon from pACYCD1-MA-
S123 was not toxic to E. coli BL21 and subunits were produced in high level. Therefore, a 
comparison of the level of subunit accumulating on the surface from E. coli BL21 (DE3) 
/pACYCD1-MA-S123 and in the periplasm from E. coli Top10/pTRC99-Mhis-S123 was 
compared. His-tagged periplasmic subunit would be simpler to purify if expressed at a 
reasonable level. Both cultures were grown overnight at 26˚C in LB with 0.6% glucose with 
appropriate antibiotics. The next day, the cultures were washed and subcultured 1/10 into LB 
and appropriate antibiotics. After an hour (OD600 ~0.5), the cells were induced with 0.5 mM 
IPTG for 4 hours followed by extraction of surface polymer at 65°C/1 hour or isolation of 
the periplasmic fraction by osmotic shock (see section 2.8.2 and 2.8.3). As can be seen on 
the SDS-PAGE (Figure 6.8), two bands at approximately 13 kDa and 14 kDa were observed 
in both surface (pACYCD1-MA-S123) and periplasmic (pTRC99-Mhis-S123) extracts of 
the respective denatured samples. At the same time, surface extracts were prepared from E. 
coli SE11, using the same growth and extraction conditions. There was no striking evidence 
of expression of these proteins, a faint band was observed at the size of 13.5 kDa and several 
other higher molecular weight bands. At present, there is no evidence that these are related 
to the plasmid encoded CU system of interest. It is also quite likely that expression of this 
SE11 system is tightly control in the host bacterium. 
In this experiment, pFM1 was used as control for periplasmic extraction as the high 
level of chaperone traps Caf1:Caf1M complexes resulting in accumulation of Caf1 polymer 
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in the periplasm. In the periplasmic of cells carrying pTRC99-MHis-S123, the level of 
chaperone appeared to be low and the level of trapped subunits lower than surface subunits. 
One conclusion here might be that the E. coli SE11 subunits behave in the same way as Caf1 
and are degraded when not bound to the chaperone.  
Unheated samples of cells carrying pACYCD1-MA-S123 were observed to have 
high molecular weight polymer where the polymer can be observed in the stacking gel and 
oligomers in the separating gel. This suggests that this polymer was stable even when the 
cells were heat shocked at 65˚C to extract the surface protein. With periplasmic extracts, 
following expression from pTRC99-MHis-S123, the same HMW polymer was not noted, but 
the subunit bands disappeared, implying that they had also polymerised. Immunoblotting 
would be required to confirm this. Notably, the bands for both denatured subunits 
disappeared in the absence of heating, suggesting that both subunits form HMW polymer. 
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Figure 6.8: SDS-PAGE of surface and periplasmic subunits/polymer of E. coli SE11 
fimbriae operon.  
(A) Heated periplasmic and surface protein at 95°C for 15 minutes (B) F1/ E. coli SE11 
polymer (stack gel) and Caf1/E. coli SE11 subunit oligomers (separating gel) in unheated 
samples.  3 OD cells after 4 hour induction were recovered and resuspend in 100µl PBS. 
 
 
A 
B 
  
206 
 
6.2.4 Heat stability of recombinant surface assembled polymer  
To assess the stability of E. coli SE11 polymer, cells carrying pACYCD1-MA-S123 
were heat shocked at 55˚C to extract surface polymer and subjected to heat denaturation at 
65˚C, 75˚C, 85˚C and 95˚C in SDS-PAGE loading dye as shown in Figure 6.9. The SE11 
polymer was stable at 55˚C where a high molecular weight polymer can be observed in the 
stacking gel. The polymer appears to denature at a temperature between 55 and 65˚C. Both 
subunits are started to denature at 65˚C with no HMW polymer in the stacking gel. 
Oligomers can be observed when the surface protein heated at 65˚C, 75˚C and 85˚C and 
fully denatured at 95˚C. This suggests that the polymer was very stable where it can only be 
fully denatured at 95˚C in SDS. Although there is consistently less of the upper subunits, 
both subunits appear to behave in the same way. 
 
Figure 6.9: Temperature stability of surface extracted cells carrying pACYCD1-MA-S123.  
4.5 OD cells after 4 hour thermoinduction were recovered and resuspended in 100µl PBS. 
Extracted surface protein (12 µl) was mixed with 4X SDS-loading buffer (4 µl) and heated 
for 10 minutes at 65°C, 75°C, 85°C, 95°C in an Eppendorf Master Cycle PCR machine. 
10µl was loaded unto the well for all samples. 
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6.3 Mass spectrometry of E. coli SE11 subunit 
Following SDS_PAGE, two protein bands were resolved at approximately 14 kDa 
and 15 kDa following expression from both pACYCD1_MA_S123 and pTRC99-Mhis-
S123. To confirm identity of both bands, mass spectometry following  tryptic digests of both 
bands was performed. A large batch of E. coli BL21 (DE3) cells carrying 
pACYCD1_MA_S123 was induced for 4 hours and surface fimbriae heat–extracted at 65°C 
for one hour. The surface extracted samples were applied to a 16% acrylamide gel for SDS-
PAGE, stained with Coomassie blue and destained.  The bands migrating at approximately 
14 kDa and 15 kDa (Figure 6.10) plus a control band of 70 kDa from the ladder and a 
background acrylamide gel control were excised, and processed for trypsin digestion and 
mass-spectometry as described (Section 2.9.6). Identified peptides are listed in Table 6.3. 
The peptide profiles confirmed that the two bands were indeed the two different subunits 
(and not a breakdown product of one subunit). Based on the peptides identified by mass 
spectometry, the upper band of 15 kDa protein was identified as subunit 2 and the lower 
band of 14 kDa protein was identified as subunit 1. It is obvious from all analysis thus far 
that there were only 2 major bands expressed from this locus. Subunit 3 would be much 
smaller and not big enough for a complete pilin subunit. From this analysis also, it can be 
confirmed that subunit 3 was not one of these bands. If expressed at all, it is not a major 
component of the fibre.  
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Figure 6.10: SDS-PAGE of surface extracted E. coli SE11 fimbriae.  
(A) SDS-PAGE before excising the gel. (B) SDS-PAGE after excising the gels. L indicates 
ladder. 
 
Table 6.2: Peptides identified by mass spectrometry 
Peptide 
Subunit peptide 
found 
RNLEFTDPNRG Subunit 1 
KFTVSTDFNDRL Subunit 1 
RSGFTASYNEIR Subunit 1 
RYSDVITVILNGQ Subunit 1 
KFTVSTDFNDRLVPGR Subunit 1 
RGDGYFTFTSPEGNSFK Subunit 1 
KFGEITLNGMTGGNLTIR Subunit 1 
KINGNIPQPWLADHISNGSKF Subunit 1 
RNLEFTDPNRGDGYFTFTSPEGNSFKA Subunit 1 
 
Peptide 
Subunit peptide 
found 
KDTAGNALLAEAFINGGAIKL Subunit 2 
KLNGAYAAGTQATGNLPAGTTNIDLKT Subunit 2 
 
A 
B 
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6.4 Purification of recombinant subunits from E. coli SE11 
6.4.1 Comparison of His tagged periplasmic chaperone complexes 
Purification of E. coli SE11 subunits can be used for antibody production to test for 
any cross-reaction between these SE11 CU fibres and Y. pestis  F1 polymer. Antibody will 
also be very useful to monitor expression from E. coli SE11. The C-terminal 6Histidine-
tagged construct (pTRC99-MHis-M123) was created to trap E. coli SE11 subunits/polymer 
within the periplasm and facilitate purification. However, to optimise binding of the 
chaperone:subunit/s complexes to the Ni-NTA, a C-terminal 8Histidine-tagged E. coli SE11 
chaperone was created using QuikChange II XL Site-Directed Mutagenesis by inserting 2 
histidine to pTRC99-MHis-M123, making the construct pTRC99-M8His-S123. At the same 
time, to produce antibody against subunit 1, a construct of pTRC99-M6his-S1 was created 
by deleting subunit 2 and 3. Similarly, a construct of pTRC99-M6his-S23 was attempted by 
deleting subunit 1, for production of antibody against subunit 2. However, creation of this 
latter construct was unsuccessful. Therefore, pTRC99-M8his-S123 and pTRC99-M6his-S1 
were processed for periplasmic extraction to compare the production of E. coli SE11 
subunits/polymer. Figure 6.11 shows that cells carrying the pTRC99-Mhis-S1 construct 
produced only subunit 1 as expected and that cells carrying pTRC99-M8his-S123 produced 
both subunit 1 and subunit 2. Both constructs produced low levels but visible subunit. 
Therefore, both constructs were used for purification with an Ni-NTA column.  
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Figure 6.11: SDS-PAGE of periplasmic subunits/polymer from pTRC99-Mhis-S1 and 
pTRC99-M8His-S123.  
After 4 hour induction with IPTG at 37˚C, periplasm was prepared from 3 OD cells in a 
final volume of 100 ul 10 mM MgCl2. 
 
  
6.4.2 Purification of E. coli SE11 chaperone:subunit/s complexes by Ni2+ NTA 
The large batch of periplasmic fraction, 9 ml from 400 ml induced cultures of E. coli 
BW25113/pTRC99-M6His-S1/DH5α and E. coli BW25113/pTRC99-M8His-S123/ DH5α, 
were applied to 1ml His-Trap columns and eluted over 30 fractions of 1 ml. Peak fractions 
were analysed by SDS-PAGE. Chaperones were observed at the size of approximately 30 
kDa at fraction 31, 32, 33 and 21, 22, 23, 24 in pTRC99-M8His-S123/DH5α and pTRC99-
M6His-S1/DH5α, respectively (Figure 6.12). This is in agreement with tighter binding of 
the 8 His tagged chaperone. However, no subunits were visible in stained gels from either 
purification. It could be that in subunit loaded chaperone the His tag is no longer accessible 
to bind the column. Due to this and the low level of subunits accumulating in periplasmic 
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fractions from these constructs, it was decided not to pursue this approach any further and 
to focus on surface assembled protein. 
6.4.3 Purification of recombinant surface assembled E. coli SE11 subunits by size 
exclusion chromatography 
Since the purification of E. coli SE11 chaperone:subunits/s complexes was 
unsuccessful, pACYCD1-MA-S123/BL21 (DE3) was used for purification. Heat extraction 
provides an excellent first step purification. This was further purified by treatment with 
TritonX 114 to remove LPS and lipids followed by size exclusion chromatography to 
separate HMW polymer from lower protein contaminants. The surface extracted sample 
(refer section 2.9.8 for procedure) was applied to a 120 ml HiPrep Sepharyl HR S-300 
column in PBS and 90 fractions of 1.5 ml each were collected at 0.5 ml/min. Peak fractions 
were analysed by SDS-PAGE. Subunits 1 and 2 were eluted together in fraction 18 and 19.  
No other proteins were visible in these fractions or in any other fraction. Due to the low 
level of contaminating proteins, samples will be reanalysed following concentration and are 
being saved at -20C to raise antibody. As these subunits have an identity of more than 30% 
to the unique F1 antigen, it is important to exclude any immunological cross-reaction 
between the E. coli SE11 subunits and .  pestis F1. Unfortunately, due to the time constraint, 
antibody production and cross reaction experiments cannot be done within this study. The 
antibody will also be useful to further characterise this commensal CU system. 
.
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Figure 6.12: NTA purification of recombinant E. coli SE11 chaperone:subunits complexes.  
(A) Chromatogram and SDS-PAGE of pTRC99-M8his-S123. (B) Chromatogram and SDS-PAGE of pTRC99-M6his-S1. Peak fractions were 
boiled for 15 mins at >95˚C ins SDS-PAGE loading dye prior to SDS-PAGE. Number correspons to eluted fraction number of 1ml each fractions. 
S indicates sample before purification and L indicates protein ladder. 
 
A B 
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Figure 6.13: Sephacryl S300 purification of E. coli SE11 subunits/polymer. Chromatogram and SDS-PAGE of pACYCD1-MA-S123.  
Peak fractions were boiled for 15 mins at >95˚C in SDS-PAGE loading dye prior to SDS-PAGE. Number correspond to eluted fraction number of 
1.5 ml each fractions. S indicates sample before purification. Spill over of sample 19 was observed at lane 46.
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6.5 Conclusions 
In this chapter, the E. coli SE11 p000001-p00005 CU fimbriae operon from pSE11-
2 plasmid has been analysed by bioinformatics analysis and identity of the subunits 
validated by in vitro analysis. The operon consists of an usher with 70% identity with Caf1A, 
a chaperone with 59% identity with Caf1M and 2 subunits, named subunit 1 and subunit 2 
with 34% and 31% identity to Caf1, respectively. A third ORF also annotated as subunit, 
appears too small to be a functional subunit. Recombinant constructs successfully produced 
surface assembled polymer of subunits 1 and 2, and a separate construct produced low 
levels of periplasmic subunit and chaperone. Mass spectrometry was used to confirm 
identity of both subunits. Attempts to purify subunit:chaperone complex using a C-
terminally His tagged chaperone were unsuccessful. However, polymer preparations with 
very high levels of subunit1 and 2 were successfully purified from E. coli 
BL21/pACYCD1-MA-S123 by heat extraction, Triton TX114 extraction and size exclusion 
chromatography. Following confirmation of purity, this preparation can be used for 
antibody production for further study, including testing any cross- reaction with F1 polymer. 
Identity between F1 and the E. coli SE11 polymers is not particularly high, although 
B cell epitope prediction revealed that loop 5, which contains the conserved Gly Asn 
sequence in both, was predicted as a discontinuous B-Cell epitope. The ancestral origin of 
the caf operon and the link between this and the closely related E. coli SE11 operon is also 
of interest. A plasmid comparison between Y. pestis (pMT1 and pFra), E. coli SE11 
(ECSE_P2) and S. enterica (pHCM2) showed that despite the higher similiarity between 
pMT1 and pFra with pHCM2 (56.2% and 57.6% respectively), pHCM2 does not have any 
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similarity with the  Caf operon. In contrast, despite the lower similarity between pMT1 and 
pFra with ECSE_P2, there is strong similarity between the 2 chaperone usher loci. 
Unfortunately, the creation of a hybrid E. coli SE11 caf CU system to determine the 
flexibility of the usher to export Caf1 polymer was unable to be performed due to time 
constraints.  
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CHAPTER 7 GENERAL 
DISCUSSION AND FUTURE 
DIRECTIONS 
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7.1 Properties of the Caf1A usher 
In this study, modelling of the Caf translocon was used to identify potential residues 
that might be important in polymerisation and translocation of Caf1. The first step of F1 
fibre translocation occurs when the Caf1M:Caf1 complex  binds to the N-terminus of Caf1A 
and opens the pore (Sauer et al., 2002; Yu et al., 2012). In PapC, a single salt bridge (Arg305 
in the plug interacts with Glu467 in an α-helix within the barrel) was shown to keep the 
plug in the closed position (Volkan et al., 2013). Arg305 corresponds to Glu291 in Caf1A. 
In the closed Caf translocon, Glu291 is shown to interact with Lys462 in the β-barrel. The 
mutations E291K, E291A and K462A all resulted in an apparent increase in the level of 
surface F1. This would be consistent with the mutation weakening the ionic interaction and 
facilitating opening of the pore and F1 export. Of the usher residues mutated in this study, 
the one that had the  highest impact on the export of surface F1 when mutated was Ser289. 
which corresponds to R303 in PapC. Ser289 was shown in the close Caf1A model to 
interact with a residue in β-hairpin, Asp217. The profound reduction of surface F1 with the 
Caf1 S289A mutation suggests that this residue could be important in translocating the 
polymer through the pore by direct interaction with Caf1 subunit or through an additional 
interaction in the pore. Tyr266 was also shown to be important in positioning the plug inside 
the pore. In the closed Caf1A model, Tyr266 formed an extensive hydrophobic interaction 
with Tyr198 (β5-6 hairpin) and Tyr215 (β5-6 hairpin). In PapC, the β5-6 hairpin was also 
shown to be important in stabilising the plug inside PapC β-barrel as deletion of this region 
significantly increased pore permeability in an Erythromycin sensitivity assay (Volkan et 
al., 2013; Mapingire et al., 2009). Much more detailed investigation is required to 
established involvement of these three Tyr residues in pore gating. 
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7.2 Caf1 as scaffold of short peptides 
A total of four loops were replaced with Gly and the charged residues (ELDKWA) 
to test the ability of Caf1 to act as scaffold for surface epitope. The modelled Caf translocon 
was used to explain problems in constructs that appeared to be non-permissive and predict 
mutations within the usher that might improve export. The most promising site among these 
four loops for insertion of short foreign epitope is loop 5. Insertion of Gly sequence or a 
charged epitope to this loop retained a significant level of surface F1, although there was a 
large reduction with the charged loop. The translocon model was used to repair the clash 
between the inserted charged residues with Glu169 in the β-barrel. This improved export 
from only 37.41%±1.26 of surface F1 from cells carrying pACYCF1::1 to 78.71%±1.47 
and 86.54%±3.86 from cells carrying pACYCF1::1_Q169A and pACYCF1::1_Q169G 
respectively. Focusing on one identified permissive site loop 5, this loop was used to insert 
polyhistidine-tag for visualisation of F1 fibres using NTA-fluorescent probes. Analysis of 
F1-His polymers expressed on the surface showed that Caf1, with 4his tagged can be 
assembled and efficiently polymerise. but that cells expressing a 6his-tagged insertion in 
loop 5 displayed signs of toxicity in the cells and would be problematic for assessing 
binding of NTA-fluorescent probe.  
7.3 E. coli SE11 fimbriae operon similar to caf operon 
Investigation of closely related ushers with Caf1A revealed that the usher from E. coli 
SE11 fimbriae operon from pSE11-2 shares 70% amino acid sequence identity over the 
whole protein. This newly identified usher was shown to group with γ3 fimbriae and next 
to Caf1A. Locus analysis showed that this operon consists of one chaperone, one usher, and 
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three subunits. However, subunit 3 is too small for a fimbrial subunit and cloning of this 
operon into pACYCDuet1 and pTRC99, and mass spectrometry identified only two 
expressed subunits, subunits 1 and 2. How these subunits assemble, within a single fibre or 
separate fibres is an interesting question for further study. This relates to other γ3-fimbriae 
members as the operon consists of one usher, one chaperone and one or two subunits. The 
subunit(s) assembled into thin and flexible fimbriae. The pTRC99-M6his-S1 and pTRC99-
M8His-S123 were used to purify the subunits but were unsuccessful due to a low level of 
these subunits accumulated in the periplasm. Therefore, the subunits were purified 
following heat extraction from the cell surface and detergent extraction, by size exclusion 
from the pACYCD1-MA-S123 construct.  The purified protein will be used for antibody 
production which can then be used to for further study of these fibres as well as testing/ 
excluding any cross-reaction with F1 polymer.  
7.4 Future directions 
Key future work is to assess any cross reaction between antibody against E. coli SE11 
subunits with F1 and Caf1. ELISA and fluorescent microscopy would both be suitable to 
determine any cross reaction. The flexibility of usher to export other subunits by infusing 
the E. coli SE11 usher into caf operon by replacing Caf1A can also be determined. The 
epifluorescence assay for binding of polyhistidine tagged Caf1 to a fluorescent probe should 
be established, as Caf1 inserted with 4His was successfully exported as polymer to the cell 
surface. Direct NTA-fluorescein binding to F1 polymer could be an efficient quantitative 
method for assembly of F1. For this, F1 polymers carrying polyhistidine-tag should 
assemble efficiently and be non-toxic. Another outstanding question to be answered is what 
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is the function of the hydrophobic path (Tyr). These residues must be mutated to identify 
the function of these tyrosines. Might these Tyrosine residues involve in gating the pore? 
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Appendix 1: Usher proteins from similarity search results, using BLASTP, used to 
construct phylogenetic tree.  
Proteins not previously included in earlier γ fimbrial clade are highlighted in yellow. 
Duplicates (100% identical) have been removed. 
 
Description 
Query 
cover 
E value Ident Accession 
fimbrial usher protein [Yersinia pestis] 100% 0 100% WP_002211763.1 
F1 capsule-anchoring protein [Escherichia 
coli SE11] 99% 0 70% WP_000877656.1 
putative fimbrial usher protein 
[Salmonella enterica] 99% 0 49% WP_001750512.1 
putative fimbrial usher protein 
[Salmonella enterica] 99% 0 47% WP_023222950.1 
putative fimbrial usher protein 
[Salmonella enterica] 99% 0 49% WP_001750818.1 
putative fimbrial usher protein 
[Salmonella enterica] 99% 0 47% WP_023222330.1 
putative fimbrial usher protein 
[Salmonella enterica] 99% 0 47% WP_023248754.1 
outer membrane usher protein AfaC 
[Escherichia coli] 99% 0 44% WP_021573024.1 
putative outer membrane usher protein 
psac [Escherichia coli] 99% 0 44% WP_023141262.1 
pilin outer membrane usher protein SafC 
[Escherichia coli] 99% 0 44% WP_001205747.1 
Outer membrane usher protein fimD 
precursor [Escherichia coli ISC41] 99% 0 44% CDL44533.1 
F1 capsule-anchoring protein [Escherichia 
coli 1-110-08_S4_C1] 99% 0 44% EYE06634.1 
pilin outer membrane usher protein SafC 
[Escherichia coli] 99% 0 44% WP_001330422.1 
pilin outer membrane usher protein SafC 
[Salmonella enterica] 99% 0 44% WP_023219945.1 
Outer membrane usher protein SfmD 
[Salmonella enterica subsp. enterica 
serovar Johannesburg str. S5-703] 99% 0 44% EHC69713.1 
DraC [Escherichia coli] 99% 0 44% AAK16477.1 
DafaC [Escherichia coli] 99% 0 44% AAK17181.1 
pilin outer membrane usher protein SafC 
[Edwardsiella hoshinae] 99% 0 44% WP_024524433.1 
pilin outer membrane usher protein SafC 
[Yersinia ruckeri] 99% 0 44% WP_004719950.1 
fimbrial usher protein [Edwardsiella 
piscicida] 99% 0 44% GAJ67292.1 
Outer membrane usher protein SfmD 
[Salmonella enterica subsp. enterica 
serovar Minnesota str. A4-603] 99% 0 44% EHC74323.1 
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aggregative adherence fimbria II usher 
protein AafC [Escherichia coli 042] 99% 0 43% AAD27810.1 
HdaC, HUS-associated diffuse adherence 
[Salmonella enterica] 99% 0 42% WP_023221224.1 
type VII secretion system (T7SS), usher 
family protein [Escherichia coli 2-005-
03_S3_C2] 99% 0 41% KDA74785.1 
type VII secretion system (T7SS), usher 
family protein [Escherichia coli 2-005-
03_S1_C3] 99% 0 41% EZK11614.1 
type VII secretion system (T7SS), usher 
family protein [Escherichia coli 1-250-
04_S1_C3] 99% 0 41% EZJ94256.1 
Outer membrane usher protein Agg3C 
[Escherichia coli] 99% 0 41% WP_001403380.1 
outer membrane usher protein AggC 
[Escherichia coli] 99% 0 41% WP_021523943.1 
P pilus assembly protein, porin PapC 
[Serratia marcescens] 99% 0 42% WP_015673850.1 
hypothetical protein [Providencia stuartii] 99% 0 39% WP_004927466.1 
psaC [Yersinia pestis EV76-CN] 99% 0 39% CAA66357.1 
fimbrial outer membrane usher protein 
SthC [Serratia odorifera] 98% 0 39% WP_004957477.1 
fimbrial outer membrane usher protein 
SthC [Enterobacter mori] 98% 0 38% WP_010431832.1 
fimbrial outer membrane usher protein 
SthC [Cronobacter sakazakii] 97% 0 38% WP_012124895.1 
fimbrial outer membrane usher protein 
SthC [Klebsiella oxytoca] 97% 0 38% WP_004851752.1 
type 1 fimbriae anchoring protein FimD 
[Klebsiella oxytoca HKOPL1] 97% 0 38% AHW88442.1 
outer membrane usher protein LpfC 
[Enterobacter cloacae] 99% 0 37% WP_023303537.1 
outer membrane usher protein FimD 
[Enterobacter hormaechei] 99% 7.00E-180 37% WP_017693574.1 
fimbrial outer membrane usher protein 
SthC [Enterobacter cloacae] 99% 9.00E-180 37% WP_017384637.1 
type 1 fimbriae anchoring protein FimD 
[Serratia fonticola] 99% 4.00E-178 38% WP_021806318.1 
fimbrial outer membrane usher protein 
SthC [Yersinia aldovae] 98% 5.00E-174 37% WP_004700856.1 
outer membrane usher protein SfmD 
[Serratia marcescens] gamma1 99% 1.00E-169 36% WP_004935286.1 
fimbrial outer membrane usher protein 
SthC [Klebsiella oxytoca] 99% 2.00E-169 37% WP_004101585.1 
MULTISPECIES: fimbrial assembly protein 
[Serratia] 96% 2.00E-169 37% WP_025122548.1 
putative uncharacterized protein 
[Klebsiella variicola CAG:634] 97% 3.00E-169 38% WP_022064652.1 
fimbrial outer membrane usher protein 
SthC [Klebsiella oxytoca] 99% 5.00E-169 37% WP_016807753.1 
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fimbrial outer membrane usher protein 
SthC [Yersinia enterocolitica] 99% 1.00E-168 37% WP_005165265.1 
P pilus assembly protein, porin PapC 
[Serratia marcescens] 95% 4.00E-168 39% WP_015673631.1 
outer membrane usher protein SfmD 
[Salmonella enterica] 98% 4.00E-167 37% WP_023136615.1 
fimbrial outer membrane usher protein 
SthC [Salmonella enterica] 98% 7.00E-167 37% WP_000990588.1 
type 1 fimbriae anchoring protein FimD 
[Klebsiella pneumoniae] 97% 1.00E-165 37% WP_016531172.1 
fimbrial outer membrane usher protein 
SthC [Klebsiella pneumoniae] 99% 8.00E-165 36% WP_011977702.1 
fimbrial outer membrane usher protein 
StbC [Salmonella enterica] 98% 2.00E-164 36% WP_000300173.1 
type 1 fimbriae anchoring protein FimD 
[Serratia fonticola] 98% 4.00E-164 37% WP_021806158.1 
putative outer membrane usher protein 
psac [Klebsiella pneumoniae] 99% 1.00E-163 36% WP_023158088.1 
outer membrane usher protein LpfC 
[Klebsiella oxytoca] 94% 2.00E-162 36% WP_004132915.1 
fimbrial outer membrane usher protein 
SthC [Serratia plymuthica] 98% 3.00E-162 37% WP_006318902.1 
outer membrane usher protein LpfC 
[Enterobacter sp. BIDMC 29] 99% 4.00E-162 36% EUM12550.1 
Outer membrane usher protein LpfC 
[Klebsiella sp.] 99% 5.00E-162 36% CDQ17421.1 
Outer membrane usher protein LpfC 
precursor [Enterobacter sp. DC3] 99% 5.00E-162 36% EWG68909.1 
type 1 fimbriae anchoring protein FimD 
[Klebsiella pneumoniae IS39] 92% 2.00E-161 38% CDL61039.1 
outer membrane usher protein LpfC 
[Enterobacter sp. MGH 38] 99% 8.00E-161 36% WP_023324354.1 
hypothetical protein L465_04515 
[Enterobacter sp. BIDMC 29] 99% 8.00E-161 36% EUM07318.1 
outer membrane usher protein LpfC 
[Enterobacter sp. MGH 14] 99% 9.00E-161 36% WP_022650650.1 
type 1 fimbriae anchoring protein FimD 
[Enterobacter cloacae ISC8] 99% 1.00E-160 36% CDL32450.1 
fimbrial outer membrane usher protein 
SthC [Klebsiella pneumoniae] 99% 2.00E-160 36% WP_004177742.1 
putative outer membrane usher protein 
psac [Klebsiella pneumoniae] 99% 3.00E-159 35% WP_023157904.1 
fimbrial assembly protein [Enterobacter 
asburiae] 99% 1.00E-158 36% WP_024908720.1 
outer membrane usher protein LpfC 
[Enterobacter sp. MGH 24] 99% 1.00E-158 36% WP_023334990.1 
outer membrane usher protein [Klebsiella 
pneumoniae] 99% 1.00E-158 35% WP_023296915.1 
outer membrane usher protein LpfC 
[Enterobacter cloacae] 99% 2.00E-158 35% WP_023299644.1 
outer membrane usher protein FimD 
[Enterobacter hormaechei] 99% 8.00E-158 35% WP_017693768.1 
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type 1 fimbriae anchoring protein FimD 
[Cronobacter dublinensis] 99% 1.00E-157 37% WP_007756586.1 
fimbrial outer membrane usher protein 
SthC [Providencia rustigianii] 99% 3.00E-157 35% WP_006813805.1 
Outer membrane usher protein [Klebsiella 
pneumoniae BJ1-GA] 97% 5.00E-157 36% CDI26527.1 
fimbrial outer membrane usher protein 
SthC [Enterobacter cancerogenus] 98% 6.00E-157 36% WP_006174891.1 
chaperone-usher secretion system usher 
protein [Klebsiella sp. AS10] 99% 6.00E-157 36% EUB41790.1 
putative fimbrial outer membrane usher 
protein SthC [Salmonella enterica] 97% 8.00E-157 36% WP_001727856.1 
fimbrial outer membrane usher protein 
SthC [Klebsiella sp. OBRC7] 99% 1.00E-156 36% WP_009652085.1 
P pilus assembly protein, porin PapC 
[Enterobacter cloacae] 99% 1.00E-156 35% WP_015571070.1 
fimbrial outer membrane usher protein 
SthC [Salmonella enterica] 97% 1.00E-156 36% WP_001536549.1 
outer membrane usher protein LpfC 
[Enterobacter sp. MGH 33] 99% 1.00E-156 35% EUM54096.1 
putative outer membrane usher protein 
psac [Salmonella enterica] 97% 2.00E-156 36% WP_001751132.1 
putative fimbrial outer membrane usher 
protein SthC [Salmonella enterica] 97% 2.00E-156 36% WP_023197800.1 
outer membrane usher protein 
[Salmonella enterica] 97% 2.00E-156 36% WP_023138573.1 
fimbrial outer membrane usher protein 
SthC [Salmonella enterica] 97% 2.00E-156 36% WP_006495791.1 
Fimbriae usher protein StcC [Salmonella 
enterica subsp. enterica serovar Inverness 
str. R8-3668] 97% 3.00E-156 36% EHC63580.1 
fimbrial assembly protein [Salmonella 
enterica] 97% 3.00E-156 35% WP_024134916.1 
fimbrial outer membrane usher protein 
SthC [Salmonella enterica] 97% 3.00E-156 36% WP_001584422.1 
fimbrial outer membrane usher protein 
SthC [Klebsiella oxytoca] 99% 3.00E-156 36% WP_014838686.1 
fimbrial outer membrane usher protein 
SthC [Salmonella enterica] 97% 3.00E-156 36% WP_001160702.1 
Fimbriae usher protein StcC [Salmonella 
enterica subsp. enterica serovar 
Hvittingfoss str. A4-620] 97% 3.00E-156 36% EHC42566.1 
fimbrial outer membrane usher protein 
SthC [Salmonella enterica] 97% 4.00E-156 36% WP_001551945.1 
fimbrial outer membrane usher protein 
SthC [Salmonella enterica] 97% 4.00E-156 36% WP_001160708.1 
putative fimbrial outer membrane usher 
protein SthC [Salmonella enterica] 97% 4.00E-156 36% WP_023203387.1 
fimbrial outer membrane usher protein 
SthC [Klebsiella pneumoniae] 97% 4.00E-156 36% WP_022631368.1 
putative fimbrial outer membrane usher 
protein SthC [Salmonella enterica] 97% 4.00E-156 36% WP_023233222.1 
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Appendix 2: Multiple sequence alignment of all γ3 fimbrial. 
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Appendix 3: Impact on subunit polymerization using plasmid pFM1 and 
surface polymer using plasmid pFMA1. 
 
Caf1 residues 
removed 
Inserted 
amino acids 
sequence 
Level of 
protein 
recovery 
Polymerization 
(pFM1) 
αGP41 
mAb/αF1 
polymer 
Surface 
polymer 
(pFMA1) 
SDS_PA
GE 
Surface 
immuniflu
oroscence 
(x103) 
αGP41mA
b/ anti-F1 
policlonal 
D33N34 
F1::3 
(ELDKWA) 
+++ 1-8 subunits +++/++ VHMW 0.82±0.08 / 
109±1.5 
F1D11 (GG) 
++++ HMW 
(sim to WT) 
++ VHMW 
 
S76QDGNNH82 
F1::2 
(ELDKWA) 
+ Regular 
polymer,faint 
Nd/++ VHMW Nd / 
54.3±8.4 
F1D12 
(GGGG) 
++++ HMW (identical 
to WT) 
++ VHMW** 
 
D92SRDF96 
F1::1 
(ELDKWA) 
++ HMW (less than 
WT) 
+(faint)/ 
+++ 
VHMW, 
some in 
well 
0.92±0.27 / 
192±10.9 
F1D13 
(GGGG) 
++++ HMW (sim to 
WT) 
++ None** 
exported 
 
K129GGK132 
F1::4 
(ELDKWA) 
++ 1-8 subunits ++/++ Aggregate 
in well 
2.81±0.25 / 
52.1±0.7 
F1D14 
(DGGG) 
++++ HMW (possibly 
less, banding 
differently) 
++ VHMW 
 
None WT ++++ HMW -/++++ VHMW 
0.29±0.04 / 
269±23.9 
Available previous unpublished results from this laboratory, Elham Moslehi and Snezana Vasiljec. 
Plasmid pFM1 encodes chaperone and subunit only and results in high levels of periplasmic 
polymer. pFMA1 also encodes usher which leads to surface assembly of F1, but only at low levels. 
Table above shows that polymerisation of F1D11, F1D12 and F1D13 were similar to wildtype and 
F1D14 also polymerises but with a slightly shifted size. All of these four loop mutants produced 
high molecular weight polymer.  F1::1, also produces high molecular weight in the periplasm 
although less than WT F1; F1::2 has low level of polymer with regular faint polymer; F1::3 and 
F1::4 accumulate oligomers of around 1-8 subunits suggesting a problem with polymerisation. 
There was an indication of surface polymer in most constructs, but this plasmid produces lower 
levels. **For the surface polymer in pFMA1 (chaperone, subunit and usher), it has been concluded 
that the results of F1D13 and F1D12 must have been mixed up and should be the other way around.  
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Appendix 4: Caf1 sequence with G or ELDKWA insertion in FASTA format. 
Coloured in red and italic indicates replacement 
 
Loop mutation Sequence Description 
Caf1-D11 
(D33N34) 
>F1D11 
ADLTASTTATATLVEPARITLTYKEGAPITIMGGGNIDTELLVGTLTLGG
YKTGTTSTSVNFTDAAGDPMYLTFTSQDGNNHQFTTKVIGKDSRDFDISP
KVNGENLVGDDVVLATGSQDFFVRSIGSKGGKLAAGKYTDAVTVTVSNQ 
Replacement 
Caf1-D12 
(S76QDGNNH8
2) 
>F1D12 
ADLTASTTATATLVEPARITLTYKEGAPITIMDNGNIDTELLVGTLTLGG
YKTGTTSTSVNFTDAAGDPMYLTFTGGGGQFTTKVIGKDSRDFDISPKVN
GENLVGDDVVLATGSQDFFVRSIGSKGGKLAAGKYTDAVTVTVSNQ 
Reduction 
from 7 to 4 
amino acids 
Caf1-D13 
(D92SRDF96) 
>F1D13 
ADLTASTTATATLVEPARITLTYKEGAPITIMDNGNIDTELLVGTLTLGG
YKTGTTSTSVNFTDAAGDPMYLTFTSQDGNNHQFTTKVIGKGGGGDISPK
VNGENLVGDDVVLATGSQDFFVRSIGSKGGKLAAGKYTDAVTVTVSNQ 
Reduction 
from 5 to 4 
amino acids 
Caf1-D14 
(K129GGK132) 
>F1D14 
ADLTASTTATATLVEPARITLTYKEGAPITIMDNGNIDTELLVGTLTLGG
YKTGTTSTSVNFTDAAGDPMYLTFTSQDGNNHQFTTKVIGKDSRDFDISP
KVNGENLVGDDVVLATGSQDFFVRSIGSDGGGLAAGKYTDAVTVTVSNQ 
Replacement 
Caf1::3 
(D33N34) 
>F1::3 
ADLTASTTATATLVEPARITLTYKEGAPITIMELDKWAGNIDTELLVGTL
TLGGYKTGTTSTSVNFTDAAGDPMYLTFTSQDGNNHQFTTKVIGKDSRDF
DISPKVNGENLVGDDVVLATGSQDFFVRSIGSKGGKLAAGKYTDAVTVTV
SNQ 
Converted 
from 5 to 6 
amino acids 
Caf1::2 
(S76QDGNNH8
2) 
> F1::2 
ADLTASTTATATLVEPARITLTYKEGAPITIMDNGNIDTELLVGTLTLGG
YKTGTTSTSVNFTDAAGDPMYLTFTELDKWAQFTTKVIGKDSRDFDISPK
VNGENLVGDDVVLATGSQDFFVRSIGSKGGKLAAGKYTDAVTVTVSNQ 
Replacement 
Caf1::1 
(D92SRDF96) 
> F1::1 
ADLTASTTATATLVEPARITLTYKEGAPITIMDNGNIDTELLVGTLTLGG
YKTGTTSTSVNFTDAAGDPMYLTFTSQDGNNHQFTTKVIGKELDKWADIS
PKVNGENLVGDDVVLATGSQDFFVRSIGSKGGKLAAGKYTDAVTVTVSNQ 
Converted 
from 2 to 6 
amino acids 
Caf1::4 
(K129GGK132) 
>F1::4 
ADLTASTTATATLVEPARITLTYKEGAPITIMDNGNIDTELLVGTLTLGG
YKTGTTSTSVNFTDAAGDPMYLTFTSQDGNNHQFTTKVIGKDSRDFDISP
KVNGENLVGDDVVLATGSQDFFVRSIGSELDKWALAAGKYTDAVTVTVSN
Q 
Converted 
from 4 to 6 
amino acids 
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Appendix 5: Alignment of pACYC-F1D13 sequencing results. 
Alignment of pACYC-F1D13 constructs using DNAdynamo. Cyan box indicates residues 
in WT and red box indicates the changed residues in mutant. From the alignment, only 
F1D13-E (D13_5S) from Stellar confirmed with loop mutant.  
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Appendix 6: Alignment of pACYC-F1D11 sequencing results 
Alignment of pACYC-F1D11 constructs using DNAdynamo. Cyan box indicates residues 
in WT and red box indicates the changed residues in mutant. From the alignment, only 
F1D11-B, -D and -G from Stellar cells confirmed with loop mutant.  
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Appendix 7: Alignment of pACYC-F1D12 sequencing results. 
Alignment of pACYC-F1D12 constructs using DNAdynamo. Cyan box indicates residues 
in WT and red box indicates the changed residues in mutant. From the alignment, only 
F1D12-B and -C from Stellar cells confirmed with loop mutant.  
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Appendix 8: Alignment of pACYC-F1D14 sequencing results. 
Alignment of pACYC-F1D14 constructs using DNAdynamo. Cyan box indicates residues 
in WT and red box indicates the changed residues in mutant. From the alignment, only 
F1D14-B and -C from Stellar cells confirmed with loop mutant.  
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Appendix 9: Alignment of pACYC-F1::1 sequencing results. 
 
Alignment of pACYC-F1::1 constructs using DNAdynamo. Cyan box indicates residues in 
WT and red box indicates the changed residues in mutant. From the alignment, only F1::1-
C from Stellar cells confirmed with loop mutant. 
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Appendix 10: Alignment of pACYC-F1::2 sequencing results. 
Alignment of pACYC-F1::2 constructs using DNAdynamo. Cyan box indicates residues 
in WT and red box indicates the changed residues in mutant. From the alignment, only 
F1::2-A, -B and -C from Stellar cells confirmed with loop mutant. 
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Appendix 11: Alignment of pACYC-F1::3 sequencing results. 
Alignment of pACYC-F1::3 constructs using DNAdynamo. Cyan box indicates residues 
in WT and red box indicates the changed residues in mutant. From the alignment, only 
F1::3-E, -G and -J from Stellar cells confirmed with loop mutant. 
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Appendix 12: Alignment of pACYC-F1::4 sequencing results. 
Alignment of pACYC-F1::4 constructs using DNAdynamo. Cyan box indicates residues 
in WT and red box indicates the changed residues in mutant. From the alignment, only 
F1::4-B from Stellar cells confirmed with loop mutant. 
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Appendix 13: Whole operon sequencing of pACYC-F1D12, F1::2, F1::3 and F1::4 
constructs 
Assembly of pACYC-F1D12, F1::2, F1::3 and F1::4 constructs in strategy view from 
DNAstar programme. From the assembly, all constructs were confirmed to have loop 
mutation and do not have any additional spontaneous mutation. In table are primers used 
for whole operon sequencing. 
A. pACYC-F1D12 
 
B. pACYC-F1::2 
 
C. pACYC-F1::3 
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D. pACYC-F1::4 
 
 
E. Sequencing primers of whole caf operon 
Primer Sequence 5’-3’ Priming site Direction 
DuetDOWN1 
GAT TAT GCG GCC GTG 
TAC AA 
Primes towards end of Caf1 Reverse 
DuetUP1 
GTC CGG GAT CTC GAC 
GCT CTC CCT TAT G 
Primes towards beginning of 
Caf1R 
Forward 
F1#1 
ATG TTG GGT CGA ACA 
TAA ATC G 
Primes towards beginning of 
Caf1R 
Forward 
F1#4 
CAC AAA CAT CGT ATG 
TTG GCG CTC 
Primes from middle of Caf1A Forward 
F1#6 
CCT TCT GCT GAA TCC 
TGA ATA C 
Primes from end of Caf1R 
towards intergenic promoter 
region 
Forward 
F1-7for 
TCA GAG GAT CCT TTC 
GTG GTC AC 
Primes from middle of Caf1M 
towards  
Forward 
F1rev2 
GAT TGG TGT TGC TGG 
GTA TG 
Primes from start of intergenic 
promoter region towards 
Caf1R 
Reverse 
Caf1Arev-1 
CTA CGA AAG CGC CAA 
GCC CCT ATG 
Primes from quarter of Caf1A 
towards Caf1M 
Reverse 
Caf1Afor-3b 
GAG GAA CTT ATG GGG 
AGA TCA GTG 
Primes from end of Caf1A 
towards Caf1 
Forward 
Caf1Afor-4 
AAA TCT GGT ACA GAG 
CAA TGT G 
Primes from start of Caf1A Forward 
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Appendix 14: Model of protein in this study attached in a CD 
 
Name of Protein Model Name of file in CD Figure in thesis 
Caf12:Caf1M complex (PDB: 
1Z9S) showing surface loops 
tested for epitope replacement 
in previous study 
Epitope labeled.pse Figure 5.3 
Translocon of WT (Caf1A 
model based on FimD 
accommodate FimH) 
Wildtype translocon.pse Figure 4.6 
Translocon of Caf1-F1D11  Translocon_F1D11.pse Figure 5.14 
(F1D11) (A) 
Translocon of Caf1-F1::3 Translocon_F1ins3.pse Figure 5.14 
(F1::3) (B) 
Translocon of Caf1-F1D12 Translocon_F1D12.pse Figure 5.14 
(F1D12) (A) 
Translocon of Caf1-F1::2 Translocon_F1ins2.pse Figure 5.14 
(F1::2) (B) 
Translocon of Caf1-F1D13 Translocon_F1D13.pse Figure 5.14 
(F1D13)v(A) 
Translocon of Caf1-F1::1 Translocon_F1ins1.pse Figure 5.14 
(F1::1) (B) 
Translocon of Caf1-F1D14 Translocon_F1D14.pse Figure 5.14 
(F1D14) (A) 
Translocon of Caf1-F1::4 Translocon_F1::4.pse Figure 5.14 
(F1::4) (B) 
Caf1A barrel, residues facing 
in labelled 
Caf1A_barrel_residues_facing_in.pse Figure 4.10 (B) 
FimD barrel, residues facing in 
labelled 
Fim_barrel_residues_facing_in.pse Figure 4.10 (B) 
E.Coli SE11 barrel, residues 
facing in labelled 
SE11_barrel_residues_facing_in.pse Figure 4.10 (B) 
Closed Caf1A model and 
interactions labelled 
Closed CAf1A labelled.pse Figure 4.8 (C) 
Superpose of closed PapC and 
closed Caf1A model 
PapC_CAf1A_superpose_interactions.ps
e 
Figure 4.12 and 
Figure 4.13 
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Appendix 15: SDS-PAGE of F1 from cells carrying polyhistidine insertion 
at loop 5 
 
 
SDS-PAGE of surface F1 containing polyhistidine inserted at loop 5. (A)Showing 
heated and unheated triplicate sample of pACYCF1_DS6his. (B) Showing heated and 
unheataed samples of pACYCF1_DS6his_Q169A and pACYCF1_DS4his. F1 was 
extracted at 65°C for 1 hour and run on SDS-PAGE showing unheated sample with 
high molecular weight polymer in stacking gel and monomer of Caf1 in separating gel. 
The heated sample was mixed with SDS loading dye and heated at>95˚C for 15 minutes 
to denature all F1 fibre to Caf1 monomer. 3 OD cells after 4 hour thermoinduction were 
recovered, extracted and resuspend in 100µl PBS. 
  
A 
B 
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